syndrome	score	normalized_score
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	1.49474654	100.0
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.1	73.5910718348276
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	1.0951250099999998	73.26493025366025
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	1.03916258	69.52098915713162
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	1.01726602	68.05608795722652
TRICARBOXYLIC ACID CYCLE, DEFECT OF	1.0172414	68.0544408552369
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	1.0126582	67.74782030938837
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	1.00775862	67.42003363326066
SENGERS SYNDROME	1.00684932	67.35920057724302
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	1.00378788	67.15438725819027
OCULOSKELETODENTAL SYNDROME; OCSKD	1.0021768739999999	67.0466093870336
EHLERS-DANLOS SYNDROME, TYPE I	1.00163132	67.01011129284835
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	66.90097439529782
CARIBBEAN PARKINSONISM	1.0	66.90097439529782
PITUITARY DERMOID AND EPIDERMOID CYSTS	1.0	66.90097439529782
CHILDHOOD-ONSET BENIGN CHOREA WITH STRIATAL INVOLVEMENT	1.0	66.90097439529782
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.933333	62.440887135286495
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.6940648140000001	46.433612350091146
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.667968984	44.6877758954371
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.658151304	44.03096353713587
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.646756484	43.268638976076836
HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA,AND PALLIDAL DEGENERATION	0.583333	39.02554609693226
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.5588235	37.38583666499071
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.5588235	37.38583666499071
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.5169492	34.58440519286969
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.514244154	34.403434979685585
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.512593754	34.29302161154359
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.5104167	34.147374577632405
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.50775862	33.96954643561176
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.504855894	33.77535123780919
BARTH SYNDROME; BTHS	0.50344828	33.68118048963672
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.501301984	33.537591195896
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.50075643	33.501093101710744
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.500545554	33.48698529183416
NOONAN SYNDROME 7; NS7	0.5	33.45048719764891
RENAL TUBULAR ACIDOSIS III	0.5	33.45048719764891
BRANCHIOOTORENAL SYNDROME 1	0.5	33.45048719764891
GLYCINE ENCEPHALOPATHY	0.5	33.45048719764891
179830 RENAL TUBULAR ACIDOSIS, PROXIMAL;;RENAL TUBULAR ACIDOSIS II;;RTA, PROXIMAL TYPE;;RTA, RATE TYPE	0.47878750000000003	32.031350278288656
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.42328116000000005	28.31792204717196
RFT1-CDG	0.41796828399999997	27.962485465930563
COASY PROTEIN-ASSOCIATED NEURODEGENERATION	0.416667	27.875428298365556
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.405921894	27.156570236984795
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.40551519999999996	27.129362012104068
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.40463253	27.070310529034575
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.393402554	26.319014192198768
PLACENTAL INSUFFICIENCY	0.3768113	25.209043133158886
GLUTATHIONE SYNTHETASE DEFICIENCY	0.3505744	23.453768958046894
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.34999969999999997	23.415320968061913
ACUTE ADRENAL INSUFFICIENCY	0.3470316	23.216752185959233
DILATED CARDIOMYOPATHY WITH ATAXIA	0.34449266	23.046894626028035
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.338422864	22.640819359247356
CANAVAN DISEASE	0.33764334	22.588668444082835
ACITRETIN/ETRETINATE EMBRYOPATHY	0.33572074999999996	22.46004529972018
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.333878554	22.33680059229306
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.333878554	22.33680059229306
EPIDERMAL NEVUS SYNDROME	0.333878554	22.33680059229306
PALLIDAL DEGENERATION, PROGRESSIVE, WITH RETINITIS PIGMENTOSA	0.333333	22.300302498107808
NEUROMYELITIS OPTICA	0.333333	22.300302498107808
ENCEPHALITIS LETHARGICA	0.333333	22.300302498107808
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.333333	22.300302498107808
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.333333	22.300302498107808
PSEUDOHYPOALDOSTERONISM, TYPE II	0.333333	22.300302498107808
MYOCLONUS AND ATAXIA	0.333333	22.300302498107808
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.333333	22.300302498107808
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.333333	22.300302498107808
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.333333	22.300302498107808
ADDISON DISEASE	0.333333	22.300302498107808
SPINOCEREBELLAR ATAXIA TYPE 42	0.333333	22.300302498107808
CYSTINOSIS, NEPHROPATHIC; CTNS	0.333333	22.300302498107808
GLUTATHIONE SYNTHETASE DEFICIENCY	0.333333	22.300302498107808
MACHADO-JOSEPH DISEASE TYPE 1	0.325	21.74281667847179
MACHADO-JOSEPH DISEASE TYPE 3	0.325	21.74281667847179
MACHADO-JOSEPH DISEASE TYPE 2	0.325	21.74281667847179
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.323961124	21.6733148617959
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.32152769999999997	21.510516425078997
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.310069554	20.743955292915413
HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE	0.30000000000000004	20.07029231858935
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.28834590000000004	19.29062167288911
AL KAISSI SYNDROME; ALKAS	0.287428394	19.229239627475568
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.27446538	18.362001359775686
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.263203754	17.608587607100265
HSD10 DISEASE	0.25906060399999997	17.331406835034386
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.2588235	17.315544346401364
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.255625154	17.10157188254806
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.25399383400000003	16.992434984997526
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.25282636	16.91432983681635
INFANTILE MYOFIBROMATOSIS	0.2522581	16.876312689106477
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.252176874	16.870878590560242
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.251301984	16.81234759707154
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.251301984	16.81234759707154
MOWAT-WILSON SYNDROME; MOWS	0.25075643	16.775849502886288
SECKEL SYNDROME 1; SCKL1	0.25075643	16.775849502886288
BIOTINIDASE DEFICIENCY	0.250545554	16.761741693009707
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.250545554	16.761741693009707
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.250545554	16.761741693009707
INHERITED CREUTZFELDT-JAKOB DISEASE	0.2500003	16.725263669116774
LACTIC ACIDOSIS, CHRONIC ADULT FORM	0.25	16.725243598824456
DYSTONIA 6, TORSION	0.25	16.725243598824456
HYPERPARATHYROIDISM 2	0.25	16.725243598824456
CONGENITAL FACTOR II DEFICIENCY	0.25	16.725243598824456
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	16.725243598824456
SPINOCEREBELLAR ATAXIA TYPE 2	0.25	16.725243598824456
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.25	16.725243598824456
HEMOPHILIA B	0.25	16.725243598824456
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.25	16.725243598824456
SEVERE HEMOPHILIA A	0.25	16.725243598824456
POSTENCEPHALITIC PARKINSONISM	0.25	16.725243598824456
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.24361343	16.297975842780676
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.24281650000000002	16.244660449255832
HYDRANENCEPHALY	0.23502835400000002	15.72362589312299
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.230303	15.407495106160274
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.22272730000000002	14.900673394433817
JUVENILE HYALINE FIBROMATOSIS	0.22	14.71821436696552
6P22 MICRODELETION SYNDROME	0.21858052	14.623249771830881
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6	0.21389157	14.309554447940052
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.21369860000000002	14.29664456691099
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.21357487400000003	14.28836717695296
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.21265820000000002	14.227040793150122
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.21265820000000002	14.227040793150122
TRICHOTHIODYSTROPHY	0.209829854	14.03782168982308
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.20903873	13.984894723355573
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.20740741000000001	13.875757825805039
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.207394874	13.874919155190016
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.20684932	13.838421061004766
AICARDI-GOUTIÈRES SYNDROME	0.205612324	13.75566482328168
RHEUMATIC FEVER	0.20344828	13.61088817104738
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.202176874	13.525829870795352
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.20075643	13.430800783121398
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.20054555400000001	13.416692973244817
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2	13.380194879059564
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.2	13.380194879059564
SHOX-RELATED SHORT STATURE	0.2	13.380194879059564
ROMANO-WARD SYNDROME	0.2	13.380194879059564
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.2	13.380194879059564
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.2	13.380194879059564
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.2	13.380194879059564
BETA-THALASSEMIA	0.2	13.380194879059564
BENIGN SCHWANNOMA	0.2	13.380194879059564
STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 2	0.2	13.380194879059564
MEDULLARY SPONGE KIDNEY	0.2	13.380194879059564
MALARIA	0.2	13.380194879059564
SYDENHAM CHOREA	0.2	13.380194879059564
ALPHA-METHYLACETOACETIC ACIDURIA	0.2	13.380194879059564
POLYARTERITIS NODOSA	0.2	13.380194879059564
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.19191897400000002	12.83956636554583
HUNTINGTON DISEASE-LIKE 1	0.1910572	12.781912845237295
ETHYLMALONIC ENCEPHALOPATHY	0.18827569	12.595827115947028
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.18523407	12.392339774206803
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.180390374	12.068291792132197
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.1785713	11.946593969035044
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.178565144	11.946182126636668
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.1773398	11.864205419067234
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.1773398	11.864205419067234
MUCOLIPIDOSIS TYPE II	0.17570573	11.754884543837111
HUNTINGTON DISEASE-LIKE 2	0.17338278	11.599476925365554
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.170480054	11.405281727562988
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.17011528	11.38087799152892
CEREBROOCULONASAL SYNDROME	0.16829832	11.259321597091638
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.167212554	11.186682793726355
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	11.150184699541102
GRANULOMATOSIS WITH POLYANGIITIS	0.166667	11.150184699541102
PFAPA SYNDROME	0.166667	11.150184699541102
CUTANEOUS SMALL VESSEL VASCULITIS	0.166667	11.150184699541102
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.166667	11.150184699541102
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.166667	11.150184699541102
DERMATOLEUKODYSTROPHY	0.166667	11.150184699541102
PEMPHIGUS VULGARIS	0.166667	11.150184699541102
PITYRIASIS RUBRA PILARIS	0.166667	11.150184699541102
PITUITARY APOPLEXY	0.166667	11.150184699541102
DE BARSY SYNDROME	0.15873247399999998	10.619357178776276
WRINKLY SKIN SYNDROME	0.15873247399999998	10.619357178776276
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.15276695999999998	10.220258479407484
EHLERS-DANLOS SYNDROME, TYPE VI	0.14827619999999997	9.919822259632056
MANGANESE POISONING	0.14630527999999998	9.787965791176877
GITELMAN SYNDROME	0.14545450000000001	9.731047780180848
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.14486227999999998	9.691427685124463
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.144158984	9.644376497436147
PHACE SYNDROME	0.144158984	9.644376497436147
XQ12-Q13.3 DUPLICATION SYNDROME	0.14405445	9.637383070978709
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.14361343	9.607878403250893
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.143402554	9.593770593374312
CONGENITAL FACTOR XIII DEFICIENCY	0.14285699999999998	9.55727249918906
HEREDITARY THROMBOPHILIA DUE TO CONGENITAL ANTITHROMBIN DEFICIENCY	0.14285699999999998	9.55727249918906
GANGLIONEUROMA	0.14285699999999998	9.55727249918906
164700 OLIVOPONTOCEREBELLAR ATROPHY V; OPCA V;;OPCA WITH DEMENTIA AND EXTRAPYRAMIDAL SIGNS	0.14285699999999998	9.55727249918906
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.14285699999999998	9.55727249918906
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.14285699999999998	9.55727249918906
JUVENILE HUNTINGTON DISEASE	0.14285699999999998	9.55727249918906
RESTRICTIVE DERMOPATHY, LETHAL	0.14285699999999998	9.55727249918906
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.13837934999999998	9.257713351187954
COFFIN-SIRIS SYNDROME 1; CSS1	0.134635184	9.00722499749021
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.13351995	8.932614756211445
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.13311061400000002	8.905229778956372
DERMATOMYOSITIS	0.1324787	8.862954116622342
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.1324787	8.862954116622342
NEUROFIBROMATOSIS TYPE 1	0.1324787	8.862954116622342
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.13000834	8.697684625515173
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.12897576	8.628604017374075
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.1266234	8.471228841245553
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	0.1266234	8.471228841245553
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.1266234	8.471228841245553
PULMONARY ARTERIOVENOUS MALFORMATION	0.1266234	8.471228841245553
PARKINSON DISEASE, LATE-ONSET; PD	0.125	8.362621799412228
DEMENTIA/PARKINSONISM WITH NON-ALZHEIMER AMYLOID PLAQUES	0.125	8.362621799412228
PARKINSON DISEASE 8, AUTOSOMAL DOMINANT; PARK8	0.125	8.362621799412228
PARKINSONIAN-PYRAMIDAL SYNDROME	0.125	8.362621799412228
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.1243902	8.321825585225975
OCULOCEREBRORENAL SYNDROME OF LOWE	0.12351602	8.263342091429093
PSEUDOHYPOALDOSTERONISM, TYPE IIC	0.12152769999999999	8.130321546019434
PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E	0.12152769999999999	8.130321546019434
GALACTOSEMIA	0.12152769999999999	8.130321546019434
HEREDITARY METHEMOGLOBINEMIA	0.11927484	7.979603016843244
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.11887508999999999	7.952859352328723
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.11851840999999999	7.928997112781408
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.11840265400000001	7.921252923589307
RABSON-MENDENHALL SYNDROME	0.11840265400000001	7.921252923589307
CHILDHOOD APRAXIA OF SPEECH	0.11800754999999999	7.894820081001826
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.11796991400000001	7.892302195929486
ACQUIRED HYPERTRICHOSIS LANUGINOSA	0.1169231	7.822269319318846
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.11596689399999999	7.758298206196216
PYRUVATE CARBOXYLASE DEFICIENCY	0.11443712400000002	7.655955102595523
OKAMOTO SYNDROME	0.112412984	7.520538164283022
PETERS-PLUS SYNDROME; PTRPLS	0.112412984	7.520538164283022
CHROMOSOME 16P13.3 DELETION SYNDROME	0.112412984	7.520538164283022
WARBURG MICRO SYNDROME 1	0.11186742999999999	7.4840400700977705
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.11186742999999999	7.4840400700977705
SPEECH-LANGUAGE DISORDER 1	0.11111110000000002	7.433440856133376
NEPHROPATHIC INFANTILE CYSTINOSIS	0.11111099999999999	7.433434166035935
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.11111099999999999	7.433434166035935
PORPHYRIA CUTANEA TARDA	0.11111099999999999	7.433434166035935
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.11111099999999999	7.433434166035935
HUNTINGTON DISEASE-LIKE 3	0.11111099999999999	7.433434166035935
MOHR-TRANEBJAERG SYNDROME	0.11111099999999999	7.433434166035935
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.11111099999999999	7.433434166035935
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.11111099999999999	7.433434166035935
ZIMMERMANN-LABAND SYNDROME	0.11111099999999999	7.433434166035935
FACIAL HYPERTRICHOSIS	0.11111099999999999	7.433434166035935
ENTERIC ANENDOCRINOSIS	0.11111099999999999	7.433434166035935
ADULT ACUTE RESPIRATORY DISTRESS SYNDROME	0.1104167	7.386984819513281
FAMILIAL HYPOALDOSTERONISM	0.1104167	7.386984819513281
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.10758780400000001	7.19772892065032
WERNER SYNDROME	0.1023018	6.844090102392878
MELAS	0.10229164000000002	6.843410388493024
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.10130198400000001	6.77720143777687
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.10130198400000001	6.77720143777687
SAY SYNDROME	0.10075643000000001	6.740703343591617
PALLISTER-HALL SYNDROME	0.10054555400000001	6.726595533715035
NARP SYNDROME	0.10054555400000001	6.726595533715035
LOWE OCULOCEREBRORENAL SYNDROME	0.1	6.690097439529782
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.1	6.690097439529782
X-LINKED ACROGIGANTISM	0.1	6.690097439529782
INSULIN-RESISTANCE SYNDROME TYPE B	0.1	6.690097439529782
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.1	6.690097439529782
HUNTINGTON DISEASE-LIKE 1	0.09599150000000001	6.421924883666231
SALT-AND-PEPPER SYNDROME	0.095675344	6.40077373920531
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.09503851400000002	6.358169191681154
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.0945378	6.324670937187786
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.09330630000000001	6.242282387219977
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.09157110000000002	6.126195816449257
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.09152052399999999	6.122812232768238
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.09142860000000001	6.116662427597927
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.0910816	6.093447789482758
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.09092110400000002	6.0827104506962115
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.0909091	6.081907371399569
ARTERIAL TORTUOSITY SYNDROME	0.0909091	6.081907371399569
MALIGNANT ATROPHIC PAPULOSIS	0.0909091	6.081907371399569
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.0909091	6.081907371399569
HISTIOCYTOID CARDIOMYOPATHY	0.09037555000000001	6.046212356510958
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.09037555000000001	6.046212356510958
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.09037555000000001	6.046212356510958
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.08818919400000001	5.899943009735953
ADNP SYNDROME	0.08639897999999999	5.780175948759847
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.08551017400000002	5.720713961311462
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.08463528400000002	5.66218296782276
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.08463528400000002	5.66218296782276
BETA-KETOTHIOLASE DEFICIENCY	0.08393272	5.615180751647701
PETTIGREW SYNDROME	0.08387885400000002	5.611577063760925
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.08387885400000002	5.611577063760925
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.08355690999999998	5.590038696460202
KEARNS-SAYRE SYNDROME; KSS	0.08355618000000001	5.589989858748896
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.08334469000000001	5.575840971674035
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.08334469000000001	5.575840971674035
DPM3-CDG	0.08333330000000001	5.575078969575673
STORMORKEN SYNDROME; STRMK	0.08333330000000001	5.575078969575673
RAVINE SYNDROME	0.08333330000000001	5.575078969575673
PERIPARTUM CARDIOMYOPATHY	0.08333330000000001	5.575078969575673
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.08333330000000001	5.575078969575673
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.08224530000000002	5.502290709433589
FAMILIAL THROMBOCYTOSIS	0.0791926	5.2980621048970615
PEDIATRIC-ONSET GRAVES DISEASE	0.07822508400000001	5.233334341754022
TRISOMY 8P	0.07767953000000001	5.196836247568769
GLYCEROL KINASE DEFICIENCY; GKD	0.077628954	5.1934526638877525
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.077628954	5.1934526638877525
N SYNDROME	0.07746865400000001	5.1827284376921865
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.07692310000000001	5.146230343506934
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.07692310000000001	5.146230343506934
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.07692310000000001	5.146230343506934
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	5.146230343506934
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.07692310000000001	5.146230343506934
PAPILLARY TUMOR OF THE PINEAL REGION	0.07692310000000001	5.146230343506934
PINEOCYTOMA	0.07692310000000001	5.146230343506934
TRICHOHEPATOENTERIC SYNDROME 1	0.07692310000000001	5.146230343506934
BECKWITH-WIEDEMANN SYNDROME	0.07692310000000001	5.146230343506934
DERMOODONTODYSPLASIA	0.07692310000000001	5.146230343506934
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	5.146230343506934
CLASSIC MYCOSIS FUNGOIDES	0.07692310000000001	5.146230343506934
TUBEROUS SCLEROSIS COMPLEX	0.07692310000000001	5.146230343506934
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.07692310000000001	5.146230343506934
CONGENITAL ENTEROVIRUS INFECTION	0.07692310000000001	5.146230343506934
DDOST-CDG	0.07692310000000001	5.146230343506934
17Q23.1Q23.2 MICRODELETION SYNDROME	0.07631254999999999	5.105383953589883
GAPO SYNDROME	0.0757727	5.069267462562583
CONGENITAL ANALBUMINEMIA	0.07573640000000001	5.066838957192034
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.074254504	4.967698670839539
LYSOSOMAL ACID LIPASE DEFICIENCY	0.07306765400000001	4.888297249378481
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.07273058400000001	4.8657469379390585
WOLCOTT-RALLISON SYNDROME	0.07250273	4.850503283319191
3MC SYNDROME 1	0.07218503000000001	4.829248843753805
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.07218503000000001	4.829248843753805
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.07197415400000001	4.8151410338772225
3MC SYNDROME 2	0.07197415400000001	4.8151410338772225
3MC SYNDROME 3	0.07142860000000001	4.77864293969197
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.07142860000000001	4.77864293969197
3MC SYNDROME	0.07142860000000001	4.77864293969197
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.07142860000000001	4.77864293969197
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.07142860000000001	4.77864293969197
SIX2-RELATED FRONTONASAL DYSPLASIA	0.07142860000000001	4.77864293969197
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.07053025400000001	4.718542716947852
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.07036015000000001	4.707162593599314
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.07019710000000001	4.696254389724161
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.069686784	4.662113752074649
YOU-HOOVER-FONG SYNDROME; YHFS	0.069274384	4.634523790234028
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.067968684	4.5471711879660885
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.06727	4.500428547571684
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.067212254	4.496565283904253
XP21 MICRODELETION SYNDROME	0.067212254	4.496565283904253
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.067212254	4.496565283904253
DIABETES MELLITUS, KETOSIS-PRONE; KPD	0.0666667	4.460067189719
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	0.0666667	4.460067189719
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.06623091	4.430912414087274
X-LINKED ADRENOLEUKODYSTROPHY	0.06605966	4.41945562222208
YUNIS-VARON SYNDROME	0.064147104	4.2915037622365055
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.062686764	4.193805593288078
VON HIPPEL-LINDAU DISEASE	0.06227178	4.166042759329618
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0611888	4.093590342078999
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.06115947	4.091628136499985
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.061000373999999996	4.08098445907759
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.060792330000000006	4.067066112760496
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0607197	4.062207094990165
VICI SYNDROME; VICIS	0.060125484	4.022453465588889
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.060125484	4.022453465588889
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.060125484	4.022453465588889
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.059891624	4.006808003716804
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.05957993	3.9859553714036364
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.05957993	3.9859553714036364
15Q OVERGROWTH SYNDROME	0.05952815	3.9824912389494473
BILATERAL POLYMICROGYRIA	0.059369054	3.971847561527053
ALAGILLE SYNDROME 1; ALGS1	0.0591531	3.9574000285024913
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	0.0588235	3.9353494673418012
ATYPICAL WERNER SYNDROME	0.0588235	3.9353494673418012
BUTYRYLCHOLINESTERASE	0.0588235	3.9353494673418012
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 4	0.0588235	3.9353494673418012
SPINOCEREBELLAR ATAXIA TYPE 40	0.0588235	3.9353494673418012
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.0588235	3.9353494673418012
3M SYNDROME	0.0588235	3.9353494673418012
CEREBRAL ARTERIOVENOUS MALFORMATION	0.0588235	3.9353494673418012
GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1	0.0588235	3.9353494673418012
ACQUIRED METHEMOGLOBINEMIA	0.0588235	3.9353494673418012
LYMPHEDEMA AND CEREBRAL ARTERIOVENOUS ANOMALY	0.0588235	3.9353494673418012
TIGLIC ACIDEMIA	0.0588235	3.9353494673418012
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.0588235	3.9353494673418012
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.0588235	3.9353494673418012
LYMPHEDEMA-CEREBRAL ARTERIOVENOUS ANOMALY SYNDROME	0.0588235	3.9353494673418012
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.0588235	3.9353494673418012
SEVERE HEREDITARY THROMBOPHILIA DUE TO CONGENITAL PROTEIN S DEFICIENCY	0.0588235	3.9353494673418012
SEVERE HEREDITARY THROMBOPHILIA DUE TO CONGENITAL PROTEIN C DEFICIENCY	0.0588235	3.9353494673418012
MULTIFOCAL MOTOR NEUROPATHY	0.0588235	3.9353494673418012
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.0588235	3.9353494673418012
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.0588235	3.9353494673418012
VEIN OF GALEN ANEURYSMAL MALFORMATION	0.0588235	3.9353494673418012
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.0588235	3.9353494673418012
PSEUDOXANTHOMA ELASTICUM	0.0588235	3.9353494673418012
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.0588235	3.9353494673418012
MOYAMOYA DISEASE	0.0588235	3.9353494673418012
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.0588235	3.9353494673418012
NOCARDIOSIS	0.0588235	3.9353494673418012
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.05863524	3.9227546899021424
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.05824875000000001	3.8968981323081042
JUVENILE POLYPOSIS SYNDROME	0.0579365	3.8760083030531725
H SYNDROME	0.0578571	3.8706963656861855
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.05776971000000001	3.864849889533781
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0573294	3.8353927214977865
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.057173184	3.824941718881651
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.057173184	3.824941718881651
BÖÖK SYNDROME	0.0566667	3.7910574457660227
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.0566483	3.789826467837149
HYDROXYKYNURENINURIA	0.056416754	3.7743358148198154
RHIZOMELIC SYNDROME, URBACH TYPE	0.056312030000000006	3.7673296771772424
NIJMEGEN BREAKAGE SYNDROME	0.056312030000000006	3.7673296771772424
DISTAL TRISOMY 6P	0.056101154	3.753221867300659
BLEPHARO-CHEILO-ODONTIC SYNDROME	0.055555600000000004	3.7167237731154072
BAMFORTH-LAZARUS SYNDROME	0.055555600000000004	3.7167237731154072
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.055555600000000004	3.7167237731154072
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.055555600000000004	3.7167237731154072
TRICHO-DENTO-OSSEOUS SYNDROME	0.055555600000000004	3.7167237731154072
NOONAN SYNDROME	0.055555600000000004	3.7167237731154072
APLASIA CUTIS CONGENITA-INTESTINAL LYMPHANGIECTASIA SYNDROME	0.055555600000000004	3.7167237731154072
ELLIS VAN CREVELD SYNDROME	0.055555600000000004	3.7167237731154072
PACHYDERMOPERIOSTOSIS	0.055555600000000004	3.7167237731154072
STEINERT MYOTONIC DYSTROPHY	0.055555600000000004	3.7167237731154072
ARGININOSUCCINIC ACIDURIA	0.055555600000000004	3.7167237731154072
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.055555600000000004	3.7167237731154072
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.05536529999999999	3.7039925176879818
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.05520687999999999	3.6933940653242785
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.05501935	3.6808481255959293
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.05501935	3.6808481255959293
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.05445044999999999	3.6427881612624433
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.054084214	3.6182866160038074
EMANUEL SYNDROME	0.053933584	3.608209322230644
MECKEL SYNDROME, TYPE 1; MKS1	0.05338803	3.571711228045392
MEIER-GORLIN SYNDROME 1; MGORS1	0.05338803	3.571711228045392
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.053137430000000006	3.5549458438619306
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0526316	3.521105323983557
KNIEST-LIKE DYSPLASIA, LETHAL	0.0526316	3.521105323983557
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0526316	3.521105323983557
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.0526316	3.521105323983557
LETHAL KNIEST-LIKE DYSPLASIA	0.0526316	3.521105323983557
SEVERE CONGENITAL NEMALINE MYOPATHY	0.0526316	3.521105323983557
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.0526316	3.521105323983557
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.0526316	3.521105323983557
CORNELIA DE LANGE SYNDROME 3	0.052452894	3.509149718453271
PSEUDOXANTHOMA ELASTICUM; PXE	0.0521601	3.4895615145561734
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.05190734	3.472651624268018
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.051386894	3.437833279747883
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.050907854	3.4057850369735596
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.050362300000000006	3.3692869427883076
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.050310394	3.3658143808113454
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.04996373	3.3426222214235732
AICARDI SYNDROME	0.04983053999999999	3.333711680643863
ERYTHERMALGIA, PRIMARY	0.0494995	3.3115647820800445
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.0494129	3.3057711576974116
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.049064484000000005	3.2824617878025
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.048739529999999996	3.2607220485688497
AMISH INFANTILE EPILEPSY SYNDROME	0.04763039000000001	3.1865195018280494
MYOCLONUS, FAMILIAL CORTICAL; FCM	0.047141	3.1537788339687345
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O	0.047141	3.1537788339687345
MESOMELIA-SYNOSTOSES SYNDROME	0.04689655	3.137424890777804
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.04689655	3.137424890777804
WARBURG MICRO SYNDROME 3; WARBM3	0.046572	3.1157121795378098
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.04650225399999999	3.111046104177635
TRISOMY 20P	0.046419	3.1054763304553297
VICI SYNDROME	0.046000054	3.077448434836317
HAMAMY SYNDROME; HMMS	0.04597704	3.075908775811583
COG1-CDG	0.045956699999999996	3.074548009992383
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.04550946	3.0446272182038303
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.0454545	3.0409503406510647
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.0454545	3.0409503406510647
OSTEOPETROSIS AND RELATED DISORDERS	0.0454545	3.0409503406510647
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.0454545	3.0409503406510647
RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS	0.0454545	3.0409503406510647
RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT	0.0454545	3.0409503406510647
ALAGILLE SYNDROME 2	0.0454545	3.0409503406510647
VASCULAR EHLERS-DANLOS SYNDROME	0.044787724	2.9963423765476658
SCHWARTZ-JAMPEL SYNDROME	0.04420471	2.9573381718615654
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.044023854	2.9452387292363293
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.044023854	2.9452387292363293
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.04387814000000001	2.9354903206532934
VIRAL HEMORRHAGIC FEVER	0.043478300000000004	2.9087406350510774
KEUTEL SYNDROME; KTLS	0.043478300000000004	2.9087406350510774
PLACENTAL SITE TROPHOBLASTIC TUMOR	0.043478300000000004	2.9087406350510774
PRIMARY CILIARY DYSKINESIA	0.043478300000000004	2.9087406350510774
HYDATIDIFORM MOLE	0.043478300000000004	2.9087406350510774
HAND-FOOT-GENITAL SYNDROME	0.043478300000000004	2.9087406350510774
GESTATIONAL CHORIOCARCINOMA	0.043478300000000004	2.9087406350510774
YELLOW FEVER	0.043478300000000004	2.9087406350510774
FAMILIAL AFIBRINOGENEMIA	0.043478300000000004	2.9087406350510774
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.043478300000000004	2.9087406350510774
LASSA FEVER	0.043478300000000004	2.9087406350510774
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.043478300000000004	2.9087406350510774
ASHERMAN SYNDROME	0.043478300000000004	2.9087406350510774
GESTATIONAL TROPHOBLASTIC NEOPLASM	0.043478300000000004	2.9087406350510774
49,XXXYY SYNDROME	0.04329801999999999	2.896679727387092
HYDROXYKYNURENINURIA	0.043220353999999996	2.891483796309707
PIERPONT SYNDROME	0.043192193999999996	2.889599864870736
LISSENCEPHALY, X-LINKED, 2	0.04312171000000001	2.8848844165914582
PRIMARY HYPEROXALURIA TYPE 1	0.0429832	2.875617962627965
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.042555699999999995	2.847017796073975
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.042423129999999996	2.8381487338983904
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.042423129999999996	2.8381487338983904
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.042423129999999996	2.8381487338983904
DISTAL 17P13.1 MICRODELETION SYNDROME	0.042423129999999996	2.8381487338983904
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.042423129999999996	2.8381487338983904
XP22.13P22.2 DUPLICATION SYNDROME	0.042423129999999996	2.8381487338983904
MOWAT-WILSON SYNDROME	0.04238775	2.8357817774242853
NON-DISTAL MONOSOMY 20Q	0.042053259999999995	2.8134040704988017
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.042036014	2.8122502962943803
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.04189021	2.8024958666236484
HISTIDINEMIA	0.041666699999999994	2.787542829836555
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.041666699999999994	2.787542829836555
49,XYYYY SYNDROME	0.041666699999999994	2.787542829836555
PGM3-CDG	0.041666699999999994	2.787542829836555
ACRORENAL-MANDIBULAR SYNDROME	0.04102532	2.744633882878899
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.04083573	2.731950127143295
GRISCELLI SYNDROME	0.040545554	2.712537069997165
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.040545554	2.712537069997165
DYSKERATOSIS CONGENITA	0.040545554	2.712537069997165
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.040421939999999996	2.7042671729482644
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.040421939999999996	2.7042671729482644
NEURONAL CEROID LIPOFUSCINOSIS	0.04035632	2.6998771310084453
ACROCEPHALOPOLYDACTYLY	0.04009282	2.682248724255284
SHPRINTZEN OMPHALOCELE SYNDROME	0.04009282	2.682248724255284
FABRY DISEASE	0.04002464000000001	2.6776874158210133
TRIOPIA	0.04	2.6760389758119127
MONILETHRIX	0.04	2.6760389758119127
ROMBO SYNDROME	0.04	2.6760389758119127
CENTRAL CONGENITAL HYPOTHYROIDISM	0.04	2.6760389758119127
ACRODERMATITIS ENTEROPATHICA	0.04	2.6760389758119127
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.04	2.6760389758119127
SPONDYLO-OCULAR SYNDROME	0.04	2.6760389758119127
VOGT-KOYANAGI-HARADA DISEASE	0.04	2.6760389758119127
MICROPHTHALMIA WITH LIMB ANOMALIES	0.04	2.6760389758119127
ACROMICRIC DYSPLASIA	0.04	2.6760389758119127
EPIDERMOLYSIS BULLOSA SIMPLEX DUE TO PLAKOPHILIN DEFICIENCY	0.04	2.6760389758119127
ULERYTHEMA OPHRYOGENESIS	0.04	2.6760389758119127
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.04	2.6760389758119127
LEUKOMELANODERMA-INFANTILISM-INTELLECTUAL DISABILITY-HYPODONTIA-HYPOTRICHOSIS SYNDROME	0.04	2.6760389758119127
PILI TORTI	0.04	2.6760389758119127
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.039968699999999996	2.6739449753133395
WILLIAMS-BEUREN SYNDROME; WBS	0.03972012	2.6573147310981566
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.03916258	2.6200147618338026
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.03915465	2.619484237106848
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.039007054	2.609609920889999
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.038888900000000004	2.6017053031612973
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.038793140000000004	2.595298865853204
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.038647604	2.58556236564361
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.038476633999999996	2.574124306051245
BLEPHAROCHALASIS AND DOUBLE LIP	0.0384615	2.5731118267047473
LIP, HAMARTOMATOUS	0.0384615	2.5731118267047473
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0384615	2.5731118267047473
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	2.5731118267047473
BAZEX SYNDROME; BZX	0.0384615	2.5731118267047473
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	2.5731118267047473
JUVENILE MYOCLONIC EPILEPSY	0.0384615	2.5731118267047473
CYCLIC NEUTROPENIA	0.0384615	2.5731118267047473
MAL DE MELEDA	0.0384615	2.5731118267047473
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0384615	2.5731118267047473
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	2.5731118267047473
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	2.5731118267047473
LIP, MEDIAN NODULE OF UPPER	0.0384615	2.5731118267047473
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	2.5731118267047473
ABLEPHARON-MACROSTOMIA SYNDROME	0.0384615	2.5731118267047473
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.0384615	2.5731118267047473
JUVENILE ABSENCE EPILEPSY	0.0384615	2.5731118267047473
ZELLWEGER SYNDROME	0.038102050000000005	2.5490642714583576
OCULOECTODERMAL SYNDROME; OES	0.037891174	2.5349564615817743
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.037760173999999994	2.52619243393599
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.03763444	2.517780706821372
COFFIN-LOWRY SYNDROME; CLS	0.03742313	2.5036438619219012
OCULODENTODIGITAL DYSPLASIA	0.0373377	2.4979285116793113
ATYPICAL RETT SYNDROME	0.037324869999999996	2.4970701721778195
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.037324869999999996	2.4970701721778195
PYRIDOXINE-DEPENDENT EPILEPSY	0.036591533999999995	2.4480092792186694
HUNTINGTON DISEASE	0.03656844	2.4464642681159847
FLYNN-AIRD SYNDROME	0.03656844	2.4464642681159847
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.03647073000000001	2.43992737390782
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.03647073000000001	2.43992737390782
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.03647073000000001	2.43992737390782
MICROHYDRANENCEPHALY; MHAC	0.03647073000000001	2.43992737390782
THUMBS, CONGENITAL CLASPED	0.0361093	2.4157473547321273
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.03604598	2.411511185033417
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.03604598	2.411511185033417
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.036002320000000004	2.4085902884913186
AICARDI-GOUTIERES SYNDROME 7	0.03591532399999999	2.4027701713228247
BRAIN-LUNG-THYROID SYNDROME	0.035784784	2.394036918125263
FAMILIAL CERVICAL ARTERY DISSECTION	0.035714300000000004	2.389321469845985
PARTIAL ATRIOVENTRICULAR CANAL	0.035714300000000004	2.389321469845985
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.035714300000000004	2.389321469845985
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	0.035714300000000004	2.389321469845985
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.035714300000000004	2.389321469845985
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.035714300000000004	2.389321469845985
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.035714300000000004	2.389321469845985
ESSENTIAL THROMBOCYTHEMIA	0.035714300000000004	2.389321469845985
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.035714300000000004	2.389321469845985
SLC39A8-CDG	0.035714300000000004	2.389321469845985
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.035714300000000004	2.389321469845985
HYPOALPHALIPOPROTEINEMIA	0.035714300000000004	2.389321469845985
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.035714300000000004	2.389321469845985
SCHINZEL-GIEDION SYNDROME	0.035714300000000004	2.389321469845985
SPINOCEREBELLAR ATAXIA TYPE 34	0.035706379999999996	2.3887916141287735
WOLF-HIRSCHHORN SYNDROME	0.035191403999999996	2.354339217938581
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.035191403999999996	2.354339217938581
JAWAD SYNDROME	0.035028354	2.343431014063428
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.035028354	2.343431014063428
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.035028354	2.343431014063428
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.035028354	2.343431014063428
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.035028354	2.343431014063428
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.035028354	2.343431014063428
SILVER-RUSSELL SYNDROME	0.0347755	2.3265148350836795
RAMON SYNDROME	0.0345238	2.3096758598283826
COCKAYNE SYNDROME A; CSA	0.03450771	2.308599423150362
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.0344828	2.3069329198781756
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.0344828	2.3069329198781756
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.0344828	2.3069329198781756
MICROCEPHALY-GLOMERULONEPHRITIS-MARFANOID HABITUS SYNDROME	0.0344828	2.3069329198781756
RICHIERI COSTA-DA SILVA SYNDROME	0.0344828	2.3069329198781756
PROGRESSIVE SUPRANUCLEAR PALSY-PURE AKINESIA WITH GAIT FREEZING SYNDROME	0.0344828	2.3069329198781756
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.0344828	2.3069329198781756
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.0344828	2.3069329198781756
LENNOX-GASTAUT SYNDROME	0.0344828	2.3069329198781756
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.0344828	2.3069329198781756
PRKAR1B-RELATED NEURODEGENERATIVE DEMENTIA WITH INTERMEDIATE FILAMENTS	0.0344828	2.3069329198781756
SPINOCEREBELLAR ATAXIA TYPE 37	0.0344828	2.3069329198781756
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY	0.0344828	2.3069329198781756
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.0344828	2.3069329198781756
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.0344828	2.3069329198781756
RAMOS-ARROYO SYNDROME	0.0344828	2.3069329198781756
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.0344828	2.3069329198781756
GIANT AXONAL NEUROPATHY	0.0344828	2.3069329198781756
PERIORAL MYOCLONIA WITH ABSENCES	0.0344828	2.3069329198781756
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.0344828	2.3069329198781756
HEREDITARY MYOPATHY WITH EARLY RESPIRATORY FAILURE	0.0344828	2.3069329198781756
MYOPATHY, TUBULAR AGGREGATE, 2; TAM2	0.0344828	2.3069329198781756
MICROCEPHALY-POLYMICROGYRIA-CORPUS CALLOSUM AGENESIS SYNDROME	0.0344828	2.3069329198781756
BECKER MUSCULAR DYSTROPHY	0.0344828	2.3069329198781756
PROGRESSIVE SUPRANUCLEAR PALSY	0.0344828	2.3069329198781756
FRIEDREICH ATAXIA	0.0344828	2.3069329198781756
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.03429683399999999	2.2944916132737787
9P13 MICRODELETION SYNDROME	0.033889419999999996	2.2672352196914938
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.033889419999999996	2.2672352196914938
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.033889419999999996	2.2672352196914938
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.033751279999999995	2.2579935190885267
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.033560084	2.245202320388044
SECKEL SYNDROME 2; SCKL2	0.03301453	2.2087042262027916
ISOLATED CEREBELLAR AGENESIS	0.03301453	2.2087042262027916
SECKEL SYNDROME	0.03301453	2.2087042262027916
ISOTRETINOIN-LIKE SYNDROME	0.03301453	2.2087042262027916
MEIER-GORLIN SYNDROME 5; MGORS5	0.03301453	2.2087042262027916
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.032803653999999995	2.1945964163262084
GRISCELLI SYNDROME TYPE 1	0.032803653999999995	2.1945964163262084
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.032803653999999995	2.1945964163262084
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.032803653999999995	2.1945964163262084
NETHERTON SYNDROME; NETH	0.032803653999999995	2.1945964163262084
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.032803653999999995	2.1945964163262084
SARCOSINEMIA	0.032803653999999995	2.1945964163262084
OXOGLUTARIC ACIDURIA	0.032803653999999995	2.1945964163262084
OCULODENTODIGITAL DYSPLASIA; ODDD	0.03269075	2.1870430287130818
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.032541504	2.1770583258884812
NEONATAL ADRENOLEUKODYSTROPHY	0.032454830000000004	2.1712597508337437
LEIGH SYNDROME; LS	0.032294223999999996	2.160515052940012
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.0322581	2.1580983221409564
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.0322581	2.1580983221409564
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.0322581	2.1580983221409564
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0322581	2.1580983221409564
DEND SYNDROME	0.0322581	2.1580983221409564
SANDHOFF DISEASE	0.0322581	2.1580983221409564
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0322581	2.1580983221409564
DYSTONIA, JUVENILE-ONSET	0.0322581	2.1580983221409564
THROMBOCYTOPENIA 1	0.0322581	2.1580983221409564
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.0322581	2.1580983221409564
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.0322581	2.1580983221409564
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.0322581	2.1580983221409564
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.0322581	2.1580983221409564
HSD10 DISEASE, ATYPICAL TYPE	0.0322581	2.1580983221409564
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0322581	2.1580983221409564
ROWLEY-ROSENBERG SYNDROME	0.0322581	2.1580983221409564
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.0322581	2.1580983221409564
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0322581	2.1580983221409564
DIENCEPHALIC SYNDROME	0.0322581	2.1580983221409564
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0322581	2.1580983221409564
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.0322581	2.1580983221409564
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	0.0322581	2.1580983221409564
DESMOID TUMOR	0.0322581	2.1580983221409564
LEIGH SYNDROME	0.0322581	2.1580983221409564
MERRF	0.0322581	2.1580983221409564
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0322581	2.1580983221409564
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0322581	2.1580983221409564
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0322581	2.1580983221409564
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.0322581	2.1580983221409564
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.0322581	2.1580983221409564
MILD CANAVAN DISEASE	0.0322581	2.1580983221409564
LESCH-NYHAN SYNDROME	0.0322581	2.1580983221409564
PROGRESSIVE HEMIFACIAL ATROPHY	0.0322581	2.1580983221409564
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0322581	2.1580983221409564
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.0322581	2.1580983221409564
CRAMPS, FAMILIAL ADOLESCENT	0.0322581	2.1580983221409564
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.0322581	2.1580983221409564
DENT DISEASE	0.0322581	2.1580983221409564
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.031604983999999996	2.114404225347797
AICARDI-GOUTIERES SYNDROME 5	0.031604983999999996	2.114404225347797
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.031510174	2.108061343965379
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.031059429999999996	2.0779061311625444
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.031059429999999996	2.0779061311625444
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.031059429999999996	2.0779061311625444
FONTAINE PROGEROID SYNDROME; FPS	0.03088642	2.0663315935824147
FOLATE MALABSORPTION, HEREDITARY	0.030848553999999997	2.0637983212859616
15Q13.3 MICRODELETION SYNDROME	0.030711104	2.054602782355328
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.030531844000000002	2.0426101136852273
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.030450854000000003	2.0371918037689523
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.030302999999999997	2.0273002271007092
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.030302999999999997	2.0273002271007092
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.030302999999999997	2.0273002271007092
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.030302999999999997	2.0273002271007092
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.030302999999999997	2.0273002271007092
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.030302999999999997	2.0273002271007092
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.030302999999999997	2.0273002271007092
NEONATAL LUPUS ERYTHEMATOSUS	0.030302999999999997	2.0273002271007092
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.030302999999999997	2.0273002271007092
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.030302999999999997	2.0273002271007092
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.030302999999999997	2.0273002271007092
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.030302999999999997	2.0273002271007092
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.030084160000000002	2.012659617864043
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.030080234	2.012396964638567
COFFIN-LOWRY SYNDROME	0.029910139999999998	2.001017510299773
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.029767044	1.9914442484677035
TYSHCHENKO SYNDROME	0.029664304000000002	1.9845708423583308
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.029607400000000002	1.9807639093113407
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.02937504	1.9652187989008492
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 4; CEMCOX4	0.02926445	1.9578202201424735
JUVENILE POLYPOSIS OF INFANCY	0.029118750000000002	1.9480727481730784
RAPADILINO SYNDROME	0.029118750000000002	1.9480727481730784
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.029079784	1.9454658848047912
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.029058534	1.944044239098891
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.028900524	1.9334732161346901
DRAVET SYNDROME	0.02870054	1.920094091671221
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.02870054	1.920094091671221
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.02853423	1.9089677906195388
MENKES DISEASE	0.02853423	1.9089677906195388
15Q24 RECURRENT MICRODELETION SYNDROME	0.02853423	1.9089677906195388
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.028407544	1.900492373777296
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.028323354000000002	1.894859980742956
SPINOCEREBELLAR ATAXIA TYPE 5	0.027838480000000002	1.8624214376840105
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	1.8583618865577036
NASAL BONES, ABSENCE OF	0.027777800000000002	1.8583618865577036
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	1.8583618865577036
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	1.8583618865577036
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	1.8583618865577036
CLEFT CHIN	0.027777800000000002	1.8583618865577036
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	1.8583618865577036
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	1.8583618865577036
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	1.8583618865577036
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	1.8583618865577036
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.027777800000000002	1.8583618865577036
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	1.8583618865577036
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	1.8583618865577036
CYANIDE, INABILITY TO SMELL	0.027777800000000002	1.8583618865577036
OROFACIAL CLEFT 3	0.027777800000000002	1.8583618865577036
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	1.8583618865577036
DWARFISM, LEVI TYPE	0.027777800000000002	1.8583618865577036
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	1.8583618865577036
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	1.8583618865577036
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	1.8583618865577036
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	1.8583618865577036
DIMPLES, FACIAL	0.027777800000000002	1.8583618865577036
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	1.8583618865577036
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.027442104000000002	1.8359034970570998
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.026972464	1.8044841234420923
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.026567074	1.7773631374319823
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.026567074	1.7773631374319823
KOOLEN-DE VRIES SYNDROME; KDVS	0.026496554	1.772645280717626
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.026485324	1.771893982775167
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.026485324	1.771893982775167
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.02637839	1.7647399939791801
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.026352160000000003	1.7629851814207915
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.026292354	1.7589841017461063
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.026216034000000003	1.7538782193802571
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.02610406	1.7463870496733178
DOWN SYNDROME	0.02605664	1.7432146054674926
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.02593977	1.7353958885899146
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.025692184	1.7188321439432803
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.025692184	1.7188321439432803
FETAL HYDANTOIN SYNDROME	0.025660604	1.7167194111718767
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.025596743999999998	1.7124471149469929
ADDUCTED THUMBS SYNDROME	0.02551008	1.706649208901999
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.025416349999999997	1.7003785805719274
COG8-CDG	0.025416349999999997	1.7003785805719274
PHELAN-MCDERMID SYNDROME	0.025155504000000002	1.6829277290048121
PITT-HOPKINS SYNDROME	0.02514663	1.682334049758028
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.024935754	1.668226239881445
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.024935754	1.668226239881445
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.024935754	1.668226239881445
SPINOCEREBELLAR ATAXIA 5; SCA5	0.024935754	1.668226239881445
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.024935754	1.668226239881445
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.024935754	1.668226239881445
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.024935754	1.668226239881445
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.024935754	1.668226239881445
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.024935754	1.668226239881445
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.024853824	1.6627450430492383
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.024853824	1.6627450430492383
BARBER-SAY SYNDROME; BBRSAY	0.024753650000000002	1.656043304840164
MAN1B1-CDG	0.024399074	1.6323218249429765
CHROMOSOME 17P13.1 DELETION SYNDROME	0.024399074	1.6323218249429765
SPINOCEREBELLAR ATAXIA 26	0.0243902	1.631728145696193
ORAL SENSIBILITY, DISTURBANCE OF	0.0243902	1.631728145696193
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.0243902	1.631728145696193
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.0243902	1.631728145696193
MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO	0.0243902	1.631728145696193
EPISODIC ATAXIA, TYPE 1; EA1	0.0243902	1.631728145696193
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.0243902	1.631728145696193
SPINOCEREBELLAR ATAXIA TYPE 6	0.0243902	1.631728145696193
ADRENOLEUKODYSTROPHY	0.0243902	1.631728145696193
CRANIOFACIOFRONTODIGITAL SYNDROME	0.024358619999999997	1.629615412924789
MILLER-DIEKER SYNDROME	0.024358619999999997	1.629615412924789
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.02435661	1.6294809419662548
CARDIOMYOPATHY-HYPOTONIA-LACTIC ACIDOSIS SYNDROME	0.02430827	1.626246948863986
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.024029283999999998	1.6075825136213393
POTOCKI-LUPSKI SYNDROME	0.024029283999999998	1.6075825136213393
FOUNTAIN SYNDROME	0.02395686	1.6027372774517343
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.02395686	1.6027372774517343
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.02395686	1.6027372774517343
SCARF SYNDROME	0.02385352	1.5958237307577245
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.02378788	1.591432350798417
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.023753414	1.5891265418149088
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.023524184	1.5737908314542743
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.023524184	1.5737908314542743
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.023524184	1.5737908314542743
SILVER-RUSSELL SYNDROME; SRS	0.023272854	1.5569766095595043
KAGAMI-OGATA SYNDROME	0.023272854	1.5569766095595043
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.02308197	1.5442062839630324
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.023010454000000003	1.5394217938781785
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.02297863	1.5372927372690222
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.02297863	1.5372927372690222
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.02297863	1.5372927372690222
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.02297863	1.5372927372690222
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.02297863	1.5372927372690222
CUTIS LAXA	0.022913954	1.532965849849032
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.022871094	1.5300984740864496
2Q23.1 MICRODUPLICATION SYNDROME	0.022767754	1.5231849273924396
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.022767754	1.5231849273924396
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.022767754	1.5231849273924396
CHROMOSOME 5Q12 DELETION SYNDROME	0.022767754	1.5231849273924396
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.022767754	1.5231849273924396
FG SYNDROME TYPE 1	0.022767754	1.5231849273924396
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.022767754	1.5231849273924396
VENULAR INSUFFICIENCY, SYSTEMIC	0.0227273	1.5204785153742522
ATROPHODERMA VERMICULATA; AVA	0.0227273	1.5204785153742522
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0227273	1.5204785153742522
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.0227273	1.5204785153742522
AMYLOIDOSIS	0.0227273	1.5204785153742522
COWDEN SYNDROME 5; CWS5	0.0227273	1.5204785153742522
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0227273	1.5204785153742522
LARSEN SYNDROME	0.0227273	1.5204785153742522
COWDEN SYNDROME 6; CWS6	0.0227273	1.5204785153742522
HYPOADRENOCORTICISM, FAMILIAL	0.0227273	1.5204785153742522
PARIS-TROUSSEAU THROMBOCYTOPENIA	0.0227273	1.5204785153742522
MUSCULAR HYPERTONIA, LETHAL	0.0227273	1.5204785153742522
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0227273	1.5204785153742522
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0227273	1.5204785153742522
PREPAPILLARY VASCULAR LOOPS	0.0227273	1.5204785153742522
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0227273	1.5204785153742522
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.0227273	1.5204785153742522
COCAINE EMBRYOFETOPATHY	0.0227273	1.5204785153742522
RHOMBENCEPHALOSYNAPSIS	0.0227273	1.5204785153742522
THUMB DEFORMITY	0.0227273	1.5204785153742522
SIRENOMELIA	0.0227273	1.5204785153742522
ARTERIES, ANOMALIES OF	0.0227273	1.5204785153742522
CONGENITAL ATRANSFERRINEMIA	0.0227273	1.5204785153742522
HEMANGIOPERICYTOMA, MALIGNANT	0.0227273	1.5204785153742522
BETHLEM MYOPATHY 1	0.0227273	1.5204785153742522
WATSON SYNDROME	0.0227273	1.5204785153742522
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0227273	1.5204785153742522
FATCO SYNDROME	0.0227273	1.5204785153742522
NEPHROSIALIDOSIS	0.02265578	1.5156937576855003
SPINAL ARACHNOIDITIS	0.02265578	1.5156937576855003
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.02265578	1.5156937576855003
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.02265578	1.5156937576855003
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.02252572	1.506992616955648
RENPENNING SYNDROME 1; RENS1	0.022387749999999998	1.4977622895183285
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.02232554	1.4936003799011972
MCDONOUGH SYNDROME	0.02232554	1.4936003799011972
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.022314844	1.492884807079065
MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	0.0222222	1.4866868332071872
SMITH-KINGSMORE SYNDROME; SKS	0.0222222	1.4866868332071872
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.0222222	1.4866868332071872
ALG13-CDG	0.0222222	1.4866868332071872
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.0222222	1.4866868332071872
FRONTOMETAPHYSEAL DYSPLASIA	0.0222222	1.4866868332071872
PERMANENT NEONATAL DIABETES MELLITUS-PANCREATIC AND CEREBELLAR AGENESIS SYNDROME	0.0222222	1.4866868332071872
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.022195744	1.4849169010285852
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.022195744	1.4849169010285852
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.02204304	1.4747008546345257
MENKES DISEASE	0.022015970000000003	1.472889845257645
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.021983694000000005	1.4707305494080625
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.021862439999999997	1.4626185386587345
UNILATERAL POLYMICROGYRIA	0.021862439999999997	1.4626185386587345
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.021850934000000002	1.4618487760473426
KNOBLOCH SYNDROME	0.02163132	1.4471563854564935
SCALP-EAR-NIPPLE SYNDROME; SENS	0.02163132	1.4471563854564935
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.02163132	1.4471563854564935
TENORIO SYNDROME; TNORS	0.021305380000000002	1.4253506818620902
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.021106009999999998	1.4120126345968995
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.021106009999999998	1.4120126345968995
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.021106009999999998	1.4120126345968995
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.021106009999999998	1.4120126345968995
GRANULOMAS, CONGENITAL CEREBRAL	0.02102928	1.4068793228315486
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02102928	1.4068793228315486
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02102928	1.4068793228315486
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02102928	1.4068793228315486
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02102928	1.4068793228315486
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.020943034	1.4011093813938515
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.020790404	1.3908982856718972
NEVUS COMEDONICUS SYNDROME	0.02075643	1.3886253919677916
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.02075643	1.3886253919677916
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.02075642	1.3886247229580475
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.020740849999999998	1.3875830747867126
CONGENITAL HYPOTHYROIDISM	0.020545554	1.3745175820912086
MEGAEPIPHYSEAL DWARFISM	0.02049922	1.3714177923435769
WILLIAMS SYNDROME	0.02039669	1.364558435438827
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.020392254000000002	1.3642616627164097
HYPERMANGANESEMIA WITH DYSTONIA 2	0.020352374000000003	1.3615936518575253
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.020169884	1.349384893040127
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.020033974	1.3402923816100623
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.020033974	1.3402923816100623
WEBB-DATTANI SYNDROME; WEDAS	0.020001164000000002	1.3380973606401525
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.020001164000000002	1.3380973606401525
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6	0.02	1.3380194879059564
EPIDERMOLYSIS BULLOSA ACQUISITA	0.02	1.3380194879059564
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.02	1.3380194879059564
MANITOBA OCULOTRICHOANAL SYNDROME	0.02	1.3380194879059564
RED SKIN PIGMENT ANOMALY OF NEW GUINEA	0.02	1.3380194879059564
RINGED HAIR	0.02	1.3380194879059564
DARIER DISEASE	0.02	1.3380194879059564
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.02	1.3380194879059564
MIDPHALANGEAL HAIR	0.02	1.3380194879059564
TRICHODENTOOSSEOUS SYNDROME	0.02	1.3380194879059564
AMELOONYCHOHYPOHIDROTIC SYNDROME	0.02	1.3380194879059564
HAIR WHORL	0.02	1.3380194879059564
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.02	1.3380194879059564
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.02	1.3380194879059564
FAMILIAL MELANOMA	0.02	1.3380194879059564
TRICHODISCOMAS, FAMILIAL MULTIPLE	0.02	1.3380194879059564
DISSECTING CELLULITIS OF THE SCALP	0.02	1.3380194879059564
%152800 LYMPHANGIECTASIA, INTESTINAL	0.02	1.3380194879059564
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.02	1.3380194879059564
VAN BOGAERT-HOZAY SYNDROME	0.02	1.3380194879059564
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.02	1.3380194879059564
GYRATE ATROPHY OF CHOROID AND RETINA	0.02	1.3380194879059564
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.02	1.3380194879059564
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.02	1.3380194879059564
HAIRY NOSE TIP	0.02	1.3380194879059564
611426 TENTED EYEBROWS	0.02	1.3380194879059564
FAMILIAL MALE-LIMITED PRECOCIOUS PUBERTY	0.02	1.3380194879059564
INHERITED EPIDERMOLYSIS BULLOSA	0.02	1.3380194879059564
CATATRICHY	0.02	1.3380194879059564
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.02	1.3380194879059564
WERNER SYNDROME; WRN	0.02	1.3380194879059564
ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	0.02	1.3380194879059564
STRIATE PALMOPLANTAR KERATODERMA	0.02	1.3380194879059564
PEHO SYNDROME	0.019882504	1.3301588910184063
8P INVERTED DUPLICATION/DELETION SYNDROME	0.0196803	1.3166312463917798
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.019636004000000002	1.3136678008299656
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.019620494	1.3126301667170943
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.019600003999999997	1.3112593657517346
DOORS SYNDROME	0.019600003999999997	1.3112593657517346
TRISOMY 18	0.019600003999999997	1.3112593657517346
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.01950752	1.30507209603576
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.01950752	1.30507209603576
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.019503894	1.3048295131026029
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.019503894	1.3048295131026029
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.01948842	1.3037942874248099
CHROMOSOME 17Q12 DELETION SYNDROME	0.01948842	1.3037942874248099
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.01948842	1.3037942874248099
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.01945561	1.3015992664549003
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.01945561	1.3015992664549003
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.01945561	1.3015992664549003
WARBURG MICRO SYNDROME 2; WARBM2	0.01945561	1.3015992664549003
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.019443074	1.300760595839881
BAND HETEROTOPIA; BH	0.019413454	1.2987789889782921
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.019413454	1.2987789889782921
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.019336950000000002	1.2936607968331542
SECKEL SYNDROME 9; SCKL9	0.019159084	1.28176138812136
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.019159084	1.28176138812136
COFFIN-SIRIS SYNDROME 4; CSS4	0.019159084	1.28176138812136
COFFIN-SIRIS SYNDROME 3; CSS3	0.019159084	1.28176138812136
JACOBSEN SYNDROME	0.019126074	1.2795529869565714
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.01905445	1.2747612715664824
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.01889752	1.2642625016546285
VAN DEN BOSCH SYNDROME	0.0188679	1.2622808947930397
PACHYDERMODACTYLY, FAMILIAL	0.0188679	1.2622808947930397
KNUCKLE PADS	0.0188679	1.2622808947930397
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	1.2622808947930397
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	1.2622808947930397
VESICOURETERAL REFLUX 1	0.0188679	1.2622808947930397
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.0188679	1.2622808947930397
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	1.2622808947930397
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	1.2622808947930397
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	1.2622808947930397
LETTERER-SIWE DISEASE	0.0188679	1.2622808947930397
HHHH SYNDROME	0.0188679	1.2622808947930397
RAYNAUD DISEASE	0.0188679	1.2622808947930397
CARPAL DISPLACEMENT	0.0188679	1.2622808947930397
DERMOCHONDROCORNEAL DYSTROPHY	0.0188679	1.2622808947930397
MONOPHALANGY OF GREAT TOE	0.0188679	1.2622808947930397
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	1.2622808947930397
TRACHEOBRONCHOMEGALY	0.0188679	1.2622808947930397
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	1.2622808947930397
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	1.2622808947930397
DOUBLE NAIL FOR FIFTH TOE	0.0188679	1.2622808947930397
THROMBOCYTOPENIA 3	0.0188679	1.2622808947930397
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	1.2622808947930397
THALIDOMIDE SUSCEPTIBILITY	0.0188679	1.2622808947930397
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	1.2622808947930397
COPPER DEFICIENCY, FAMILIAL BENIGN	0.0188679	1.2622808947930397
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	1.2622808947930397
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	1.2622808947930397
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	1.2622808947930397
TOE, MISSHAPEN	0.0188679	1.2622808947930397
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	1.2622808947930397
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	1.2622808947930397
PUBIC BONE DYSPLASIA	0.0188679	1.2622808947930397
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	1.2622808947930397
BEEMER LETHAL MALFORMATION SYNDROME	0.0188679	1.2622808947930397
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	1.2622808947930397
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	1.2622808947930397
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	1.2622808947930397
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.018843574	1.2606534616898994
FUMARASE DEFICIENCY; FMRD	0.018760934000000003	1.2551247651658726
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.018760934	1.2551247651658721
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.018747464	1.2542236090407675
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.018747464	1.2542236090407675
BLOOM SYNDROME	0.01861353	1.2452632939361077
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.01861353	1.2452632939361077
FILIPPI SYNDROME; FLPIS	0.01861353	1.2452632939361077
AMISH LETHAL MICROCEPHALY	0.01858054	1.2430562307908068
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.01858052	1.243054892771319
WHITE FORELOCK WITH MALFORMATIONS	0.01858052	1.243054892771319
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.01858052	1.243054892771319
RING CHROMOSOME 8 SYNDROME	0.01858052	1.243054892771319
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.01858052	1.243054892771319
CARTILAGE-HAIR HYPOPLASIA	0.01858052	1.243054892771319
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.01858052	1.243054892771319
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.01858052	1.243054892771319
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.018580094000000002	1.2430263929562269
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.018568004000000003	1.2422175601757877
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.018554493999999998	1.2413137280117068
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.018554493999999998	1.2413137280117068
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.018554493999999998	1.2413137280117068
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.018402654	1.2311554840595251
SRD5A3-CDG	0.018402654	1.2311554840595251
COFFIN-SIRIS SYNDROME 2; CSS2	0.018402654	1.2311554840595251
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.018402654	1.2311554840595251
SAETHRE-CHOTZEN SYNDROME	0.018298019999999998	1.2241553675046473
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.018298019999999998	1.2241553675046473
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.018298019999999998	1.2241553675046473
COSTELLO SYNDROME	0.018298019999999998	1.2241553675046473
CEREBROOCULONASAL SYNDROME	0.018298019999999998	1.2241553675046473
NASODIGITOACOUSTIC SYNDROME	0.018298019999999998	1.2241553675046473
PITT-HOPKINS SYNDROME	0.018251184	1.2210219934678692
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.018201909999999998	1.2177255148555153
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.018175320000000002	1.2159466179463445
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.018022450000000002	1.2057194659905353
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.018022450000000002	1.2057194659905353
RETT SYNDROME, CONGENITAL VARIANT	0.018008939999999998	1.2048156338264546
PROPIONIC ACIDEMIA	0.018004504	1.2045188611040372
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.018004504	1.2045188611040372
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.017970094000000002	1.2022167985750951
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.017968684	1.2021224682011975
BOHRING-OPITZ SYNDROME	0.017968684	1.2021224682011975
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.017968684	1.2021224682011975
PAPILLON-LEFÈVRE SYNDROME	0.0178571	1.1946573898742727
ADRENOCORTICAL CARCINOMA	0.0178571	1.1946573898742727
DENTAL ANOMALIES AND SHORT STATURE; DASS	0.0178571	1.1946573898742727
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.0178571	1.1946573898742727
TUFTED ANGIOMA	0.0178571	1.1946573898742727
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.0178571	1.1946573898742727
POEMS SYNDROME	0.0178571	1.1946573898742727
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.0178571	1.1946573898742727
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.0178571	1.1946573898742727
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.0178571	1.1946573898742727
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.0178571	1.1946573898742727
PORPHYRIA CUTANEA TARDA, TYPE I	0.0178571	1.1946573898742727
ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 2; EKVP2	0.0178571	1.1946573898742727
KASABACH-MERRITT SYNDROME	0.0178571	1.1946573898742727
MUCOPOLYSACCHARIDOSIS, TYPE II	0.0178571	1.1946573898742727
144800 HYPEROSTOSIS FRONTALIS INTERNA;;MORGAGNI-STEWART-MOREL SYNDROME	0.0178571	1.1946573898742727
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.0178571	1.1946573898742727
HEREDITARY COPROPORPHYRIA	0.0178571	1.1946573898742727
CONGENITAL ERYTHROPOIETIC PORPHYRIA	0.0178571	1.1946573898742727
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.0178571	1.1946573898742727
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.017811574	1.1916116561139523
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.01770563	1.184523899282617
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.01770563	1.184523899282617
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.01770563	1.184523899282617
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.01770563	1.184523899282617
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.01770563	1.184523899282617
DYSOSTOSIS, STANESCU TYPE	0.01770563	1.184523899282617
TRISOMY 4P	0.01770563	1.184523899282617
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.01770563	1.184523899282617
COCKAYNE SYNDROME	0.01770563	1.184523899282617
TEMTAMY SYNDROME	0.017494754	1.170416089406034
COLCHICINE POISONING	0.01745895	1.168020766918785
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.01745895	1.168020766918785
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.01745895	1.168020766918785
PEARSON SYNDROME	0.01745895	1.168020766918785
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.017424540000000002	1.1657187043898427
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.01742313	1.165624374015945
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.01726602	1.1551135619287
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3	0.01726602	1.1551135619287
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.01726602	1.1551135619287
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.01726602	1.1551135619287
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.01726602	1.1551135619287
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.01726602	1.1551135619287
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	1.1534664599390878
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	1.1534664599390878
CARDIAC ARRHYTHMIA	0.0172414	1.1534664599390878
MOSAIC TRISOMY 15	0.0172414	1.1534664599390878
MYOPATHY, CONGENITAL	0.0172414	1.1534664599390878
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	1.1534664599390878
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	1.1534664599390878
CERVICAL RIB	0.0172414	1.1534664599390878
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	1.1534664599390878
CONGENITAL TRACHEAL STENOSIS	0.0172414	1.1534664599390878
PALMOMENTAL REFLEX	0.0172414	1.1534664599390878
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	1.1534664599390878
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	1.1534664599390878
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	1.1534664599390878
RHEUMATOID ARTHRITIS	0.0172414	1.1534664599390878
JUMPING FRENCHMAN OF MAINE	0.0172414	1.1534664599390878
SICKLE CELL ANEMIA	0.0172414	1.1534664599390878
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	1.1534664599390878
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	1.1534664599390878
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	1.1534664599390878
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	1.1534664599390878
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	1.1534664599390878
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	1.1534664599390878
MOTION SICKNESS	0.0172414	1.1534664599390878
TRANSSEXUALITY	0.0172414	1.1534664599390878
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	1.1534664599390878
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	1.1534664599390878
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	1.1534664599390878
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	1.1534664599390878
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	1.1534664599390878
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	1.1534664599390878
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	1.1534664599390878
ENDOCARDIAL FIBROELASTOSIS	0.0172414	1.1534664599390878
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	1.1534664599390878
SPASTIC PSEUDOSCLEROSIS	0.0172414	1.1534664599390878
269800 SENILE PLAQUE FORMATION	0.0172414	1.1534664599390878
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	1.1534664599390878
DIASTEMATOMYELIA	0.0172414	1.1534664599390878
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	1.1534664599390878
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	1.1534664599390878
ANDROSTENONE, ABILITY TO SMELL	0.0172414	1.1534664599390878
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	1.1534664599390878
ALCOHOL DEPENDENCE	0.0172414	1.1534664599390878
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.017212254	1.1515165641393625
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.017212254	1.1515165641393625
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.017212254	1.1515165641393625
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.017212254	1.1515165641393625
ALPHA-MANNOSIDOSIS	0.017212254	1.1515165641393625
ABETA AMYLOIDOSIS, IOWA TYPE	0.01714688	1.1471429798392443
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.01714688	1.1471429798392443
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.01696854	1.135211860065587
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.01696854	1.135211860065587
CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-POLYDACTYLY SYNDROME	0.0169492	1.1339179952207816
BRACHYDACTYLY-MESOMELIA-INTELLECTUAL DISABILITY-HEART DEFECTS SYNDROME	0.0169492	1.1339179952207816
DEAFNESS-CRANIOFACIAL SYNDROME	0.0169492	1.1339179952207816
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.0169492	1.1339179952207816
MUCKLE-WELLS SYNDROME	0.0169492	1.1339179952207816
THIN RIBS-TUBULAR BONES-DYSMORPHISM SYNDROME	0.0169492	1.1339179952207816
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.0169492	1.1339179952207816
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.0169492	1.1339179952207816
FAMILIAL TUMORAL CALCINOSIS	0.0169492	1.1339179952207816
CATARACT-HYPERTRICHOSIS-INTELLECTUAL DISABILITY SYNDROME	0.0169492	1.1339179952207816
GAMMA-HEAVY CHAIN DISEASE	0.0169492	1.1339179952207816
JACKSON-WEISS SYNDROME	0.0169492	1.1339179952207816
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.0169492	1.1339179952207816
CATARACT-INTELLECTUAL DISABILITY-ANAL ATRESIA-URINARY DEFECTS SYNDROME	0.0169492	1.1339179952207816
HEART-HAND SYNDROME TYPE 2	0.0169492	1.1339179952207816
MCCUNE-ALBRIGHT SYNDROME	0.0169492	1.1339179952207816
GRANT SYNDROME	0.0169492	1.1339179952207816
ENDOCARDIAL FIBROELASTOSIS	0.0169492	1.1339179952207816
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.016904094	1.1309003598697076
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.016904094	1.1309003598697076
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.016904094	1.1309003598697076
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.016904094	1.1309003598697076
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.016904094	1.1309003598697076
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.01669171	1.1166916633237365
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.0166667	1.1150184699541101
MARFAN SYNDROME; MFS	0.0166667	1.1150184699541101
PYCNODYSOSTOSIS	0.0166667	1.1150184699541101
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.0166667	1.1150184699541101
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.0166667	1.1150184699541101
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.0166667	1.1150184699541101
WEILL-MARCHESANI SYNDROME 2; WMS2	0.0166667	1.1150184699541101
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.0166667	1.1150184699541101
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.0166667	1.1150184699541101
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.0166667	1.1150184699541101
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.0166667	1.1150184699541101
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.0166667	1.1150184699541101
PYCNODYSOSTOSIS	0.0166667	1.1150184699541101
WEILL-MARCHESANI SYNDROME 1; WMS1	0.0166667	1.1150184699541101
RAMON SYNDROME	0.0166667	1.1150184699541101
APERT SYNDROME	0.0166667	1.1150184699541101
CROUZON DISEASE	0.0166667	1.1150184699541101
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.016631904	1.1126905836490513
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.016631903999999996	1.112690583649051
RETT SYNDROME; RTT	0.01635854	1.0944022656844552
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.01635854	1.0944022656844552
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.01635854	1.0944022656844552
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.016106480000000003	1.0775392060783766
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.016106480000000003	1.0775392060783766
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.015875473999999997	1.0620846795872159
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.015875473999999997	1.0620846795872159
PEHO SYNDROME; PEHO	0.015875473999999997	1.0620846795872159
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.015875473999999997	1.0620846795872159
PEHO-LIKE SYNDROME; PEHOL	0.015875473999999997	1.0620846795872159
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.015558714000000001	1.0408931269377617
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.015346424000000001	1.0266907190833838
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.015272594	1.021751420143779
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.015193554	1.0164635671275746
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.015193554	1.0164635671275746
LOWRY-MACLEAN SYNDROME	0.01506039	1.0075547657731994
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.015000583999999999	1.003553686098514
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.015000583999999999	1.003553686098514
CEDNIK SYNDROME	0.015000583999999999	1.003553686098514
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.014981504000000003	1.002277215507052
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.01472704	0.9852533259585269
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.014648	0.9799654729423225
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.014437123999999999	0.9658576630657395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.014437123999999999	0.9658576630657395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.014437123999999999	0.9658576630657395
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.014437123999999999	0.9658576630657395
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.014437123999999999	0.9658576630657395
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.014437123999999999	0.9658576630657395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.014437123999999999	0.9658576630657395
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.014437123999999999	0.9658576630657395
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.014437123999999999	0.9658576630657395
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.01441507	0.9643822289764258
QAZI-MARKOUIZOS SYNDROME	0.014303960000000001	0.9569488617113643
TRISOMY 13	0.014303960000000001	0.9569488617113643
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.014244153999999998	0.9529477820366788
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.014244153999999998	0.9529477820366788
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.014244153999999998	0.9529477820366788
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.014244153999999998	0.9529477820366788
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.014244153999999998	0.9529477820366788
ABETAL34V AMYLOIDOSIS	0.014244153999999998	0.9529477820366788
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.014244153999999998	0.9529477820366788
CITRULLINEMIA, CLASSIC	0.014244153999999998	0.9529477820366788
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.014244153999999998	0.9529477820366788
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.014244153999999998	0.9529477820366788
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.014244153999999998	0.9529477820366788
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.014244153999999998	0.9529477820366788
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.014244153999999998	0.9529477820366788
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.014244153999999998	0.9529477820366788
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.014244153999999998	0.9529477820366788
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.014244153999999998	0.9529477820366788
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.014244153999999998	0.9529477820366788
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.014244153999999998	0.9529477820366788
MEIER-GORLIN SYNDROME 7	0.014244153999999998	0.9529477820366788
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.014244153999999998	0.9529477820366788
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.014244153999999998	0.9529477820366788
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.014244153999999998	0.9529477820366788
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.014244153999999998	0.9529477820366788
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.014244153999999998	0.9529477820366788
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.014244153999999998	0.9529477820366788
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.014244153999999998	0.9529477820366788
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.014244153999999998	0.9529477820366788
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.014244153999999998	0.9529477820366788
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.014244153999999998	0.9529477820366788
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.014225074000000002	0.9516713114452168
8Q24.3 MICRODELETION SYNDROME	0.014225074	0.9516713114452168
WITTEVEEN-KOLK SYNDROME	0.014140194000000002	0.9459927567385439
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.013960184000000002	0.9339499123376465
LIVER FAILURE, INFANTILE, TRANSIENT	0.013891569999999999	0.9293595688804872
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.013891569999999999	0.9293595688804872
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.013891569999999999	0.9293595688804872
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.013891569999999999	0.9293595688804872
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.013891569999999999	0.9293595688804872
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.013891569999999999	0.9293595688804872
MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE	0.013891569999999999	0.9293595688804872
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.013891569999999999	0.9293595688804872
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.013698599999999998	0.9164496878514266
WOLFF-PARKINSON-WHITE SYNDROME	0.013698599999999998	0.9164496878514266
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.013698599999999998	0.9164496878514266
DERMOGRAPHISM, FAMILIAL	0.013698599999999998	0.9164496878514266
APPARENT MINERALOCORTICOID EXCESS	0.013698599999999998	0.9164496878514266
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.013698599999999998	0.9164496878514266
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.013698599999999998	0.9164496878514266
POLYCYTHEMIA VERA	0.013698599999999998	0.9164496878514266
ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3	0.013698599999999998	0.9164496878514266
PRADER-WILLI SYNDROME	0.013698599999999998	0.9164496878514266
SNEDDON SYNDROME	0.013698599999999998	0.9164496878514266
FIBROMUSCULAR DYSPLASIA OF ARTERIES	0.013698599999999998	0.9164496878514266
AORTIC ANEURYSM, FAMILIAL THORACIC 4	0.013698599999999998	0.9164496878514266
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.013698599999999998	0.9164496878514266
%602248 MALIGNANT ATROPHIC PAPULOSIS;;DEGOS DISEASE;;PAPULOSIS, MALIGNANT ATROPHIC	0.013698599999999998	0.9164496878514266
AMYLOIDOSIS VI	0.013698599999999998	0.9164496878514266
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.013698599999999998	0.9164496878514266
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.013698599999999998	0.9164496878514266
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.013698599999999998	0.9164496878514266
SECONDARY POLYCYTHEMIA	0.013698599999999998	0.9164496878514266
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.013698599999999998	0.9164496878514266
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.013698599999999998	0.9164496878514266
GENERALIZED GLUCOCORTICOID RESISTANCE SYNDROME	0.013698599999999998	0.9164496878514266
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.013698599999999998	0.9164496878514266
FAMILIAL AORTIC DISSECTION	0.013698599999999998	0.9164496878514266
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.013698599999999998	0.9164496878514266
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.013698599999999998	0.9164496878514266
HEPARIN-INDUCED THROMBOCYTOPENIA	0.013698599999999998	0.9164496878514266
STURGE-WEBER SYNDROME	0.013698599999999998	0.9164496878514266
CARDIOMYOPATHY, DILATED, 1E	0.013698599999999998	0.9164496878514266
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.013698599999999998	0.9164496878514266
STROKE, ISCHEMIC	0.013698599999999998	0.9164496878514266
AORTA COARCTATION	0.013698599999999998	0.9164496878514266
SICKLE CELL ANEMIA	0.013698599999999998	0.9164496878514266
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.013698599999999998	0.9164496878514266
EISENMENGER SYNDROME	0.013698599999999998	0.9164496878514266
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.013698599999999998	0.9164496878514266
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.013698599999999998	0.9164496878514266
WALDENSTRÖM MACROGLOBULINEMIA	0.013698599999999998	0.9164496878514266
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.013698599999999998	0.9164496878514266
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.013698599999999998	0.9164496878514266
MOYAMOYA DISEASE WITH EARLY-ONSET ACHALASIA	0.013698599999999998	0.9164496878514266
ATRIAL FIBRILLATION, FAMILIAL, 1; ATFB1	0.013698599999999998	0.9164496878514266
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.013698599999999998	0.9164496878514266
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.013698599999999998	0.9164496878514266
ABETA AMYLOIDOSIS, DUTCH TYPE	0.013698599999999998	0.9164496878514266
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.013698599999999998	0.9164496878514266
ANEURYSM OF SINUS OF VALSALVA	0.013698599999999998	0.9164496878514266
ACYS AMYLOIDOSIS	0.013698599999999998	0.9164496878514266
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.013698599999999998	0.9164496878514266
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.013679520000000002	0.9151732172599646
PALLISTER-KILLIAN SYNDROME	0.013679520000000002	0.9151732172599646
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.013574874	0.9081722978933942
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.01354018	0.9058512354877236
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.013414630000000002	0.897451818152394
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.013414630000000002	0.897451818152394
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.013414630000000002	0.897451818152394
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.013350184000000003	0.8931403179565148
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.013350004000000002	0.8931282757811236
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.013203754000000002	0.8833440082758113
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.013203754000000002	0.8833440082758113
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.013203754000000002	0.8833440082758113
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.013203754000000002	0.8833440082758113
CORNELIA DE LANGE SYNDROME 1	0.01302932	0.8716742037081417
4Q21 MICRODELETION SYNDROME	0.01278375	0.8552453314258884
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.012658200000000001	0.8468459140905589
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.012658200000000001	0.8468459140905589
SPINOCEREBELLAR ATAXIA 37; SCA37	0.012658200000000001	0.8468459140905589
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.012658200000000001	0.8468459140905589
ATAXIA-OCULOMOTOR APRAXIA 3; AOA3	0.012658200000000001	0.8468459140905589
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.012658200000000001	0.8468459140905589
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.012658200000000001	0.8468459140905589
MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15	0.012658200000000001	0.8468459140905589
GAMMA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R5	0.012658200000000001	0.8468459140905589
MYOPATHY AND DIABETES MELLITUS	0.012658200000000001	0.8468459140905589
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.012658200000000001	0.8468459140905589
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.012658200000000001	0.8468459140905589
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC; CMT2CC	0.012658200000000001	0.8468459140905589
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.012658200000000001	0.8468459140905589
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.012658200000000001	0.8468459140905589
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.012658200000000001	0.8468459140905589
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.012658200000000001	0.8468459140905589
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.012658200000000001	0.8468459140905589
AUTOSOMAL RECESSIVE AXONAL NEUROPATHY WITH NEUROMYOTONIA	0.012658200000000001	0.8468459140905589
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.012658200000000001	0.8468459140905589
PURE MITOCHONDRIAL MYOPATHY	0.012658200000000001	0.8468459140905589
MULTIPLE SYSTEM ATROPHY	0.012658200000000001	0.8468459140905589
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1G; CMT1G	0.012658200000000001	0.8468459140905589
CAP MYOPATHY	0.012658200000000001	0.8468459140905589
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.012658200000000001	0.8468459140905589
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 3	0.012658200000000001	0.8468459140905589
ALPHA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R3	0.012658200000000001	0.8468459140905589
ADENYLOSUCCINATE SYNTHETASE-LIKE 1-RELATED DISTAL MYOPATHY	0.012658200000000001	0.8468459140905589
SPINOCEREBELLAR ATAXIA 44; SCA44	0.012658200000000001	0.8468459140905589
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.012658200000000001	0.8468459140905589
X-LINKED DYSTONIA-PARKINSONISM	0.012658200000000001	0.8468459140905589
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.012658200000000001	0.8468459140905589
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.012658200000000001	0.8468459140905589
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.012658200000000001	0.8468459140905589
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.012658200000000001	0.8468459140905589
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	0.012658200000000001	0.8468459140905589
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.012658200000000001	0.8468459140905589
HEREDITARY MOTOR AND SENSORY NEUROPATHY V	0.012658200000000001	0.8468459140905589
STIFF-PERSON SYNDROME; SPS	0.012658200000000001	0.8468459140905589
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.012658200000000001	0.8468459140905589
HYPEREKPLEXIA 1; HKPX1	0.012658200000000001	0.8468459140905589
NEMALINE MYOPATHY 3; NEM3	0.012658200000000001	0.8468459140905589
MYOPATHY, MYOFIBRILLAR, 9, WITH EARLY RESPIRATORY FAILURE; MFM9	0.012658200000000001	0.8468459140905589
NEMALINE MYOPATHY 2; NEM2	0.012658200000000001	0.8468459140905589
PRIMARY PROGRESSIVE FREEZING GAIT	0.012658200000000001	0.8468459140905589
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.012658200000000001	0.8468459140905589
EPISODIC ATAXIA TYPE 4	0.012658200000000001	0.8468459140905589
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.012658200000000001	0.8468459140905589
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.012654574	0.8466033311574015
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.012593754000000002	0.8425344138946796
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.012593754000000002	0.8425344138946796
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.012593754000000002	0.8425344138946796
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.012593754000000002	0.8425344138946796
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.012593754000000002	0.8425344138946796
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.012593754000000002	0.8425344138946796
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.012593754000000002	0.8425344138946796
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.012593754000000002	0.8425344138946796
RECOMBINANT CHROMOSOME 8 SYNDROME	0.012593754000000002	0.8425344138946796
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.012593754000000002	0.8425344138946796
MENTAL RETARDATION, X-LINKED 98; MRX98	0.012593754000000002	0.8425344138946796
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.012593754000000002	0.8425344138946796
COG2-CDG	0.012593754000000002	0.8425344138946796
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.012593754000000002	0.8425344138946796
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.012593754000000002	0.8425344138946796
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.012593754000000002	0.8425344138946796
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.012593754000000002	0.8425344138946796
LISSENCEPHALY 1; LIS1	0.012593754000000002	0.8425344138946796
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.012593754000000002	0.8425344138946796
ANGELMAN SYNDROME	0.012593754000000002	0.8425344138946796
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.012593754000000002	0.8425344138946796
TRISOMY XQ28	0.01248701	0.8353931362838277
CHRISTIANSON SYNDROME	0.01247418	0.8345347967823361
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.01247418	0.8345347967823361
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.01247418	0.8345347967823361
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.012461644000000001	0.8336961261673168
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.012461644000000001	0.8336961261673168
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.012461644000000001	0.8336961261673168
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.01210902	0.8101052369721492
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.012048200000000002	0.8060363197094272
MENTAL RETARDATION, X-LINKED 1	0.012048200000000002	0.8060363197094272
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.012048200000000002	0.8060363197094272
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.012048200000000002	0.8060363197094272
INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; CASGID	0.012048200000000002	0.8060363197094272
BARAITSER-WINTER SYNDROME 2; BRWS2	0.012048200000000002	0.8060363197094272
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.01195172	0.7995817136997688
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.011951719999999999	0.7995817136997688
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.011898144	0.7959974270955662
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.011757924000000001	0.7866165724658578
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.011718684000000002	0.7839913782305863
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.011718684000000002	0.7839913782305863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.011717749999999999	0.7839288927205009
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.011705214	0.7830902221054816
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.011705214	0.7830902221054816
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.011705214	0.7830902221054816
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.01161212	0.7768621427951257
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.01135259	0.759499332910314
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.011229984	0.7512968720436042
KLEEFSTRA SYNDROME	0.010988664	0.7351523289025309
ISOLATED GLYCEROL KINASE DEFICIENCY	0.010962254000000001	0.7333854741687512
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.010962254000000001	0.7333854741687512
MICROVILLUS INCLUSION DISEASE	0.010962254000000001	0.7333854741687512
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.010962254000000001	0.7333854741687512
METHYLMALONIC ACIDURIA, CBLA TYPE	0.010962254000000001	0.7333854741687512
ISOVALERIC ACIDEMIA	0.010962254000000001	0.7333854741687512
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.010962254000000001	0.7333854741687512
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.010962254000000001	0.7333854741687512
METHYLMALONIC ACIDURIA, CBLB TYPE	0.010962254000000001	0.7333854741687512
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.010962254000000001	0.7333854741687512
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.010843154	0.7254175681182712
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.01068443	0.7147987778583519
GAPO SYNDROME; GAPOS	0.01068443	0.7147987778583519
NON-DISTAL MONOSOMY 10Q	0.01045594	0.6995125742187702
GLUTARIC ACIDEMIA I; GA1	0.010416700000000001	0.6968873799834988
LACTASE DEFICIENCY, CONGENITAL	0.010416700000000001	0.6968873799834988
HEREDITARY FRUCTOSE INTOLERANCE	0.010416700000000001	0.6968873799834988
PRIMARY HYPEROXALURIA	0.010416700000000001	0.6968873799834988
NEUROLEPTIC MALIGNANT SYNDROME	0.010416700000000001	0.6968873799834988
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.010416700000000001	0.6968873799834988
RIBOFLAVIN DEFICIENCY	0.010416700000000001	0.6968873799834988
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.010416700000000001	0.6968873799834988
MALIGNANT HYPERTHERMIA OF ANESTHESIA	0.010416700000000001	0.6968873799834988
SUDDEN CARDIAC FAILURE, INFANTILE	0.010416700000000001	0.6968873799834988
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.010416700000000001	0.6968873799834988
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.010416700000000001	0.6968873799834988
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.010416700000000001	0.6968873799834988
HAWKINSINURIA	0.010416700000000001	0.6968873799834988
HYPEROXALURIA, PRIMARY, TYPE I; HP1	0.010416700000000001	0.6968873799834988
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.010416700000000001	0.6968873799834988
HAWKINSINURIA	0.010416700000000001	0.6968873799834988
GLUCOSE/GALACTOSE MALABSORPTION; GGM	0.010416700000000001	0.6968873799834988
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.010416700000000001	0.6968873799834988
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.010344830000000001	0.6920792069537088
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.010344830000000001	0.6920792069537088
SMITH-MAGENIS SYNDROME	0.010126604	0.6774796749153206
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.009829854	0.6576268107635158
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.009829854	0.6576268107635158
KOOLEN-DE VRIES SYNDROME	0.009829854	0.6576268107635158
HALL-RIGGS SYNDROME	0.00979516	0.6553057483578454
RING CHROMOSOME 7 SYNDROME	0.00979516	0.6553057483578454
TEMPLE-BARAITSER SYNDROME	0.00979516	0.6553057483578454
MONOSOMY 5P	0.00979516	0.6553057483578454
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.00968668	0.6480483306554434
ACROOTOOCULAR SYNDROME	0.0092843	0.6211287165782635
RENPENNING SYNDROME	0.0092843	0.6211287165782635
MARDEN-WALKER SYNDROME	0.0092843	0.6211287165782635
EPILEPSY-TELANGIECTASIA	0.00916422	0.6130952475728763
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.009073424	0.6070209067016807
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.009073424	0.6070209067016807
11Q22.2Q22.3 MICRODELETION SYNDROME	0.009073424	0.6070209067016807
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.009073424	0.6070209067016807
LATERAL MENINGOCELE SYNDROME	0.009073424	0.6070209067016807
SIALURIA	0.009073424	0.6070209067016807
COFFIN-SIRIS SYNDROME 6; CSS6	0.009073424	0.6070209067016807
SIMPSON-GOLABI-BEHMEL SYNDROME	0.009073424	0.6070209067016807
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.009073424	0.6070209067016807
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.009073424	0.6070209067016807
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.009073424	0.6070209067016807
DISTAL MONOSOMY 9P	0.009073424	0.6070209067016807
PERLMAN SYNDROME	0.009073424	0.6070209067016807
CHROMOSOME 9P DELETION SYNDROME	0.009073424	0.6070209067016807
14Q11.2 MICRODELETION SYNDROME	0.00903873	0.6046998442960102
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00903873	0.6046998442960102
CRANIOFACIAL DYSSYNOSTOSIS	0.00903873	0.6046998442960102
ASPARTYLGLUCOSAMINURIA; AGU	0.00885465	0.5923847129293238
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.00882462	0.590375676668233
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.00882462	0.590375676668233
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.008709394	0.5826669449925606
ADENYLOSUCCINASE DEFICIENCY	0.008709394	0.5826669449925606
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.008709394	0.5826669449925606
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.008643774	0.5782769030527409
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.008538144000000001	0.5712101531273658
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00852787	0.5705228125164284
LEGIUS SYNDROME	0.00852787	0.5705228125164284
VELO-FACIAL-SKELETAL SYNDROME	0.00852787	0.5705228125164284
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.00852787	0.5705228125164284
TURNER SYNDROME	0.00852787	0.5705228125164284
CLASSICAL EHLERS-DANLOS SYNDROME	0.00852787	0.5705228125164284
3P25.3 MICRODELETION SYNDROME	0.00852787	0.5705228125164284
MONOSOMY X	0.00852787	0.5705228125164284
CRANIOECTODERMAL DYSPLASIA 1	0.00852787	0.5705228125164284
MOSAIC MONOSOMY X	0.00852787	0.5705228125164284
600736 VELOFACIOSKELETAL SYNDROME	0.00852787	0.5705228125164284
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00852787	0.5705228125164284
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.00852787	0.5705228125164284
16P12.1P12.3 TRIPLICATION SYNDROME	0.00852787	0.5705228125164284
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.008515050000000001	0.5696651420246808
PELIZAEUS-MERZBACHER DISEASE	0.00851505	0.5696651420246807
ISOLATED COMPLEX I DEFICIENCY	0.008344233999999999	0.5582373851823734
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.008344233999999999	0.5582373851823734
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.008344233999999999	0.5582373851823734
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.008344233999999999	0.5582373851823734
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.008344233999999999	0.5582373851823734
INFANTILE LIVER FAILURE SYNDROME 1	0.008344233999999999	0.5582373851823734
HOLOPROSENCEPHALY	0.008309644000000001	0.5559232804780402
CHROMOSOME 1P36 DELETION SYNDROME	0.008309644000000001	0.5559232804780402
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.008309644000000001	0.5559232804780402
19P13.12 MICRODELETION SYNDROME	0.008309644	0.5559232804780401
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.008309644	0.5559232804780401
DESBUQUOIS DYSPLASIA 2; DBQD2	0.008309644	0.5559232804780401
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.008309644	0.5559232804780401
17Q21.31 MICRODUPLICATION SYNDROME	0.008309644	0.5559232804780401
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.008309644	0.5559232804780401
1Q44 MICRODELETION SYNDROME	0.008309644	0.5559232804780401
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.008309644	0.5559232804780401
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.008309644	0.5559232804780401
FETAL TRIMETHADIONE SYNDROME	0.008309644	0.5559232804780401
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.008309644	0.5559232804780401
MONOSOMY 9P	0.008309644	0.5559232804780401
BARATELA-SCOTT SYNDROME	0.008309644	0.5559232804780401
2Q31.1 MICRODELETION SYNDROME	0.008309644	0.5559232804780401
NIEMANN-PICK DISEASE TYPE C	0.008304174000000001	0.5555573321480979
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.008304174000000001	0.5555573321480979
OCULO-PALATO-CEREBRAL SYNDROME	0.008198534	0.5484899132129786
OROFACIODIGITAL SYNDROME TYPE 4	0.008198534	0.5484899132129786
DISTAL MONOSOMY 12Q	0.008198534	0.5484899132129786
COHEN SYNDROME	0.008198534	0.5484899132129786
RING CHROMOSOME 12 SYNDROME	0.008198534	0.5484899132129786
EAR-PATELLA-SHORT STATURE SYNDROME	0.008198534	0.5484899132129786
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.008198534	0.5484899132129786
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.008198534	0.5484899132129786
HEART AND BRAIN MALFORMATION SYNDROME	0.008198534	0.5484899132129786
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.00816384	0.5461688508073081
DISTAL MONOSOMY 10P	0.00816384	0.5461688508073081
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.00816384	0.5461688508073081
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.00816384	0.5461688508073081
DPM1-CDG	0.00816384	0.5461688508073081
YUNIS-VARON SYNDROME	0.00816384	0.5461688508073081
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.00816384	0.5461688508073081
COFS SYNDROME	0.00816384	0.5461688508073081
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00816384	0.5461688508073081
SECKEL SYNDROME 7; SCKL7	0.00816384	0.5461688508073081
ALLAN-HERNDON-DUDLEY SYNDROME	0.00816384	0.5461688508073081
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00816384	0.5461688508073081
ADENYLOSUCCINATE LYASE DEFICIENCY	0.00816384	0.5461688508073081
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.00816384	0.5461688508073081
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.00816384	0.5461688508073081
HENNEKAM-BEEMER SYNDROME	0.00816384	0.5461688508073081
BOWEN-CONRADI SYNDROME	0.00816384	0.5461688508073081
CROME SYNDROME	0.00816384	0.5461688508073081
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00816384	0.5461688508073081
21Q22.11Q22.12 MICRODELETION SYNDROME	0.00816384	0.5461688508073081
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.00816384	0.5461688508073081
KEPPEN-LUBINSKY SYNDROME	0.00816384	0.5461688508073081
MEHMO SYNDROME	0.00816384	0.5461688508073081
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.008151304	0.5453301801922886
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.008151304	0.5453301801922886
REFSUM DISEASE	0.00809822	0.5417788088674886
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.007952964	0.5320610409307253
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.007952964	0.5320610409307253
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.007952964	0.5320610409307253
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007952964	0.5320610409307253
300270 ADRENOMYODYSTROPHY	0.007952964	0.5320610409307253
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00779868	0.5217392909971211
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.00779868	0.5217392909971211
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.00779868	0.5217392909971211
3-HYDROXYISOBUTYRIC ACIDURIA	0.00779868	0.5217392909971211
PSEUDO-TORCH SYNDROME 2	0.00779868	0.5217392909971211
DUPLICATION/INVERSION 15Q11	0.00776409	0.5194251862927879
MONOSOMY 22	0.00776409	0.5194251862927879
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00776409	0.5194251862927879
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.00776409	0.5194251862927879
WIEDEMANN-STEINER SYNDROME	0.00776409	0.5194251862927879
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.00776409	0.5194251862927879
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.00776409	0.5194251862927879
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.007758620000000001	0.5190592379628456
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.007758620000000001	0.5190592379628456
FAMILIAL COLORECTAL CANCER TYPE X	0.007758620000000001	0.5190592379628456
METACHROMATIC LEUKODYSTROPHY	0.007758620000000001	0.5190592379628456
ALEXANDER DISEASE	0.007758620000000001	0.5190592379628456
NEUROFERRITINOPATHY	0.007758620000000001	0.5190592379628456
CADASIL	0.007758620000000001	0.5190592379628456
BEHÇET DISEASE	0.007758620000000001	0.5190592379628456
CHOREOACANTHOCYTOSIS	0.007758620000000001	0.5190592379628456
ATAXIA WITH VITAMIN E DEFICIENCY	0.007758620000000001	0.5190592379628456
LYNCH SYNDROME	0.007758620000000001	0.5190592379628456
TRISOMY 18P	0.00765298	0.5119918190277263
TEEBI-SHALTOUT SYNDROME; TBSH	0.00765298	0.5119918190277263
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.00765298	0.5119918190277263
MICROPHTHALMIA, SYNDROMIC 1	0.00765298	0.5119918190277263
HALLERMANN-STREIFF SYNDROME	0.00765298	0.5119918190277263
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00765298	0.5119918190277263
LEPRECHAUNISM	0.00765298	0.5119918190277263
COHEN SYNDROME	0.00765298	0.5119918190277263
OROFACIODIGITAL SYNDROME TYPE 5	0.00765298	0.5119918190277263
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.00765298	0.5119918190277263
HALLERMANN-STREIFF SYNDROME; HSS	0.00765298	0.5119918190277263
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.00765298	0.5119918190277263
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00765298	0.5119918190277263
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.00765298	0.5119918190277263
SHPRINTZEN-GOLDBERG SYNDROME	0.00765298	0.5119918190277263
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.00765298	0.5119918190277263
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.007587804	0.5076314811205384
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.007587804	0.5076314811205384
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.007587804	0.5076314811205384
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.007587804	0.5076314811205384
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.007587804	0.5076314811205384
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.007587804	0.5076314811205384
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.007587804	0.5076314811205384
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.007587804	0.5076314811205384
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.007587804	0.5076314811205384
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.007587804	0.5076314811205384
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.007587804	0.5076314811205384
NAVAJO NEUROHEPATOPATHY	0.007587804	0.5076314811205384
HYPOTONIA-CYSTINURIA SYNDROME	0.007587804	0.5076314811205384
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.007587804	0.5076314811205384
2P21 MICRODELETION SYNDROME	0.007587804	0.5076314811205384
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.007587804	0.5076314811205384
WIEDEMANN-STEINER SYNDROME; WDSTS	0.007553214000000001	0.5053173764162051
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.007553214000000001	0.5053173764162051
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.007553214000000001	0.5053173764162051
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.007553214000000001	0.5053173764162051
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.007442104000000001	0.49788400915114345
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.007442104000000001	0.49788400915114345
6Q TERMINAL DELETION SYNDROME	0.007442104000000001	0.49788400915114345
OGDEN SYNDROME	0.007442104000000001	0.49788400915114345
BARDET-BIEDL SYNDROME 1; BBS1	0.007442104000000001	0.49788400915114345
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.007442104000000001	0.49788400915114345
DIGEORGE SYNDROME; DGS	0.007442104000000001	0.49788400915114345
OCCIPITAL HORN SYNDROME	0.007442104000000001	0.49788400915114345
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.007442104000000001	0.49788400915114345
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.007442104000000001	0.49788400915114345
3C SYNDROME	0.007442104000000001	0.49788400915114345
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.007442104000000001	0.49788400915114345
MUENKE SYNDROME	0.007442104000000001	0.49788400915114345
ADRENOMYODYSTROPHY	0.00740741	0.49556294674547297
2Q24 MICRODELETION SYNDROME	0.00740741	0.49556294674547297
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00740741	0.49556294674547297
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.00740741	0.49556294674547297
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.00740741	0.49556294674547297
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.00740741	0.49556294674547297
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.00740741	0.49556294674547297
GABRIELE-DE VRIES SYNDROME	0.00740741	0.49556294674547297
INTELLECTUAL DISABILITY, WOLFF TYPE	0.00740741	0.49556294674547297
1Q41Q42 MICRODELETION SYNDROME	0.00740741	0.49556294674547297
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00740741	0.49556294674547297
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.00740741	0.49556294674547297
SMITH-FINEMAN-MYERS SYNDROME	0.00740741	0.49556294674547297
FRYNS SYNDROME	0.00740741	0.49556294674547297
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.00740741	0.49556294674547297
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.00740741	0.49556294674547297
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.00740741	0.49556294674547297
LISSENCEPHALY 5; LIS5	0.00740741	0.49556294674547297
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.00740741	0.49556294674547297
PITT-HOPKINS-LIKE SYNDROME	0.00740741	0.49556294674547297
ALLAN-HERNDON-DUDLEY SYNDROME	0.00740741	0.49556294674547297
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00740741	0.49556294674547297
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.00740741	0.49556294674547297
CONO-SPONDYLAR DYSPLASIA	0.00740741	0.49556294674547297
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.00740741	0.49556294674547297
GLUTAMINE DEFICIENCY, CONGENITAL	0.00740741	0.49556294674547297
KID SYNDROME	0.00740741	0.49556294674547297
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00740741	0.49556294674547297
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.007394874	0.4947242761304535
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.007394874	0.4947242761304535
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.007394874	0.4947242761304535
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.007394874	0.4947242761304535
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.007394874	0.4947242761304535
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.007394874	0.4947242761304535
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.007394874	0.4947242761304535
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.007394874	0.4947242761304535
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.007394874	0.4947242761304535
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.007394874	0.4947242761304535
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.007394874	0.4947242761304535
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.007394874	0.4947242761304535
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.0072436440000000005	0.48460684177265273
RING CHROMOSOME 22 SYNDROME	0.0072436440000000005	0.48460684177265273
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00723616	0.48410615488027825
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00723616	0.48410615488027825
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00723616	0.48410615488027825
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.00704225	0.47113338693528606
GLYCOGEN STORAGE DISEASE IB	0.00704225	0.47113338693528606
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.00704225	0.47113338693528606
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.00704225	0.47113338693528606
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.00704225	0.47113338693528606
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.00704225	0.47113338693528606
GLYCOGEN STORAGE DISEASE IA	0.00704225	0.47113338693528606
MAPLE SYRUP URINE DISEASE; MSUD	0.00704225	0.47113338693528606
GLYCOGEN STORAGE DISEASE IXC	0.00704225	0.47113338693528606
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.00704225	0.47113338693528606
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00704225	0.47113338693528606
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.00704225	0.47113338693528606
PHENFORMIN 4-HYDROXYLATION	0.00704225	0.47113338693528606
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.00704225	0.47113338693528606
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.00704225	0.47113338693528606
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00704225	0.47113338693528606
GRACILE SYNDROME	0.00704225	0.47113338693528606
MYOPATHY, MITOCHONDRIAL, LETHAL INFANTILE	0.00704225	0.47113338693528606
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	0.00704225	0.47113338693528606
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	0.00704225	0.47113338693528606
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.00704225	0.47113338693528606
SUCCINIC ACIDEMIA	0.00704225	0.47113338693528606
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.00704225	0.47113338693528606
LICHTENSTEIN SYNDROME	0.007007660000000001	0.46881928223095276
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.007007660000000001	0.46881928223095276
CEREBROFACIOTHORACIC DYSPLASIA	0.007007660000000001	0.46881928223095276
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.007007660000000001	0.46881928223095276
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.007007660000000001	0.46881928223095276
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.007007660000000001	0.46881928223095276
PHOCOMELIA, SCHINZEL TYPE	0.00689655	0.46138591496589115
MYOPATHIC EHLERS-DANLOS SYNDROME	0.00689655	0.46138591496589115
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00689655	0.46138591496589115
%157700 MITRAL VALVE PROLAPSE 1; MVP1;;MITRAL VALVE PROLAPSE, MYXOMATOUS 1; MMVP1;;MYXOMATOUS MITRAL VALVE PROLAPSE 1;;MITRAL VALVE PROLAPSE, FAMILIAL; MVP PROLAPSED MITRAL VALVE; PMV;;MITRAL REGURGITATION, FAMILIAL;;FLOPPY MITRAL VALVE;;BARLOW SYNDROME;;MYXOMATOUS VALVULAR DISEASE, FAMILIAL;;CLICK-MURMUR SYNDROME	0.00689655	0.46138591496589115
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.00689655	0.46138591496589115
CLEIDOCRANIAL DYSPLASIA	0.00689655	0.46138591496589115
MARFAN SYNDROME	0.00689655	0.46138591496589115
OROFACIODIGITAL SYNDROME XVII	0.00689655	0.46138591496589115
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00689655	0.46138591496589115
NEONATAL MARFAN SYNDROME	0.00689655	0.46138591496589115
CENANI-LENZ SYNDROME	0.00689655	0.46138591496589115
RADIO-RENAL SYNDROME	0.00689655	0.46138591496589115
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.00689655	0.46138591496589115
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00689655	0.46138591496589115
FAMILIAL ANETODERMA	0.00689655	0.46138591496589115
OCULOPHARYNGODISTAL MYOPATHY	0.00689655	0.46138591496589115
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.00689655	0.46138591496589115
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.00689655	0.46138591496589115
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.00689655	0.46138591496589115
STICKLER SYNDROME, TYPE II	0.00689655	0.46138591496589115
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00689655	0.46138591496589115
HYDROCEPHALUS-OBESITY-HYPOGONADISM SYNDROME	0.00689655	0.46138591496589115
INTERMEDIATE NEMALINE MYOPATHY	0.00689655	0.46138591496589115
SIMOSA CRANIOFACIAL SYNDROME	0.00689655	0.46138591496589115
ACROPECTOROVERTEBRAL DYSPLASIA	0.00689655	0.46138591496589115
118980 CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL	0.00689655	0.46138591496589115
CARDIOSPONDYLOCARPOFACIAL SYNDROME	0.00689655	0.46138591496589115
CLEIDOCRANIAL DYSPLASIA; CCD	0.00689655	0.46138591496589115
MARFANOID HYPERMOBILITY SYNDROME	0.00689655	0.46138591496589115
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00689655	0.46138591496589115
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.00689655	0.46138591496589115
601095 HARROD SYNDROME	0.00689655	0.46138591496589115
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.00689655	0.46138591496589115
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.00684932	0.4582261819452012
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00684932	0.4582261819452012
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.00684932	0.4582261819452012
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00684932	0.4582261819452012
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.00684932	0.4582261819452012
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.00684932	0.4582261819452012
GLYCOGEN STORAGE DISEASE DUE TO LACTATE DEHYDROGENASE DEFICIENCY	0.00684932	0.4582261819452012
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.00684932	0.4582261819452012
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.00684932	0.4582261819452012
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00684932	0.4582261819452012
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.00684932	0.4582261819452012
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.00684932	0.4582261819452012
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.00684932	0.4582261819452012
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00684932	0.4582261819452012
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.00684932	0.4582261819452012
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00684932	0.4582261819452012
PERRAULT SYNDROME 5; PRLTS5	0.00684932	0.4582261819452012
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00684932	0.4582261819452012
LEBER OPTIC ATROPHY AND DYSTONIA	0.00684932	0.4582261819452012
GLYCOGEN STORAGE DISEASE 0, LIVER	0.00684932	0.4582261819452012
GLYCOGEN STORAGE DISEASE XI; GSD11	0.00684932	0.4582261819452012
AUTOSOMAL DOMINANT MITOCHONDRIAL MYOPATHY WITH EXERCISE INTOLERANCE	0.00684932	0.4582261819452012
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00684932	0.4582261819452012
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00684932	0.4582261819452012
BARAITSER-WINTER SYNDROME 1; BRWS1	0.006721184	0.44965375869008534
CHROMOSOME 10Q26 DELETION SYNDROME	0.006721184	0.44965375869008534
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.006721184	0.44965375869008534
14Q12 MICRODELETION SYNDROME	0.00669809	0.4481087475874003
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.006678324	0.4467863829275029
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.006678324	0.4467863829275029
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.006678324	0.4467863829275029
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.006678324	0.4467863829275029
KBG SYNDROME	0.006678324	0.4467863829275029
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.006678324	0.4467863829275029
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.006678324	0.4467863829275029
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.006678324	0.4467863829275029
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.006678324	0.4467863829275029
ALAZAMI-YUAN SYNDROME	0.006678324	0.4467863829275029
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.006678324	0.4467863829275029
HOLOPROSENCEPHALY 11	0.006678324	0.4467863829275029
BOHRING-OPITZ SYNDROME	0.006678324	0.4467863829275029
12Q14 MICRODELETION SYNDROME	0.006678324	0.4467863829275029
GOLDBERG-SHPRINTZEN SYNDROME	0.006678324	0.4467863829275029
HOLOPROSENCEPHALY 5; HPE5	0.006678324	0.4467863829275029
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.006678324	0.4467863829275029
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.006678324	0.4467863829275029
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.006487214	0.4340009377108175
2P15P16.1 MICRODELETION SYNDROME	0.006381584000000001	0.4269341877854423
PYRUVATE DEHYDROGENASE DEFICIENCY	0.006381584000000001	0.4269341877854423
1P36 DELETION SYNDROME	0.006381584000000001	0.4269341877854423
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.00617563	0.41315566450483304
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.00613277	0.41028828874225054
XYLT1-CDG	0.00613277	0.41028828874225054
2Q23.1 MICRODELETION SYNDROME	0.00613277	0.41028828874225054
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00613277	0.41028828874225054
CORNELIA DE LANGE SYNDROME	0.00613277	0.41028828874225054
BRANCHIOSKELETOGENITAL SYNDROME	0.00613277	0.41028828874225054
20P13 MICRODELETION SYNDROME	0.00613277	0.41028828874225054
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00613277	0.41028828874225054
MICROTRIPLICATION 11Q24.1	0.00613277	0.41028828874225054
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00613277	0.41028828874225054
9Q SUBTELOMERIC DELETION SYNDROME	0.00613277	0.41028828874225054
NON-DISTAL TRISOMY 13Q	0.00613277	0.41028828874225054
KLEEFSTRA SYNDROME	0.00613277	0.41028828874225054
PIEBALDISM	0.00613277	0.41028828874225054
SMITH-MAGENIS SYNDROME; SMS	0.0059218940000000005	0.3961804788656678
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.0059218940000000005	0.3961804788656678
11P15.4 MICRODUPLICATION SYNDROME	0.0059218940000000005	0.3961804788656678
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.0059218940000000005	0.3961804788656678
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.0059218940000000005	0.3961804788656678
ELSAHY-WATERS SYNDROME; ESWS	0.0059218940000000005	0.3961804788656678
EVEN-PLUS SYNDROME	0.0059218940000000005	0.3961804788656678
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.0059218940000000005	0.3961804788656678
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.0059218940000000005	0.3961804788656678
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.0059218940000000005	0.3961804788656678
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.0059218940000000005	0.3961804788656678
DESANTO-SHINAWI SYNDROME	0.0059218940000000005	0.3961804788656678
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.0059218940000000005	0.3961804788656678
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.0059218940000000005	0.3961804788656678
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.0059218940000000005	0.3961804788656678
GERMAN SYNDROME	0.0059218940000000005	0.3961804788656678
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.005836030000000001	0.39043609360018994
TETRASOMY 18P	0.00583603	0.39043609360018994
OROFACIODIGITAL SYNDROME TYPE 6	0.005625154	0.3763282837236071
COHEN-GIBSON SYNDROME; COGIS	0.005625154	0.3763282837236071
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.005625154	0.3763282837236071
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.005612324	0.37546994422211544
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.005612324	0.37546994422211544
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.005612324	0.37546994422211544
AICARDI-GOUTIERES SYNDROME 6	0.005612324	0.37546994422211544
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.005612324	0.37546994422211544
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.005612324	0.37546994422211544
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.005612324	0.37546994422211544
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.005612324	0.37546994422211544
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.005612324	0.37546994422211544
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.005612324	0.37546994422211544
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.005612324	0.37546994422211544
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.005612324	0.37546994422211544
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.005612324	0.37546994422211544
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.005612324	0.37546994422211544
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.005612324	0.37546994422211544
ALPERS-HUTTENLOCHER SYNDROME	0.005612324	0.37546994422211544
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.005612324	0.37546994422211544
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.005612324	0.37546994422211544
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.005612324	0.37546994422211544
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.005612324	0.37546994422211544
MULTIPLE SULFATASE DEFICIENCY	0.005612324	0.37546994422211544
EDINBURGH MALFORMATION SYNDROME	0.00537634	0.35968238468041547
PRIMROSE SYNDROME; PRIMS	0.00537634	0.35968238468041547
ISOLATED TRIGONOCEPHALY	0.00537634	0.35968238468041547
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.00537634	0.35968238468041547
17Q12 MICRODUPLICATION SYNDROME	0.00537634	0.35968238468041547
ACROOSTEOLYSIS DOMINANT TYPE	0.00537634	0.35968238468041547
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.00537634	0.35968238468041547
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.00537634	0.35968238468041547
WAARDENBURG SYNDROME	0.00537634	0.35968238468041547
MCDONOUGH SYNDROME	0.00537634	0.35968238468041547
GINGIVAL FIBROMATOSIS-FACIAL DYSMORPHISM SYNDROME	0.00537634	0.35968238468041547
14Q24.1Q24.3 MICRODELETION SYNDROME	0.00537634	0.35968238468041547
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.00537634	0.35968238468041547
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.00537634	0.35968238468041547
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.00537634	0.35968238468041547
GASTROCUTANEOUS SYNDROME	0.00537634	0.35968238468041547
X-LINKED INTELLECTUAL DISABILITY, SIDERIUS TYPE	0.00537634	0.35968238468041547
17Q24.2 MICRODELETION SYNDROME	0.00537634	0.35968238468041547
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00537634	0.35968238468041547
ZLOTOGORA-OGUR SYNDROME	0.00537634	0.35968238468041547
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.00537634	0.35968238468041547
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.00537634	0.35968238468041547
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.00537634	0.35968238468041547
MENTAL RETARDATION, X-LINKED 21	0.00537634	0.35968238468041547
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.00537634	0.35968238468041547
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.00537634	0.35968238468041547
SOMATOMAMMOTROPINOMA	0.00537634	0.35968238468041547
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.00537634	0.35968238468041547
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.00537634	0.35968238468041547
WAARDENBURG SYNDROME, TYPE 1; WS1	0.00537634	0.35968238468041547
ACROMEGALY	0.00537634	0.35968238468041547
ZIMMERMANN-LABAND SYNDROME 1	0.00537634	0.35968238468041547
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00537634	0.35968238468041547
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.00537634	0.35968238468041547
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00537634	0.35968238468041547
MARSHALL-SMITH SYNDROME; MRSHSS	0.00537634	0.35968238468041547
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00537634	0.35968238468041547
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00537634	0.35968238468041547
MENTAL RETARDATION, X-LINKED 73	0.00537634	0.35968238468041547
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.00537634	0.35968238468041547
WAARDENBURG SYNDROME TYPE 1	0.00537634	0.35968238468041547
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.00537634	0.35968238468041547
WAARDENBURG-SHAH SYNDROME	0.00537634	0.35968238468041547
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.00537634	0.35968238468041547
TRANSALDOLASE DEFICIENCY	0.00537634	0.35968238468041547
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00537634	0.35968238468041547
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.00537634	0.35968238468041547
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.00537634	0.35968238468041547
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.00537634	0.35968238468041547
EMANUEL SYNDROME	0.005089864	0.34051686113954815
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.0050898639999999995	0.3405168611395481
MOEBIUS SYNDROME; MBS	0.0050796	0.3398301895383548
MYOTONIA PERMANENS	0.0050796	0.3398301895383548
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.0050796	0.3398301895383548
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.00506677	0.3389718500368631
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.00506677	0.3389718500368631
RETT SYNDROME	0.00506677	0.3389718500368631
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	0.00506677	0.3389718500368631
NORRIE DISEASE	0.00506677	0.3389718500368631
TRIPLE A SYNDROME	0.00506677	0.3389718500368631
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.00506677	0.3389718500368631
XERODERMA PIGMENTOSUM	0.00506677	0.3389718500368631
CANAVAN DISEASE	0.004855894	0.3248640401602803
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.004855894	0.3248640401602803
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.004855894	0.3248640401602803
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.004855894	0.3248640401602803
MUCOPOLYSACCHARIDOSIS TYPE 2	0.004855894	0.3248640401602803
TAY-SACHS DISEASE	0.004855894	0.3248640401602803
CHÉDIAK-HIGASHI SYNDROME	0.004855894	0.3248640401602803
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.004855894	0.3248640401602803
SCHINDLER DISEASE, TYPE I	0.004855894	0.3248640401602803
MYOCLONIC EPILEPSY OF INFANCY	0.004855894	0.3248640401602803
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.004855894	0.3248640401602803
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.004855894	0.3248640401602803
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.004855894	0.3248640401602803
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.004855894	0.3248640401602803
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.004855894	0.3248640401602803
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.004855894	0.3248640401602803
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.004855894	0.3248640401602803
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.004855894	0.3248640401602803
MYOCLONIC-ASTASTIC EPILEPSY	0.004855894	0.3248640401602803
OPTIC PATHWAY GLIOMA	0.004855894	0.3248640401602803
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.004855894	0.3248640401602803
ZTTK SYNDROME; ZTTKS	0.004855894	0.3248640401602803
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.004855894	0.3248640401602803
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.004855894	0.3248640401602803
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.004855894	0.3248640401602803
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.004855894	0.3248640401602803
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.004855894	0.3248640401602803
RIDDLE SYNDROME	0.004750264000000001	0.31779729023490505
3Q29 MICRODELETION SYNDROME	0.004750264000000001	0.31779729023490505
16P13.2 MICRODELETION SYNDROME	0.004750264000000001	0.31779729023490505
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.004750264	0.31779729023490494
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.004750264	0.31779729023490494
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00454431	0.3040187669542958
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00454431	0.3040187669542958
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00454431	0.3040187669542958
46,XX GONADAL DYSGENESIS	0.00454431	0.3040187669542958
CARDIAC LIPIDOSIS, FAMILIAL	0.00454431	0.3040187669542958
XYLOSIDASE DEFICIENCY	0.00454431	0.3040187669542958
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.004333434	0.28991095707771297
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.004333434	0.28991095707771297
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.004333434	0.28991095707771297
REVESZ SYNDROME	0.004333434	0.28991095707771297
SALLA DISEASE	0.004333434	0.28991095707771297
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.004333434	0.28991095707771297
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.004333434	0.28991095707771297
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.004333434	0.28991095707771297
EPILEPSY, PYRIDOXINE-DEPENDENT	0.004333434	0.28991095707771297
LARSEN-LIKE SYNDROME	0.004333434	0.28991095707771297
SNEDDON SYNDROME	0.00431034	0.288365945975028
WHIPPLE DISEASE	0.00431034	0.288365945975028
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.00431034	0.288365945975028
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.00431034	0.288365945975028
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.00431034	0.288365945975028
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.00431034	0.288365945975028
GM2 GANGLIOSIDOSIS, AB VARIANT	0.00431034	0.288365945975028
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.00431034	0.288365945975028
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00431034	0.288365945975028
MUCOPOLYSACCHARIDOSIS TYPE 3	0.00431034	0.288365945975028
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00431034	0.288365945975028
CEREBROTENDINOUS XANTHOMATOSIS	0.00431034	0.288365945975028
WOLFRAM SYNDROME	0.00431034	0.288365945975028
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.00431034	0.288365945975028
DYSOSTEOSCLEROSIS	0.00431034	0.288365945975028
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.00431034	0.288365945975028
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.00431034	0.288365945975028
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.00431034	0.288365945975028
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.00431034	0.288365945975028
DYSOSTEOSCLEROSIS	0.00431034	0.288365945975028
ALEXANDER DISEASE	0.00431034	0.288365945975028
NASU-HAKOLA DISEASE	0.00431034	0.288365945975028
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.00431034	0.288365945975028
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.00431034	0.288365945975028
KRABBE DISEASE	0.00431034	0.288365945975028
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.00431034	0.288365945975028
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.00431034	0.288365945975028
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.00431034	0.288365945975028
SPASTIC TETRAPLEGIA-RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY SYNDROME	0.00431034	0.288365945975028
CHILDHOOD DISINTEGRATIVE DISORDER	0.00431034	0.288365945975028
ADIPOSIS DOLOROSA	0.00431034	0.288365945975028
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.00431034	0.288365945975028
WEST SYNDROME	0.00431034	0.288365945975028
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.00431034	0.288365945975028
TRISOMY 5P	0.00431034	0.288365945975028
INFANTILE NEUROAXONAL DYSTROPHY	0.00431034	0.288365945975028
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00431034	0.288365945975028
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.00431034	0.288365945975028
CARNOSINASE DEFICIENCY	0.00431034	0.288365945975028
GAUCHER DISEASE	0.00431034	0.288365945975028
PANDAS	0.00431034	0.288365945975028
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.00431034	0.288365945975028
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00431034	0.288365945975028
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00431034	0.288365945975028
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00420471	0.2812991960496527
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00420471	0.2812991960496527
MUCOLIPIDOSIS TYPE IV	0.00420471	0.2812991960496527
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.00420471	0.2812991960496527
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00420471	0.2812991960496527
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00420471	0.2812991960496527
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00420471	0.2812991960496527
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.003993834	0.26719138617306987
FRIED SYNDROME	0.003993834	0.26719138617306987
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.003993834	0.26719138617306987
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.003993834	0.26719138617306987
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.003993834	0.26719138617306987
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.003993834	0.26719138617306987
INCONTINENTIA PIGMENTI	0.003993834	0.26719138617306987
SHWACHMAN-DIAMOND SYNDROME	0.003993834	0.26719138617306987
KRABBE DISEASE	0.003993834	0.26719138617306987
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.003993834	0.26719138617306987
JOUBERT SYNDROME 24	0.003993834	0.26719138617306987
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.003993834	0.26719138617306987
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.003993834	0.26719138617306987
JOUBERT SYNDROME	0.003993834	0.26719138617306987
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.003993834	0.26719138617306987
JOUBERT SYNDROME WITH OCULAR DEFECT	0.003993834	0.26719138617306987
FREE SIALIC ACID STORAGE DISEASE	0.003993834	0.26719138617306987
JOUBERT SYNDROME WITH RENAL DEFECT	0.003993834	0.26719138617306987
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.003993834	0.26719138617306987
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.003993834	0.26719138617306987
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.003993834	0.26719138617306987
L1 SYNDROME	0.003993834	0.26719138617306987
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.003993834	0.26719138617306987
HYDROCEPHALUS, NORMAL-PRESSURE	0.003993834	0.26719138617306987
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.003993834	0.26719138617306987
FOIX-CHAVANY-MARIE SYNDROME	0.003993834	0.26719138617306987
BLOOD GROUP, DUFFY SYSTEM; FY	0.00378788	0.2534128628924607
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.00378788	0.2534128628924607
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00378788	0.2534128628924607
MYELOPEROXIDASE DEFICIENCY	0.00378788	0.2534128628924607
CARBOXYLESTERASE 1	0.00378788	0.2534128628924607
FLOOD FACTOR DEFICIENCY	0.00378788	0.2534128628924607
OSTEOGENESIS IMPERFECTA, TYPE V	0.00378788	0.2534128628924607
BEETURIA	0.00378788	0.2534128628924607
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00378788	0.2534128628924607
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00378788	0.2534128628924607
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00378788	0.2534128628924607
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00378788	0.2534128628924607
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00378788	0.2534128628924607
GLOMUVENOUS MALFORMATIONS	0.00378788	0.2534128628924607
GLUTATHIONE REDUCTASE	0.00378788	0.2534128628924607
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00378788	0.2534128628924607
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00378788	0.2534128628924607
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00378788	0.2534128628924607
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00378788	0.2534128628924607
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00378788	0.2534128628924607
XANTHINURIA, TYPE I	0.00378788	0.2534128628924607
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00378788	0.2534128628924607
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00378788	0.2534128628924607
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00378788	0.2534128628924607
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00378788	0.2534128628924607
COUMARIN RESISTANCE	0.00378788	0.2534128628924607
T-SUBSTANCE ANOMALY	0.00378788	0.2534128628924607
BARTTER SYNDROME	0.00378788	0.2534128628924607
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00378788	0.2534128628924607
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00378788	0.2534128628924607
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00378788	0.2534128628924607
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00378788	0.2534128628924607
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00378788	0.2534128628924607
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00378788	0.2534128628924607
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00378788	0.2534128628924607
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00378788	0.2534128628924607
PENDRED SYNDROME	0.00378788	0.2534128628924607
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00378788	0.2534128628924607
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.00378788	0.2534128628924607
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00378788	0.2534128628924607
HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME	0.00378788	0.2534128628924607
CHOROIDAL OSTEOMA, BILATERAL	0.00378788	0.2534128628924607
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00378788	0.2534128628924607
TESTICULAR GERM CELL TUMOR; TGCT	0.00378788	0.2534128628924607
CATECHOL-O-METHYLTRANSFERASE	0.00378788	0.2534128628924607
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00378788	0.2534128628924607
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00378788	0.2534128628924607
HEINZ BODY ANEMIAS	0.00378788	0.2534128628924607
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00378788	0.2534128628924607
CEREBELLOPARENCHYMAL DISORDER V	0.00378788	0.2534128628924607
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00378788	0.2534128628924607
URATE-BINDING GLOBULIN, DECREASE IN	0.00378788	0.2534128628924607
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.00378788	0.2534128628924607
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00378788	0.2534128628924607
CITRULLINE TRANSPORT DEFECT	0.00378788	0.2534128628924607
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00378788	0.2534128628924607
DERMATITIS, ATOPIC	0.00378788	0.2534128628924607
PROPERDIN DEFICIENCY, X-LINKED	0.00378788	0.2534128628924607
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00378788	0.2534128628924607
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.00378788	0.2534128628924607
PREMATURE OVARIAN FAILURE 1	0.00378788	0.2534128628924607
MACULAR DYSTROPHY, CORNEAL, 1	0.00378788	0.2534128628924607
OSTEOGENIC SARCOMA	0.00378788	0.2534128628924607
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00378788	0.2534128628924607
CEPHALIN LIPIDOSIS	0.00378788	0.2534128628924607
POLYCYSTIC OVARY SYNDROME 1	0.00378788	0.2534128628924607
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00378788	0.2534128628924607
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00378788	0.2534128628924607
MYOPATHY, SPHEROID BODY	0.00378788	0.2534128628924607
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00378788	0.2534128628924607
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00378788	0.2534128628924607
LUTHERAN SUPPRESSOR, X-LINKED	0.00378788	0.2534128628924607
ICHTHYOSIS AND MALE HYPOGONADISM	0.00378788	0.2534128628924607
DERMATOLEUKODYSTROPHY	0.00378788	0.2534128628924607
ICHTHYOSIS, X-LINKED	0.00378788	0.2534128628924607
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00378788	0.2534128628924607
SERTOLI CELL-ONLY SYNDROME	0.00378788	0.2534128628924607
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00378788	0.2534128628924607
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00378788	0.2534128628924607
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00378788	0.2534128628924607
XM SYSTEM	0.00378788	0.2534128628924607
LACTOSE INTOLERANCE, ADULT TYPE	0.00378788	0.2534128628924607
AREDYLD	0.00378788	0.2534128628924607
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00378788	0.2534128628924607
ALKAPTONURIA	0.00378788	0.2534128628924607
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00378788	0.2534128628924607
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00378788	0.2534128628924607
TRISOMY 18-LIKE SYNDROME	0.00378788	0.2534128628924607
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00378788	0.2534128628924607
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00378788	0.2534128628924607
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00378788	0.2534128628924607
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00378788	0.2534128628924607
SCHIZOPHRENIA 4	0.00378788	0.2534128628924607
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.00378788	0.2534128628924607
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00378788	0.2534128628924607
CONE-ROD DYSTROPHY 1; CORD1	0.00378788	0.2534128628924607
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00378788	0.2534128628924607
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00378788	0.2534128628924607
DELETED IN AZOOSPERMIA	0.00378788	0.2534128628924607
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00378788	0.2534128628924607
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00378788	0.2534128628924607
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00378788	0.2534128628924607
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00378788	0.2534128628924607
ZINC, ELEVATED PLASMA	0.00378788	0.2534128628924607
WHITE SPONGE NEVUS OF CANNON	0.00378788	0.2534128628924607
MACROCYTOSIS, FAMILIAL	0.00378788	0.2534128628924607
ONCOCYTOMA	0.00378788	0.2534128628924607
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00378788	0.2534128628924607
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00378788	0.2534128628924607
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00378788	0.2534128628924607
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.00378788	0.2534128628924607
PROGESTERONE RESISTANCE	0.00378788	0.2534128628924607
GONADOBLASTOMA	0.00378788	0.2534128628924607
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00378788	0.2534128628924607
FINGERPRINT BODY MYOPATHY	0.00378788	0.2534128628924607
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00378788	0.2534128628924607
257960 OCULOTRICHODYSPLASIA; OTD	0.00378788	0.2534128628924607
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00378788	0.2534128628924607
LARON SYNDROME	0.00378788	0.2534128628924607
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00378788	0.2534128628924607
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00378788	0.2534128628924607
MACULAR CORNEAL DYSTROPHY	0.00378788	0.2534128628924607
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00378788	0.2534128628924607
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00378788	0.2534128628924607
PYGMY	0.00378788	0.2534128628924607
HYPOASCORBEMIA	0.00378788	0.2534128628924607
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.00378788	0.2534128628924607
ACETYLATION, SLOW	0.00378788	0.2534128628924607
OSTEOMESOPYKNOSIS	0.00378788	0.2534128628924607
ALAND ISLAND EYE DISEASE	0.00378788	0.2534128628924607
APOLIPOPROTEIN(A)	0.00378788	0.2534128628924607
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00378788	0.2534128628924607
HOOFT DISEASE	0.00378788	0.2534128628924607
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00378788	0.2534128628924607
KERATOSIS, FAMILIAL ACTINIC	0.00378788	0.2534128628924607
LIPASE DEFICIENCY, COMBINED	0.00378788	0.2534128628924607
CUTANEOUS COLLAGENOUS VASCULOPATHY	0.00378788	0.2534128628924607
OCULORENOCEREBELLAR SYNDROME	0.00378788	0.2534128628924607
SPERMATOGENIC FAILURE 1; SPGF1	0.00378788	0.2534128628924607
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00378788	0.2534128628924607
CONGENITAL ADRENAL HYPERPLASIA	0.00378788	0.2534128628924607
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00378788	0.2534128628924607
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00378788	0.2534128628924607
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00378788	0.2534128628924607
HYPERPROGLUCAGONEMIA	0.00378788	0.2534128628924607
LYMPHOKINE DEFICIENCY	0.00378788	0.2534128628924607
MAGNESIUM, ELEVATED RED CELL	0.00378788	0.2534128628924607
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00378788	0.2534128628924607
HYPERLEUCINE-ISOLEUCINEMIA	0.00378788	0.2534128628924607
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.00378788	0.2534128628924607
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.00378788	0.2534128628924607
FETAL IODINE DEFICIENCY DISORDER	0.00378788	0.2534128628924607
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00378788	0.2534128628924607
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00378788	0.2534128628924607
ETHANOLAMINOSIS	0.00378788	0.2534128628924607
CALVARIAL HYPEROSTOSIS	0.00378788	0.2534128628924607
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00378788	0.2534128628924607
NORMOKALEMIC PERIODIC PARALYSIS	0.00378788	0.2534128628924607
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00378788	0.2534128628924607
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00378788	0.2534128628924607
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00378788	0.2534128628924607
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00378788	0.2534128628924607
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00378788	0.2534128628924607
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00378788	0.2534128628924607
NEUTROPHIL ACTIN DYSFUNCTION	0.00378788	0.2534128628924607
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00378788	0.2534128628924607
PREMATURE CENTROMERE DIVISION; PCD	0.00378788	0.2534128628924607
PARAOXONASE 1	0.00378788	0.2534128628924607
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00378788	0.2534128628924607
%608572 BURN-MCKEOWN SYNDROME	0.00378788	0.2534128628924607
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00378788	0.2534128628924607
PITUITARY DWARFISM IV	0.00378788	0.2534128628924607
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00378788	0.2534128628924607
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00378788	0.2534128628924607
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00378788	0.2534128628924607
GLUTATHIONURIA	0.00378788	0.2534128628924607
OVARIAN CANCER	0.00378788	0.2534128628924607
PACMAN DYSPLASIA	0.00378788	0.2534128628924607
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00378788	0.2534128628924607
PERRY SYNDROME	0.00378788	0.2534128628924607
MYOCLONIC EPILEPSY OF LAFORA	0.00344828	0.23069329198781757
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.00344828	0.23069329198781757
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00344828	0.23069329198781757
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00344828	0.23069329198781757
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.00344828	0.23069329198781757
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00344828	0.23069329198781757
AUTOSOMAL DOMINANT STRIATAL NEURODEGENERATION	0.00344828	0.23069329198781757
MUTILATING HEREDITARY SENSORY NEUROPATHY WITH SPASTIC PARAPLEGIA	0.00344828	0.23069329198781757
RICHARDS-RUNDLE SYNDROME	0.00344828	0.23069329198781757
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.00344828	0.23069329198781757
OSTEOCHONDRITIS DISSECANS	0.00344828	0.23069329198781757
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00344828	0.23069329198781757
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00344828	0.23069329198781757
HEREDITARY HYPEREKPLEXIA	0.00344828	0.23069329198781757
MYOPATHY, DISTAL, 1; MPD1	0.00344828	0.23069329198781757
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.00344828	0.23069329198781757
LATE-ONSET DISTAL MYOPATHY, MARKESBERY-GRIGGS TYPE	0.00344828	0.23069329198781757
PRIMARY DYSTONIA, DYT4 TYPE	0.00344828	0.23069329198781757
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00344828	0.23069329198781757
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.00344828	0.23069329198781757
EARLY-ONSET GENERALIZED LIMB-ONSET DYSTONIA	0.00344828	0.23069329198781757
SPINOCEREBELLAR ATAXIA TYPE 4	0.00344828	0.23069329198781757
SPINOCEREBELLAR ATAXIA TYPE 17	0.00344828	0.23069329198781757
DOPA-RESPONSIVE DYSTONIA	0.00344828	0.23069329198781757
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.00344828	0.23069329198781757
MULTIPLE SCLEROSIS-ICHTHYOSIS-FACTOR VIII DEFICIENCY SYNDROME	0.00344828	0.23069329198781757
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00344828	0.23069329198781757
ACETAZOLAMIDE-RESPONSIVE MYOTONIA	0.00344828	0.23069329198781757
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2K	0.00344828	0.23069329198781757
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00344828	0.23069329198781757
ROUSSY-LÉVY SYNDROME	0.00344828	0.23069329198781757
JUVENILE AMYOTROPHIC LATERAL SCLEROSIS	0.00344828	0.23069329198781757
CHOREOATHETOSIS, FAMILIAL INVERTED	0.00344828	0.23069329198781757
SPONTANEOUS PERIODIC HYPOTHERMIA	0.00344828	0.23069329198781757
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00344828	0.23069329198781757
SPASTIC PARAPLEGIA-FACIAL-CUTANEOUS LESIONS SYNDROME	0.00344828	0.23069329198781757
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.00344828	0.23069329198781757
MYOTONIA FLUCTUANS	0.00344828	0.23069329198781757
LERI PLEONOSTEOSIS	0.00344828	0.23069329198781757
PELVIC DYSPLASIA-ARTHROGRYPOSIS OF LOWER LIMBS SYNDROME	0.00344828	0.23069329198781757
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.00344828	0.23069329198781757
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.00344828	0.23069329198781757
SPONDYLOMETAPHYSEAL DYSPLASIA	0.00344828	0.23069329198781757
SUBEPENDYMOMA	0.00344828	0.23069329198781757
EPENDYMOMA	0.00344828	0.23069329198781757
MAST SYNDROME	0.00344828	0.23069329198781757
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.00344828	0.23069329198781757
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.00344828	0.23069329198781757
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.00344828	0.23069329198781757
MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO COLLAGEN 9 ANOMALY	0.00344828	0.23069329198781757
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.00344828	0.23069329198781757
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00344828	0.23069329198781757
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 5	0.00344828	0.23069329198781757
MULTIPLE METAPHYSEAL DYSPLASIA	0.00344828	0.23069329198781757
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 1	0.00344828	0.23069329198781757
METACHROMATIC LEUKODYSTROPHY	0.00344828	0.23069329198781757
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.00344828	0.23069329198781757
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.00344828	0.23069329198781757
BENIGN HEREDITARY CHOREA	0.00344828	0.23069329198781757
AMYOTROPHIC LATERAL SCLEROSIS TYPE 4	0.00344828	0.23069329198781757
SPONASTRIME DYSPLASIA	0.00344828	0.23069329198781757
FAMILIAL DYSAUTONOMIA	0.00344828	0.23069329198781757
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.00344828	0.23069329198781757
224550 DYSTONIA WITH RINGBINDEN	0.00344828	0.23069329198781757
MASA SYNDROME	0.00344828	0.23069329198781757
BEHR SYNDROME	0.00344828	0.23069329198781757
MULTIPLE SYMMETRIC LIPOMATOSIS	0.00344828	0.23069329198781757
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00344828	0.23069329198781757
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.00344828	0.23069329198781757
PALMOPLANTAR KERATODERMA-SPASTIC PARALYSIS SYNDROME	0.00344828	0.23069329198781757
CYSTINOSIS	0.00344828	0.23069329198781757
DYSEQUILIBRIUM SYNDROME	0.00344828	0.23069329198781757
ADULT POLYGLUCOSAN BODY DISEASE	0.00344828	0.23069329198781757
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.00344828	0.23069329198781757
PARTINGTON SYNDROME	0.00344828	0.23069329198781757
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00344828	0.23069329198781757
GLYCOGEN STORAGE DISEASE DUE TO LAMP-2 DEFICIENCY	0.00344828	0.23069329198781757
THORACOMELIC DYSPLASIA	0.00344828	0.23069329198781757
ATAXIA-OCULOMOTOR APRAXIA TYPE 1	0.00344828	0.23069329198781757
HEREDITARY SPASTIC PARAPLEGIA	0.00344828	0.23069329198781757
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.00344828	0.23069329198781757
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	0.00344828	0.23069329198781757
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.00344828	0.23069329198781757
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.00344828	0.23069329198781757
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.00344828	0.23069329198781757
GAUCHER DISEASE TYPE 3	0.00344828	0.23069329198781757
KENNEDY DISEASE	0.00344828	0.23069329198781757
NONAKA MYOPATHY	0.00344828	0.23069329198781757
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00344828	0.23069329198781757
DYSTONIA 16; DYT16	0.00344828	0.23069329198781757
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.00344828	0.23069329198781757
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.00344828	0.23069329198781757
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.00344828	0.23069329198781757
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.00344828	0.23069329198781757
KALLMANN SYNDROME	0.00344828	0.23069329198781757
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00344828	0.23069329198781757
DYSTONIA 23; DYT23	0.00344828	0.23069329198781757
PSEUDOACHONDROPLASIA	0.00344828	0.23069329198781757
X-LINKED CENTRONUCLEAR MYOPATHY	0.00344828	0.23069329198781757
CENTRONUCLEAR MYOPATHY	0.00344828	0.23069329198781757
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.00344828	0.23069329198781757
OSTEOGENESIS IMPERFECTA	0.00344828	0.23069329198781757
ATAXIA-TELANGIECTASIA	0.00344828	0.23069329198781757
KUFOR-RAKEB SYNDROME	0.00344828	0.23069329198781757
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00344828	0.23069329198781757
TRYPTOPHANURIA WITH DWARFISM	0.00344828	0.23069329198781757
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.00344828	0.23069329198781757
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.00344828	0.23069329198781757
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.00344828	0.23069329198781757
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.00344828	0.23069329198781757
PSYCHOGENIC MOVEMENT DISORDERS	0.00344828	0.23069329198781757
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.00344828	0.23069329198781757
POLYMYOSITIS	0.00344828	0.23069329198781757
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00344828	0.23069329198781757
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.00344828	0.23069329198781757
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00344828	0.23069329198781757
ALZHEIMER DISEASE 3; AD	0.00344828	0.23069329198781757
SIALIDOSIS TYPE 1	0.00344828	0.23069329198781757
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.00344828	0.23069329198781757
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.00344828	0.23069329198781757
NEMALINE MYOPATHY 7; NEM7	0.00344828	0.23069329198781757
NEUROFIBROMATOSIS TYPE 2	0.00344828	0.23069329198781757
BRITTLE CORNEA SYNDROME 2; BCS2	0.00344828	0.23069329198781757
POTASSIUM-AGGRAVATED MYOTONIA	0.00344828	0.23069329198781757
MELNICK-NEEDLES SYNDROME	0.00344828	0.23069329198781757
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.00344828	0.23069329198781757
IDIOPATHIC JUVENILE OSTEOPOROSIS	0.00344828	0.23069329198781757
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.00344828	0.23069329198781757
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.00344828	0.23069329198781757
LAING EARLY-ONSET DISTAL MYOPATHY	0.00344828	0.23069329198781757
MUSCLE-EYE-BRAIN DISEASE	0.00344828	0.23069329198781757
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.00344828	0.23069329198781757
BRITTLE CORNEA SYNDROME	0.00344828	0.23069329198781757
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.00344828	0.23069329198781757
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.00344828	0.23069329198781757
CORTICOBASAL SYNDROME	0.00344828	0.23069329198781757
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00344828	0.23069329198781757
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00344828	0.23069329198781757
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.00344828	0.23069329198781757
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.00344828	0.23069329198781757
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00344828	0.23069329198781757
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.00344828	0.23069329198781757
KUSKOKWIM SYNDROME	0.00344828	0.23069329198781757
NEMALINE MYOPATHY 6	0.00344828	0.23069329198781757
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.00344828	0.23069329198781757
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00344828	0.23069329198781757
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.00344828	0.23069329198781757
CLASSIC GALACTOSEMIA	0.00344828	0.23069329198781757
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00344828	0.23069329198781757
HYPERKALEMIC PERIODIC PARALYSIS	0.00344828	0.23069329198781757
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.0029333040000000003	0.19624089579762471
10Q22.3Q23.3 MICRODELETION SYNDROME	0.0029333040000000003	0.19624089579762471
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0029333040000000003	0.19624089579762471
RUBINSTEIN-TAYBI SYNDROME	0.0029333040000000003	0.19624089579762471
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.0029333040000000003	0.19624089579762471
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.0029333040000000003	0.19624089579762471
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.0029333040000000003	0.19624089579762471
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.0029333040000000003	0.19624089579762471
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.0029333040000000003	0.19624089579762471
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.0029333040000000003	0.19624089579762471
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.0029333040000000003	0.19624089579762471
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.0029333040000000003	0.19624089579762471
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.0029333040000000003	0.19624089579762471
MONOSOMY 18Q	0.0029333040000000003	0.19624089579762471
MONOSOMY 18P	0.0029333040000000003	0.19624089579762471
FANCONI ANEMIA	0.0029333040000000003	0.19624089579762471
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.0029333040000000003	0.19624089579762471
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.0029333040000000003	0.19624089579762471
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.0029333040000000003	0.19624089579762471
LATHOSTEROLOSIS	0.0029333040000000003	0.19624089579762471
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.0029333040000000003	0.19624089579762471
MATERNAL PHENYLKETONURIA	0.0029333040000000003	0.19624089579762471
DISTAL TRISOMY 17Q	0.0029333040000000003	0.19624089579762471
15Q24 MICRODELETION SYNDROME	0.0029333040000000003	0.19624089579762471
DISTAL MONOSOMY 10Q	0.0029333040000000003	0.19624089579762471
TOLUENE EMBRYOPATHY	0.0029333040000000003	0.19624089579762471
FETAL ALCOHOL SYNDROME	0.0029333040000000003	0.19624089579762471
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.0029333040000000003	0.19624089579762471
19P13.3 MICRODUPLICATION SYNDROME	0.0029333040000000003	0.19624089579762471
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.0029333040000000003	0.19624089579762471
CEREBROFACIOARTICULAR SYNDROME	0.0029333040000000003	0.19624089579762471
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.0029333040000000003	0.19624089579762471
SMITH-LEMLI-OPITZ SYNDROME	0.0029333040000000003	0.19624089579762471
HOLMES-GANG SYNDROME	0.0029333040000000003	0.19624089579762471
22Q11.2 DELETION SYNDROME	0.0029333040000000003	0.19624089579762471
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.0029333040000000003	0.19624089579762471
OGDEN SYNDROME; OGDNS	0.0029333040000000003	0.19624089579762471
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.0029333040000000003	0.19624089579762471
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.0029333040000000003	0.19624089579762471
22Q11.2 MICRODUPLICATION SYNDROME	0.0029333040000000003	0.19624089579762471
6Q16 MICRODELETION SYNDROME	0.0029333040000000003	0.19624089579762471
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.0029333040000000003	0.19624089579762471
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.0029333040000000003	0.19624089579762471
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0029333040000000003	0.19624089579762471
C SYNDROME	0.0029333040000000003	0.19624089579762471
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.0029333040000000003	0.19624089579762471
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.0029333040000000003	0.19624089579762471
MONOSOMY 13Q34	0.0029333040000000003	0.19624089579762471
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.0029333040000000003	0.19624089579762471
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.0029333040000000003	0.19624089579762471
COFFIN-SIRIS SYNDROME	0.0029333040000000003	0.19624089579762471
WARSAW BREAKAGE SYNDROME; WABS	0.0029333040000000003	0.19624089579762471
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.0029333040000000003	0.19624089579762471
6Q25 MICRODELETION SYNDROME	0.0029333040000000003	0.19624089579762471
8P11.2 DELETION SYNDROME	0.0029333040000000003	0.19624089579762471
8P23.1 MICRODELETION SYNDROME	0.0029333040000000003	0.19624089579762471
ROTHMUND-THOMSON SYNDROME	0.0029333040000000003	0.19624089579762471
CK SYNDROME	0.0029333040000000003	0.19624089579762471
HARTSFIELD SYNDROME; HRTFDS	0.0029333040000000003	0.19624089579762471
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.0029333040000000003	0.19624089579762471
CHARGE SYNDROME	0.0029333040000000003	0.19624089579762471
LIG4 SYNDROME	0.0029333040000000003	0.19624089579762471
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.0029333040000000003	0.19624089579762471
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.0029333040000000003	0.19624089579762471
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.0029333040000000003	0.19624089579762471
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.0029333040000000003	0.19624089579762471
HADZISELIMOVIC SYNDROME	0.0029333040000000003	0.19624089579762471
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.0029333040000000003	0.19624089579762471
20Q11.2 MICRODUPLICATION SYNDROME	0.0029333040000000003	0.19624089579762471
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.0029333040000000003	0.19624089579762471
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.0029333040000000003	0.19624089579762471
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.0029333040000000003	0.19624089579762471
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.0029333040000000003	0.19624089579762471
1Q21.1 MICRODELETION SYNDROME	0.0029333040000000003	0.19624089579762471
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.0029333040000000003	0.19624089579762471
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.0029333039999999994	0.19624089579762463
PHENOBARBITAL EMBRYOPATHY	0.0029333039999999994	0.19624089579762463
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.0029333039999999994	0.19624089579762463
DISTAL MONOSOMY 1Q	0.0029333039999999994	0.19624089579762463
RING CHROMOSOME 14 SYNDROME	0.0029333039999999994	0.19624089579762463
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.0029333039999999994	0.19624089579762463
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.0029333039999999994	0.19624089579762463
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.00238775	0.15974280161237236
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00238775	0.15974280161237236
DISTAL TRISOMY 5Q	0.00238775	0.15974280161237236
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00238775	0.15974280161237236
FEINGOLD SYNDROME 1; FGLDS1	0.00238775	0.15974280161237236
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00238775	0.15974280161237236
MARTSOLF SYNDROME	0.00238775	0.15974280161237236
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.00238775	0.15974280161237236
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00238775	0.15974280161237236
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00238775	0.15974280161237236
DUBOWITZ SYNDROME	0.00238775	0.15974280161237236
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00238775	0.15974280161237236
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00238775	0.15974280161237236
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00238775	0.15974280161237236
C SYNDROME	0.00238775	0.15974280161237236
PRIMARY PULMONARY HYPOPLASIA	0.00238775	0.15974280161237236
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.00238775	0.15974280161237236
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00238775	0.15974280161237236
OROFACIODIGITAL SYNDROME I; OFD1	0.00238775	0.15974280161237236
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00238775	0.15974280161237236
DIAMOND-BLACKFAN ANEMIA 1	0.00238775	0.15974280161237236
JACOBSEN SYNDROME	0.00238775	0.15974280161237236
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.00238775	0.15974280161237236
MONOSOMY 13Q14	0.00238775	0.15974280161237236
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.00238775	0.15974280161237236
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00238775	0.15974280161237236
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00238775	0.15974280161237236
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.00238775	0.15974280161237236
CAREY-FINEMAN-ZITER SYNDROME	0.00238775	0.15974280161237236
COFFIN-SIRIS SYNDROME 10; CSS10	0.00238775	0.15974280161237236
RING CHROMOSOME 13 SYNDROME	0.00238775	0.15974280161237236
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.00238775	0.15974280161237236
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.00238775	0.15974280161237236
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00238775	0.15974280161237236
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00238775	0.15974280161237236
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.00238775	0.15974280161237236
LATHOSTEROLOSIS	0.00238775	0.15974280161237236
DISTAL MONOSOMY 3P	0.00238775	0.15974280161237236
ACHALASIA-MICROCEPHALY SYNDROME	0.00238775	0.15974280161237236
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.00238775	0.15974280161237236
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.00238775	0.15974280161237236
RING CHROMOSOME 6 SYNDROME	0.00238775	0.15974280161237236
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00238775	0.15974280161237236
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.00238775	0.15974280161237236
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00238775	0.15974280161237236
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00238775	0.15974280161237236
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00238775	0.15974280161237236
DESMOSTEROLOSIS	0.00238775	0.15974280161237236
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00238775	0.15974280161237236
GMS SYNDROME	0.00238775	0.15974280161237236
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00238775	0.15974280161237236
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.00238775	0.15974280161237236
DUBOWITZ SYNDROME	0.00238775	0.15974280161237236
CHROMOSOME 18Q DELETION SYNDROME	0.00238775	0.15974280161237236
CRI-DU-CHAT SYNDROME	0.00238775	0.15974280161237236
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00238775	0.15974280161237236
XQ25 MICRODUPLICATION SYNDROME	0.0021768739999999996	0.1456349917357895
WEAVER SYNDROME	0.0021768739999999996	0.1456349917357895
XQ25 DUPLICATION SYNDROME	0.0021768739999999996	0.1456349917357895
AARSKOG-SCOTT SYNDROME	0.0021768739999999996	0.1456349917357895
OPITZ G/BBB SYNDROME	0.0021768739999999996	0.1456349917357895
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.0021768739999999996	0.1456349917357895
POTOCKI-SHAFFER SYNDROME	0.0021768739999999996	0.1456349917357895
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.0021768739999999996	0.1456349917357895
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.0021768739999999996	0.1456349917357895
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.0021768739999999996	0.1456349917357895
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.0021768739999999996	0.1456349917357895
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.0021768739999999996	0.1456349917357895
THAUVIN-ROBINET-FAIVRE SYNDROME	0.0021768739999999996	0.1456349917357895
ICF SYNDROME	0.0021768739999999996	0.1456349917357895
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.0021768739999999996	0.1456349917357895
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.0021768739999999996	0.1456349917357895
48,XXYY SYNDROME	0.0021768739999999996	0.1456349917357895
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.0021768739999999996	0.1456349917357895
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.0021768739999999996	0.1456349917357895
PSEUDOAMINOPTERIN SYNDROME	0.0021768739999999996	0.1456349917357895
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.0021768739999999996	0.1456349917357895
JOUBERT SYNDROME 14	0.0021768739999999996	0.1456349917357895
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.0021768739999999996	0.1456349917357895
CHROMOSOME 16Q22 DELETION SYNDROME	0.0021768739999999996	0.1456349917357895
TRISOMY X	0.0021768739999999996	0.1456349917357895
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.0021768739999999996	0.1456349917357895
TETRASOMY 9P	0.0021768739999999996	0.1456349917357895
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.0021768739999999996	0.1456349917357895
CARDIOFACIOCUTANEOUS SYNDROME	0.0021768739999999996	0.1456349917357895
NOONAN SYNDROME 3; NS3	0.0021768739999999996	0.1456349917357895
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.0021768739999999996	0.1456349917357895
TETRASOMY 5P	0.0021768739999999996	0.1456349917357895
DISTAL MONOSOMY 6P	0.0021768739999999996	0.1456349917357895
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.0021768739999999996	0.1456349917357895
PMM2-CDG	0.0021768739999999996	0.1456349917357895
LYMPHEDEMA, HEREDITARY, III	0.0021768739999999996	0.1456349917357895
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.0021768739999999996	0.1456349917357895
COSTELLO SYNDROME; CSTLO	0.0021768739999999996	0.1456349917357895
LAMB-SHAFFER SYNDROME	0.0021768739999999996	0.1456349917357895
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.0021768739999999996	0.1456349917357895
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.0021768739999999996	0.1456349917357895
16P11.2P12.2 MICRODELETION SYNDROME	0.0021768739999999996	0.1456349917357895
DIAPHANOSPONDYLODYSOSTOSIS	0.0021768739999999996	0.1456349917357895
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.0021768739999999996	0.1456349917357895
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.0021768739999999996	0.1456349917357895
14Q22Q23 MICRODELETION SYNDROME	0.0021768739999999996	0.1456349917357895
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.0021768739999999996	0.1456349917357895
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.0021768739999999996	0.1456349917357895
48,XYYY SYNDROME	0.0021768739999999996	0.1456349917357895
MENTAL RETARDATION, X-LINKED 91; MRX91	0.0021768739999999996	0.1456349917357895
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.0021768739999999996	0.1456349917357895
MONOSOMY 9Q22.3	0.0021768739999999996	0.1456349917357895
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.0021768739999999996	0.1456349917357895
TRISOMY 12P	0.0021768739999999996	0.1456349917357895
15Q11Q13 MICRODUPLICATION SYNDROME	0.0021768739999999996	0.1456349917357895
NOONAN SYNDROME 6; NS6	0.0021768739999999996	0.1456349917357895
19P13.13 MICRODELETION SYNDROME	0.0021768739999999996	0.1456349917357895
MONOSOMY 22Q13.3	0.0021768739999999996	0.1456349917357895
X SMALL RINGS	0.0021768739999999996	0.1456349917357895
48,XXXY SYNDROME	0.0021768739999999996	0.1456349917357895
INFANTILE SIALIC ACID STORAGE DISEASE	0.0021768739999999996	0.1456349917357895
49,XXXXY SYNDROME	0.0021768739999999996	0.1456349917357895
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.0021768739999999996	0.1456349917357895
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.0021768739999999996	0.1456349917357895
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.0021768739999999996	0.1456349917357895
TEMPLE-BARAITSER SYNDROME; TMBTS	0.0021768739999999996	0.1456349917357895
CODAS SYNDROME	0.0021768739999999996	0.1456349917357895
20P12.3 MICRODELETION SYNDROME	0.0021768739999999996	0.1456349917357895
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.0021768739999999996	0.1456349917357895
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.0021768739999999996	0.1456349917357895
NOONAN SYNDROME 5; NS5	0.0021768739999999996	0.1456349917357895
JOUBERT SYNDROME 10	0.0021768739999999996	0.1456349917357895
BAKER-GORDON SYNDROME; BAGOS	0.0021768739999999996	0.1456349917357895
TETRASOMY X	0.0021768739999999996	0.1456349917357895
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.0021768739999999996	0.1456349917357895
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.0021768739999999996	0.1456349917357895
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.0021768739999999996	0.1456349917357895
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.0021768739999999996	0.1456349917357895
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.0021768739999999996	0.1456349917357895
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.0021768739999999996	0.1456349917357895
OROFACIODIGITAL SYNDROME VI	0.0021768739999999996	0.1456349917357895
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.0021768739999999996	0.1456349917357895
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.0021768739999999996	0.1456349917357895
8Q12 MICRODUPLICATION SYNDROME	0.0021768739999999996	0.1456349917357895
FRONTOOCULAR SYNDROME	0.0021768739999999996	0.1456349917357895
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.0021768739999999996	0.1456349917357895
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.0021768739999999996	0.1456349917357895
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.0021768739999999996	0.1456349917357895
JOUBERT SYNDROME 1	0.0021768739999999996	0.1456349917357895
OROFACIODIGITAL SYNDROME TYPE 1	0.00163132	0.10913689755053724
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00163132	0.10913689755053724
DUANE-RADIAL RAY SYNDROME; DRRS	0.00163132	0.10913689755053724
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.00163132	0.10913689755053724
KEIPERT SYNDROME	0.00163132	0.10913689755053724
MOMO SYNDROME	0.00163132	0.10913689755053724
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00163132	0.10913689755053724
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.00163132	0.10913689755053724
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00163132	0.10913689755053724
OROFACIAL CLEFT 15	0.00163132	0.10913689755053724
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.00163132	0.10913689755053724
PTERYGIUM COLLI, ISOLATED	0.00163132	0.10913689755053724
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00163132	0.10913689755053724
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00163132	0.10913689755053724
20Q13.33 MICRODELETION SYNDROME	0.00163132	0.10913689755053724
NOONAN SYNDROME 8; NS8	0.00163132	0.10913689755053724
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.00163132	0.10913689755053724
ACRO-RENAL-OCULAR SYNDROME	0.00163132	0.10913689755053724
SUMMITT SYNDROME	0.00163132	0.10913689755053724
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00163132	0.10913689755053724
ATELOSTEOGENESIS TYPE II	0.00163132	0.10913689755053724
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00163132	0.10913689755053724
STICKLER SYNDROME	0.00163132	0.10913689755053724
NEUROFACIODIGITORENAL SYNDROME	0.00163132	0.10913689755053724
AUTOSOMAL AGAMMAGLOBULINEMIA	0.00163132	0.10913689755053724
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00163132	0.10913689755053724
ACROCALLOSAL SYNDROME; ACLS	0.00163132	0.10913689755053724
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.00163132	0.10913689755053724
JOUBERT SYNDROME 3; JBTS3	0.00163132	0.10913689755053724
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00163132	0.10913689755053724
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00163132	0.10913689755053724
LAURENCE-MOON SYNDROME	0.00163132	0.10913689755053724
MILROY DISEASE	0.00163132	0.10913689755053724
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.00163132	0.10913689755053724
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00163132	0.10913689755053724
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00163132	0.10913689755053724
POTOCKI-SHAFFER SYNDROME	0.00163132	0.10913689755053724
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00163132	0.10913689755053724
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00163132	0.10913689755053724
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00163132	0.10913689755053724
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00163132	0.10913689755053724
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.00163132	0.10913689755053724
NOONAN SYNDROME 4; NS4	0.00163132	0.10913689755053724
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.00163132	0.10913689755053724
PROGEROID SYNDROME, PETTY TYPE	0.00163132	0.10913689755053724
HYPOTONIA-CYSTINURIA SYNDROME	0.00163132	0.10913689755053724
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.00163132	0.10913689755053724
ZUNICH NEUROECTODERMAL SYNDROME	0.00163132	0.10913689755053724
SCARF SYNDROME	0.00163132	0.10913689755053724
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00163132	0.10913689755053724
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.00163132	0.10913689755053724
EPICANTHUS	0.00163132	0.10913689755053724
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.00163132	0.10913689755053724
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00163132	0.10913689755053724
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.00163132	0.10913689755053724
MOEBIUS SYNDROME	0.00163132	0.10913689755053724
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.00163132	0.10913689755053724
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00163132	0.10913689755053724
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.00163132	0.10913689755053724
CHIME SYNDROME	0.00163132	0.10913689755053724
FRONTONASAL DYSPLASIA 1; FND1	0.00163132	0.10913689755053724
CHROMOSOME 13Q14 DELETION SYNDROME	0.00163132	0.10913689755053724
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00163132	0.10913689755053724
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00163132	0.10913689755053724
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.00163132	0.10913689755053724
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.00163132	0.10913689755053724
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.00163132	0.10913689755053724
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.00163132	0.10913689755053724
PHAVER SYNDROME	0.00163132	0.10913689755053724
3Q13 MICRODELETION SYNDROME	0.00163132	0.10913689755053724
OHDO SYNDROME	0.00163132	0.10913689755053724
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00163132	0.10913689755053724
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00163132	0.10913689755053724
DEAFNESS-HYPOGONADISM SYNDROME	0.00163132	0.10913689755053724
OROFACIODIGITAL SYNDROME IV; OFD4	0.00163132	0.10913689755053724
OMODYSPLASIA 1; OMOD1	0.00163132	0.10913689755053724
BALLER-GEROLD SYNDROME	0.00163132	0.10913689755053724
PFEIFFER-PALM-TELLER SYNDROME	0.00163132	0.10913689755053724
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00163132	0.10913689755053724
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00163132	0.10913689755053724
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.00163132	0.10913689755053724
FRAXE INTELLECTUAL DISABILITY	0.00163132	0.10913689755053724
HYPOGLOSSIA-HYPODACTYLIA	0.00163132	0.10913689755053724
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00163132	0.10913689755053724
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.00163132	0.10913689755053724
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00163132	0.10913689755053724
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.00163132	0.10913689755053724
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00163132	0.10913689755053724
ABRUZZO-ERICKSON SYNDROME	0.00163132	0.10913689755053724
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.00163132	0.10913689755053724
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00163132	0.10913689755053724
GORLIN SYNDROME	0.00163132	0.10913689755053724
FRONTORHINY	0.00163132	0.10913689755053724
CRANIOECTODERMAL DYSPLASIA	0.00163132	0.10913689755053724
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00163132	0.10913689755053724
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00163132	0.10913689755053724
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00163132	0.10913689755053724
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.00163132	0.10913689755053724
BRADDOCK SYNDROME	0.00163132	0.10913689755053724
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.00163132	0.10913689755053724
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.00163132	0.10913689755053724
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.00163132	0.10913689755053724
SIFRIM-HITZ-WEISS SYNDROME	0.00163132	0.10913689755053724
BRITTLE CORNEA SYNDROME	0.00163132	0.10913689755053724
HENNEKAM SYNDROME	0.00163132	0.10913689755053724
PENOSCROTAL TRANSPOSITION	0.00163132	0.10913689755053724
8Q21.11 MICRODELETION SYNDROME	0.00163132	0.10913689755053724
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.00163132	0.10913689755053724
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00163132	0.10913689755053724
MECKEL SYNDROME, TYPE 10; MKS10	0.00163132	0.10913689755053724
ACRODYSOSTOSIS	0.00163132	0.10913689755053724
SCHOLTE SYNDROME; SHLTS	0.00163132	0.10913689755053724
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.00163132	0.10913689755053724
FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE	0.00163132	0.10913689755053724
RENAL AGENESIS, BILATERAL	0.00163132	0.10913689755053724
PFEIFFER-PALM-TELLER SYNDROME	0.00163132	0.10913689755053724
JUBERG-MARSIDI SYNDROME	0.00163132	0.10913689755053724
HYPERTELORISM AND TETRALOGY OF FALLOT	0.00163132	0.10913689755053724
URBAN-ROGERS-MEYER SYNDROME	0.00163132	0.10913689755053724
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00163132	0.10913689755053724
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.00163132	0.10913689755053724
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00163132	0.10913689755053724
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00163132	0.10913689755053724
SILLENCE SYNDROME	0.00163132	0.10913689755053724
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.00163132	0.10913689755053724
FETAL VALPROATE SYNDROME	0.00163132	0.10913689755053724
MOSAIC TRISOMY 9	0.001301984	0.08710399824708742
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.001301984	0.08710399824708742
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.001301984	0.08710399824708742
BETA-UREIDOPROPIONASE DEFICIENCY	0.001301984	0.08710399824708742
15Q14 MICRODELETION SYNDROME	0.001301984	0.08710399824708742
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001301984	0.08710399824708742
PETERS PLUS SYNDROME	0.001301984	0.08710399824708742
ADAMS-OLIVER SYNDROME 3; AOS3	0.001301984	0.08710399824708742
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001301984	0.08710399824708742
GENITOPATELLAR SYNDROME; GTPTS	0.001301984	0.08710399824708742
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.001301984	0.08710399824708742
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001301984	0.08710399824708742
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.001301984	0.08710399824708742
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.001301984	0.08710399824708742
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.001301984	0.08710399824708742
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.001301984	0.08710399824708742
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001301984	0.08710399824708742
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001301984	0.08710399824708742
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.001301984	0.08710399824708742
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.001301984	0.08710399824708742
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.001301984	0.08710399824708742
MIETENS SYNDROME	0.001301984	0.08710399824708742
GLASS SYNDROME	0.001301984	0.08710399824708742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.001301984	0.08710399824708742
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001301984	0.08710399824708742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001301984	0.08710399824708742
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001301984	0.08710399824708742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.001301984	0.08710399824708742
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.001301984	0.08710399824708742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001301984	0.08710399824708742
XQ28 (MECP2) DUPLICATION	0.001301984	0.08710399824708742
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.001301984	0.08710399824708742
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.001301984	0.08710399824708742
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.001301984	0.08710399824708742
ADAMS-OLIVER SYNDROME 1; AOS1	0.001301984	0.08710399824708742
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001301984	0.08710399824708742
HOLOPROSENCEPHALY 2; HPE2	0.001301984	0.08710399824708742
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.001301984	0.08710399824708742
ROBERTS SYNDROME	0.001301984	0.08710399824708742
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001301984	0.08710399824708742
RUVALCABA SYNDROME	0.001301984	0.08710399824708742
TOWNES-BROCKS SYNDROME 1; TBS1	0.001301984	0.08710399824708742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001301984	0.08710399824708742
16P13.11 MICRODELETION SYNDROME	0.001301984	0.08710399824708742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.001301984	0.08710399824708742
ALG11-CDG	0.001301984	0.08710399824708742
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001301984	0.08710399824708742
CONGENITAL VARICELLA SYNDROME	0.001301984	0.08710399824708742
MEVALONIC ACIDURIA	0.001301984	0.08710399824708742
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001301984	0.08710399824708742
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.001301984	0.08710399824708742
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.001301984	0.08710399824708742
COG4-CDG	0.001301984	0.08710399824708742
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.001301984	0.08710399824708742
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001301984	0.08710399824708742
MEVALONIC ACIDURIA; MEVA	0.001301984	0.08710399824708742
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.001301984	0.08710399824708742
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.001301984	0.08710399824708742
MYHRE SYNDROME	0.001301984	0.08710399824708742
ALAZAMI SYNDROME; ALAZS	0.001301984	0.08710399824708742
DUPLICATION OF THE PITUITARY GLAND	0.001301984	0.08710399824708742
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.001301984	0.08710399824708742
LISSENCEPHALY 4	0.001301984	0.08710399824708742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.001301984	0.08710399824708742
MARINESCO-SJÖGREN SYNDROME	0.001301984	0.08710399824708742
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001301984	0.08710399824708742
HOLOPROSENCEPHALY 3; HPE3	0.001301984	0.08710399824708742
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001301984	0.08710399824708742
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001301984	0.08710399824708742
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.001301984	0.08710399824708742
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001301984	0.08710399824708742
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001301984	0.08710399824708742
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.001301984	0.08710399824708742
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.001301984	0.08710399824708742
SAY-BARBER-MILLER SYNDROME	0.001301984	0.08710399824708742
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001301984	0.08710399824708742
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.001301984	0.08710399824708742
ADAMS-OLIVER SYNDROME 2; AOS2	0.001301984	0.08710399824708742
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.001301984	0.08710399824708742
FORSYTHE-WAKELING SYNDROME; FWS	0.001301984	0.08710399824708742
TRISOMY 17P	0.001301984	0.08710399824708742
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.001301984	0.08710399824708742
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.001301984	0.08710399824708742
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001301984	0.08710399824708742
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.001301984	0.08710399824708742
LIG4 SYNDROME	0.001301984	0.08710399824708742
CHROMOSOME 19P13.13 DELETION SYNDROME	0.001301984	0.08710399824708742
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.001301984	0.08710399824708742
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001301984	0.08710399824708742
KBG SYNDROME	0.001301984	0.08710399824708742
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.001301984	0.08710399824708742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.001301984	0.08710399824708742
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001301984	0.08710399824708742
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.001301984	0.08710399824708742
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.001301984	0.08710399824708742
CLASSIC PHENYLKETONURIA	0.001301984	0.08710399824708742
KABUKI SYNDROME 1	0.001301984	0.08710399824708742
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.001301984	0.08710399824708742
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001301984	0.08710399824708742
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001301984	0.08710399824708742
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.001301984	0.08710399824708742
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.001301984	0.08710399824708742
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.001301984	0.08710399824708742
BRESEK SYNDROME	0.001301984	0.08710399824708742
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.001301984	0.08710399824708742
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001301984	0.08710399824708742
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.001301984	0.08710399824708742
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.001301984	0.08710399824708742
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001301984	0.08710399824708742
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.001301984	0.08710399824708742
8Q22.1 MICRODELETION SYNDROME	0.001301984	0.08710399824708742
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.001301984	0.08710399824708742
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.001301984	0.08710399824708742
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001301984	0.08710399824708742
%300712 CRANIOFACIOSKELETAL SYNDROME	0.001301984	0.08710399824708742
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001301984	0.08710399824708742
OROFACIODIGITAL SYNDROME TYPE 14	0.001301984	0.08710399824708742
KLEEFSTRA SYNDROME 2; KLEFS2	0.001301984	0.08710399824708742
17P11.2 MICRODUPLICATION SYNDROME	0.001301984	0.08710399824708742
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001301984	0.08710399824708742
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.001301984	0.08710399824708742
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.001301984	0.08710399824708742
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.001301984	0.08710399824708742
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.001301984	0.08710399824708742
CHROMOSOME 1P35 DELETION SYNDROME	0.001301984	0.08710399824708742
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001301984	0.08710399824708742
MACDERMOT-WINTER SYNDROME	0.001301984	0.08710399824708742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.001301984	0.08710399824708742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.001301984	0.08710399824708742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.001301984	0.08710399824708742
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.001301984	0.08710399824708742
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.001301984	0.08710399824708742
LISSENCEPHALY 8; LIS8	0.001301984	0.08710399824708742
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001301984	0.08710399824708742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.001301984	0.08710399824708742
GENITOPATELLAR SYNDROME	0.001301984	0.08710399824708742
DYSTONIA 28, CHILDHOOD-ONSET	0.001301984	0.08710399824708742
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.001301984	0.08710399824708742
MENTAL RETARDATION, X-LINKED 106; MRX106	0.001301984	0.08710399824708742
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.001301984	0.08710399824708742
OPTIC ATROPHY 11; OPA11	0.001301984	0.08710399824708742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.001301984	0.08710399824708742
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.001301984	0.08710399824708742
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.001301984	0.08710399824708742
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.001301984	0.08710399824708742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001301984	0.08710399824708742
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001301984	0.08710399824708742
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001301984	0.08710399824708742
HOLOPROSENCEPHALY 1; HPE1	0.001301984	0.08710399824708742
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.001301984	0.08710399824708742
TONNE-KALSCHEUER SYNDROME; TOKAS	0.001301984	0.08710399824708742
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.001301984	0.08710399824708742
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.001301984	0.08710399824708742
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.001301984	0.08710399824708742
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001301984	0.08710399824708742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001301984	0.08710399824708742
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.001301984	0.08710399824708742
JABERI-ELAHI SYNDROME; JABELS	0.001301984	0.08710399824708742
GALLOWAY-MOWAT SYNDROME	0.001301984	0.08710399824708742
GALACTOSEMIA	0.001301984	0.08710399824708742
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001301984	0.08710399824708742
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.001301984	0.08710399824708742
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.001301984	0.08710399824708742
MUCOLIPIDOSIS IV; ML4	0.001301984	0.08710399824708742
17Q11.2 MICRODUPLICATION SYNDROME	0.001301984	0.08710399824708742
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001301984	0.08710399824708742
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001301984	0.08710399824708742
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.001301984	0.08710399824708742
WALKER-WARBURG SYNDROME	0.001301984	0.08710399824708742
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001301984	0.08710399824708742
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.001301984	0.08710399824708742
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.001301984	0.08710399824708742
SSR4-CDG	0.001301984	0.08710399824708742
STT3B-CDG	0.001301984	0.08710399824708742
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.001301984	0.08710399824708742
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.001301984	0.08710399824708742
STT3A-CDG	0.001301984	0.08710399824708742
2Q37 MICRODELETION SYNDROME	0.001301984	0.08710399824708742
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001301984	0.08710399824708742
LISSENCEPHALY 2; LIS2	0.001301984	0.08710399824708742
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.001301984	0.08710399824708742
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.001301984	0.08710399824708742
OROFACIODIGITAL SYNDROME IX; OFD9	0.001301984	0.08710399824708742
PENTASOMY X	0.001301984	0.08710399824708742
RAINE SYNDROME	0.001301984	0.08710399824708742
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.001301984	0.08710399824708742
TURNPENNY-FRY SYNDROME; TPFS	0.001301984	0.08710399824708742
SLC35A2-CDG	0.001301984	0.08710399824708742
DPAGT1-CDG	0.001301984	0.08710399824708742
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.001301984	0.08710399824708742
MEHMO SYNDROME; MEHMO	0.001301984	0.08710399824708742
MARINESCO-SJOGREN SYNDROME; MSS	0.001301984	0.08710399824708742
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001301984	0.08710399824708742
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001301984	0.08710399824708742
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.001301984	0.08710399824708742
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.001301984	0.08710399824708742
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.001301984	0.08710399824708742
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001301984	0.08710399824708742
CONGENITAL TOXOPLASMOSIS	0.001301984	0.08710399824708742
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.001301984	0.08710399824708742
DISTAL MONOSOMY 15Q	0.001301984	0.08710399824708742
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001301984	0.08710399824708742
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001301984	0.08710399824708742
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001301984	0.08710399824708742
CRANIOTELENCEPHALIC DYSPLASIA	0.001301984	0.08710399824708742
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.001301984	0.08710399824708742
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001301984	0.08710399824708742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001301984	0.08710399824708742
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001301984	0.08710399824708742
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.001301984	0.08710399824708742
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001301984	0.08710399824708742
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.001301984	0.08710399824708742
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.001301984	0.08710399824708742
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.001301984	0.08710399824708742
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.001301984	0.08710399824708742
OROFACIODIGITAL SYNDROME XIV; OFD14	0.001301984	0.08710399824708742
AL-RAQAD SYNDROME; ARS	0.001301984	0.08710399824708742
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001301984	0.08710399824708742
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.001301984	0.08710399824708742
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.001301984	0.08710399824708742
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.001301984	0.08710399824708742
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.001301984	0.08710399824708742
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001301984	0.08710399824708742
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.001301984	0.08710399824708742
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.001301984	0.08710399824708742
TRISOMY 9P	0.001301984	0.08710399824708742
CRANIOSYNOSTOSIS 6; CRS6	0.001301984	0.08710399824708742
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.001301984	0.08710399824708742
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.001301984	0.08710399824708742
FILIPPI SYNDROME	0.001301984	0.08710399824708742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.001301984	0.08710399824708742
DUANE RETRACTION SYNDROME	0.001301984	0.08710399824708742
ROIFMAN SYNDROME; RFMN	0.001301984	0.08710399824708742
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.001301984	0.08710399824708742
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.001301984	0.08710399824708742
WIEACKER-WOLFF SYNDROME	0.001301984	0.08710399824708742
ALG1-CDG	0.001301984	0.08710399824708742
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001301984	0.08710399824708742
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001301984	0.08710399824708742
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.001301984	0.08710399824708742
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.001301984	0.08710399824708742
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.001301984	0.08710399824708742
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.001301984	0.08710399824708742
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001301984	0.08710399824708742
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001301984	0.08710399824708742
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.001301984	0.08710399824708742
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001301984	0.08710399824708742
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.001301984	0.08710399824708742
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.001301984	0.08710399824708742
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.001301984	0.08710399824708742
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.001301984	0.08710399824708742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001301984	0.08710399824708742
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.001301984	0.08710399824708742
MICRO SYNDROME	0.001301984	0.08710399824708742
MARDEN-WALKER SYNDROME	0.001301984	0.08710399824708742
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.001301984	0.08710399824708742
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.001301984	0.08710399824708742
MICROPHTHALMIA, SYNDROMIC 3	0.001301984	0.08710399824708742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001301984	0.08710399824708742
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001301984	0.08710399824708742
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.001301984	0.08710399824708742
WHITE-SUTTON SYNDROME; WHSUS	0.001301984	0.08710399824708742
2Q32Q33 MICRODELETION SYNDROME	0.001301984	0.08710399824708742
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.001301984	0.08710399824708742
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001301984	0.08710399824708742
LOWRY-MACLEAN SYNDROME	0.001301984	0.08710399824708742
3Q29 MICRODUPLICATION SYNDROME	0.001301984	0.08710399824708742
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001301984	0.08710399824708742
CEREBELLOFACIODENTAL SYNDROME	0.001301984	0.08710399824708742
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001301984	0.08710399824708742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.001301984	0.08710399824708742
COFFIN-SIRIS SYNDROME 5	0.001301984	0.08710399824708742
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.001301984	0.08710399824708742
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.001301984	0.08710399824708742
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001301984	0.08710399824708742
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.001301984	0.08710399824708742
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.001301984	0.08710399824708742
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.001301984	0.08710399824708742
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.001301984	0.08710399824708742
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001301984	0.08710399824708742
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001301984	0.08710399824708742
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001301984	0.08710399824708742
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.001301984	0.08710399824708742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.001301984	0.08710399824708742
SECKEL SYNDROME 8; SCKL8	0.001301984	0.08710399824708742
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.001301984	0.08710399824708742
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001301984	0.08710399824708742
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.001301984	0.08710399824708742
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.001301984	0.08710399824708742
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001301984	0.08710399824708742
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.001301984	0.08710399824708742
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.001301984	0.08710399824708742
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.001301984	0.08710399824708742
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.001301984	0.08710399824708742
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.001301984	0.08710399824708742
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001301984	0.08710399824708742
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.001301984	0.08710399824708742
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.001301984	0.08710399824708742
HYPERTRICHOSIS CUBITI	0.001301984	0.08710399824708742
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001301984	0.08710399824708742
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.001301984	0.08710399824708742
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.001301984	0.08710399824708742
ALG3-CDG	0.001301984	0.08710399824708742
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.001301984	0.08710399824708742
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.001301984	0.08710399824708742
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.001301984	0.08710399824708742
HOYERAAL-HREIDARSSON SYNDROME	0.001301984	0.08710399824708742
PELIZAEUS-MERZBACHER DISEASE	0.001301984	0.08710399824708742
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.001301984	0.08710399824708742
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.001301984	0.08710399824708742
KLIPPEL-TRÉNAUNAY SYNDROME	0.00075643	0.05060590406183513
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00075643	0.05060590406183513
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.00075643	0.05060590406183513
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.00075643	0.05060590406183513
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00075643	0.05060590406183513
WAARDENBURG SYNDROME TYPE 3	0.00075643	0.05060590406183513
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.00075643	0.05060590406183513
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.00075643	0.05060590406183513
ERMINE PHENOTYPE	0.00075643	0.05060590406183513
PRIMARY CUTIS VERTICIS GYRATA	0.00075643	0.05060590406183513
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00075643	0.05060590406183513
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00075643	0.05060590406183513
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00075643	0.05060590406183513
MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA, SAUL-WILSON TYPE	0.00075643	0.05060590406183513
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00075643	0.05060590406183513
ROIFMAN SYNDROME	0.00075643	0.05060590406183513
MMEP SYNDROME	0.00075643	0.05060590406183513
MECKEL SYNDROME	0.00075643	0.05060590406183513
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.00075643	0.05060590406183513
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.00075643	0.05060590406183513
CAMOS SYNDROME	0.00075643	0.05060590406183513
MICROPHTHALMIA, LENZ TYPE	0.00075643	0.05060590406183513
RENIER-GABREELS-JASPER SYNDROME	0.00075643	0.05060590406183513
WEAVER-WILLIAMS SYNDROME	0.00075643	0.05060590406183513
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.00075643	0.05060590406183513
STIMMLER SYNDROME	0.00075643	0.05060590406183513
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.00075643	0.05060590406183513
ERYTHROKERATODERMIA VARIABILIS	0.00075643	0.05060590406183513
PAGOD SYNDROME	0.00075643	0.05060590406183513
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.00075643	0.05060590406183513
ACROCRANIOFACIAL DYSOSTOSIS	0.00075643	0.05060590406183513
HOLOPROSENCEPHALY-RADIAL HEART RENAL ANOMALIES SYNDROME	0.00075643	0.05060590406183513
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.00075643	0.05060590406183513
TETRAPLOIDY	0.00075643	0.05060590406183513
WORSTER-DROUGHT SYNDROME	0.00075643	0.05060590406183513
ANGELMAN SYNDROME	0.00075643	0.05060590406183513
SJÖGREN-LARSSON SYNDROME	0.00075643	0.05060590406183513
9Q33.3Q34.11 MICRODELETION SYNDROME	0.00075643	0.05060590406183513
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00075643	0.05060590406183513
OCULOAURICULOFRONTONASAL SYNDROME	0.00075643	0.05060590406183513
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00075643	0.05060590406183513
SATOYOSHI SYNDROME	0.00075643	0.05060590406183513
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.00075643	0.05060590406183513
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00075643	0.05060590406183513
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00075643	0.05060590406183513
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.00075643	0.05060590406183513
SCHISIS ASSOCIATION	0.00075643	0.05060590406183513
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00075643	0.05060590406183513
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.00075643	0.05060590406183513
HUMERO-RADIAL SYNOSTOSIS	0.00075643	0.05060590406183513
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.00075643	0.05060590406183513
XK APROSENCEPHALY SYNDROME	0.00075643	0.05060590406183513
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO ZNF335 DEFICIENCY	0.00075643	0.05060590406183513
WAGR SYNDROME	0.00075643	0.05060590406183513
WOLF-HIRSCHHORN SYNDROME	0.00075643	0.05060590406183513
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.00075643	0.05060590406183513
SECKEL SYNDROME 10; SCKL10	0.00075643	0.05060590406183513
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.00075643	0.05060590406183513
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00075643	0.05060590406183513
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00075643	0.05060590406183513
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00075643	0.05060590406183513
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00075643	0.05060590406183513
VERVERI-BRADY SYNDROME; VERBRAS	0.00075643	0.05060590406183513
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00075643	0.05060590406183513
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.00075643	0.05060590406183513
MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23	0.00075643	0.05060590406183513
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.00075643	0.05060590406183513
FRONTONASAL DYSPLASIA 2; FND2	0.00075643	0.05060590406183513
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.00075643	0.05060590406183513
PHENYLKETONURIA	0.00075643	0.05060590406183513
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.00075643	0.05060590406183513
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00075643	0.05060590406183513
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.00075643	0.05060590406183513
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.00075643	0.05060590406183513
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00075643	0.05060590406183513
OCULOPALATOCEREBRAL SYNDROME	0.00075643	0.05060590406183513
RHIZOMELIC SYNDROME	0.00075643	0.05060590406183513
ROBERTS SYNDROME; RBS	0.00075643	0.05060590406183513
IMMUNODEFICIENCY 55; IMD55	0.00075643	0.05060590406183513
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00075643	0.05060590406183513
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.00075643	0.05060590406183513
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00075643	0.05060590406183513
MENTAL RETARDATION, X-LINKED 63	0.00075643	0.05060590406183513
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.00075643	0.05060590406183513
MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18	0.00075643	0.05060590406183513
DE SANCTIS-CACCHIONE SYNDROME	0.00075643	0.05060590406183513
MEIER-GORLIN SYNDROME 8; MGORS8	0.00075643	0.05060590406183513
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00075643	0.05060590406183513
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00075643	0.05060590406183513
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00075643	0.05060590406183513
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00075643	0.05060590406183513
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00075643	0.05060590406183513
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.00075643	0.05060590406183513
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.00075643	0.05060590406183513
SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY	0.00075643	0.05060590406183513
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.00075643	0.05060590406183513
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00075643	0.05060590406183513
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.00075643	0.05060590406183513
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.00075643	0.05060590406183513
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.00075643	0.05060590406183513
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00075643	0.05060590406183513
FEINGOLD SYNDROME	0.00075643	0.05060590406183513
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.05060590406183513
APHALANGY-SYNDACTYLY-MICROCEPHALY SYNDROME	0.00075643	0.05060590406183513
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00075643	0.05060590406183513
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.00075643	0.05060590406183513
BARTSOCAS-PAPAS SYNDROME	0.00075643	0.05060590406183513
BLOOM SYNDROME	0.00075643	0.05060590406183513
BONNEMANN-MEINECKE-REICH SYNDROME	0.00075643	0.05060590406183513
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.00075643	0.05060590406183513
SYMMETRICAL THALAMIC CALCIFICATIONS	0.00075643	0.05060590406183513
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00075643	0.05060590406183513
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.00075643	0.05060590406183513
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.00075643	0.05060590406183513
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.00075643	0.05060590406183513
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00075643	0.05060590406183513
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.00075643	0.05060590406183513
CEREBROCOSTOMANDIBULAR SYNDROME	0.00075643	0.05060590406183513
OTOMANDIBULAR SYNDROME	0.00075643	0.05060590406183513
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00075643	0.05060590406183513
ANONYCHIA-MICROCEPHALY SYNDROME	0.00075643	0.05060590406183513
HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	0.00075643	0.05060590406183513
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.00075643	0.05060590406183513
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.00075643	0.05060590406183513
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.00075643	0.05060590406183513
NIJMEGEN BREAKAGE SYNDROME	0.00075643	0.05060590406183513
PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12	0.00075643	0.05060590406183513
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.00075643	0.05060590406183513
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00075643	0.05060590406183513
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00075643	0.05060590406183513
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00075643	0.05060590406183513
MICROCEPHALY-CARDIOMYOPATHY	0.00075643	0.05060590406183513
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.00075643	0.05060590406183513
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.00075643	0.05060590406183513
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00075643	0.05060590406183513
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00075643	0.05060590406183513
LAMBOTTE SYNDROME	0.00075643	0.05060590406183513
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00075643	0.05060590406183513
JOHANSON-BLIZZARD SYNDROME; JBS	0.00075643	0.05060590406183513
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.05060590406183513
STROMME SYNDROME; STROMS	0.00075643	0.05060590406183513
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00075643	0.05060590406183513
CHROMOSOME XP11.3 DELETION SYNDROME	0.00075643	0.05060590406183513
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00075643	0.05060590406183513
GERODERMA OSTEODYSPLASTICUM; GO	0.00075643	0.05060590406183513
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00075643	0.05060590406183513
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00075643	0.05060590406183513
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.00075643	0.05060590406183513
LISSENCEPHALY 3; LIS3	0.00075643	0.05060590406183513
MECKEL SYNDROME, TYPE 4; MKS4	0.00075643	0.05060590406183513
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.00075643	0.05060590406183513
XFE PROGEROID SYNDROME; XFEPS	0.00075643	0.05060590406183513
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.00075643	0.05060590406183513
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00075643	0.05060590406183513
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.00075643	0.05060590406183513
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00075643	0.05060590406183513
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00075643	0.05060590406183513
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.00075643	0.05060590406183513
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00075643	0.05060590406183513
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.00075643	0.05060590406183513
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00075643	0.05060590406183513
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00075643	0.05060590406183513
GAUCHER DISEASE, PERINATAL LETHAL	0.00075643	0.05060590406183513
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00075643	0.05060590406183513
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00075643	0.05060590406183513
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.00075643	0.05060590406183513
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.00075643	0.05060590406183513
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00075643	0.05060590406183513
SECKEL SYNDROME 5; SCKL5	0.00075643	0.05060590406183513
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.00075643	0.05060590406183513
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00075643	0.05060590406183513
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.00075643	0.05060590406183513
SECKEL SYNDROME 4	0.00075643	0.05060590406183513
MEIER-GORLIN SYNDROME 2; MGORS2	0.00075643	0.05060590406183513
MEIER-GORLIN SYNDROME 3; MGORS3	0.00075643	0.05060590406183513
FACIOCARDIOMELIC SYNDROME	0.00075643	0.05060590406183513
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	0.00075643	0.05060590406183513
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00075643	0.05060590406183513
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00075643	0.05060590406183513
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00075643	0.05060590406183513
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.00075643	0.05060590406183513
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00075643	0.05060590406183513
PERRAULT SYNDROME 3	0.00075643	0.05060590406183513
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.00075643	0.05060590406183513
FEINGOLD SYNDROME 2; FGLDS2	0.00075643	0.05060590406183513
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00075643	0.05060590406183513
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00075643	0.05060590406183513
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.00075643	0.05060590406183513
NEU-LAXOVA SYNDROME 2; NLS2	0.00075643	0.05060590406183513
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.00075643	0.05060590406183513
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.00075643	0.05060590406183513
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00075643	0.05060590406183513
INCONTINENTIA PIGMENTI; IP	0.00075643	0.05060590406183513
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.00075643	0.05060590406183513
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00075643	0.05060590406183513
FOCAL DERMAL HYPOPLASIA; FDH	0.00075643	0.05060590406183513
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.00075643	0.05060590406183513
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.00075643	0.05060590406183513
AICARDI SYNDROME; AIC	0.00075643	0.05060590406183513
MASA SYNDROME	0.00075643	0.05060590406183513
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.00075643	0.05060590406183513
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.00075643	0.05060590406183513
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.00075643	0.05060590406183513
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.00075643	0.05060590406183513
BARDET-BIEDL SYNDROME 20	0.00075643	0.05060590406183513
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.00075643	0.05060590406183513
MENTAL RETARDATION, X-LINKED 102	0.00075643	0.05060590406183513
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.00075643	0.05060590406183513
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00075643	0.05060590406183513
KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	0.00075643	0.05060590406183513
MEIER-GORLIN SYNDROME 6; MGORS6	0.00075643	0.05060590406183513
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.00075643	0.05060590406183513
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00075643	0.05060590406183513
MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12	0.00075643	0.05060590406183513
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00075643	0.05060590406183513
MECKEL SYNDROME 12; MKS12	0.00075643	0.05060590406183513
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00075643	0.05060590406183513
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00075643	0.05060590406183513
601453 TRICHODENTAL DYSPLASIA	0.00075643	0.05060590406183513
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.00075643	0.05060590406183513
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00075643	0.05060590406183513
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.00075643	0.05060590406183513
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.00075643	0.05060590406183513
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.00075643	0.05060590406183513
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.00075643	0.05060590406183513
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.00075643	0.05060590406183513
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.00075643	0.05060590406183513
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00075643	0.05060590406183513
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.00075643	0.05060590406183513
CYCLIC VOMITING SYNDROME	0.00075643	0.05060590406183513
PAINE SYNDROME	0.00075643	0.05060590406183513
RING CHROMOSOME 1 SYNDROME	0.00075643	0.05060590406183513
PSEUDOTRISOMY 13 SYNDROME	0.00075643	0.05060590406183513
HYPERREFLEXIA	0.00075643	0.05060590406183513
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00075643	0.05060590406183513
CHARGE SYNDROME	0.00075643	0.05060590406183513
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00075643	0.05060590406183513
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.00075643	0.05060590406183513
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00075643	0.05060590406183513
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.00075643	0.05060590406183513
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.00075643	0.05060590406183513
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00075643	0.05060590406183513
MICROCEPHALY-ALBINISM-DIGITAL ANOMALIES SYNDROME	0.00075643	0.05060590406183513
19Q13.11 MICRODELETION SYNDROME	0.00075643	0.05060590406183513
TRIGLYCERIDE STORAGE DISEASE, TYPE I	0.00075643	0.05060590406183513
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.00075643	0.05060590406183513
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00075643	0.05060590406183513
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.00075643	0.05060590406183513
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00075643	0.05060590406183513
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.00075643	0.05060590406183513
HARROD SYNDROME	0.00075643	0.05060590406183513
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.00075643	0.05060590406183513
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.00075643	0.05060590406183513
FRASER SYNDROME	0.00075643	0.05060590406183513
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.05060590406183513
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.00075643	0.05060590406183513
FRYNS-SMEETS-THIRY SYNDROME	0.00075643	0.05060590406183513
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00075643	0.05060590406183513
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00075643	0.05060590406183513
BRANCHIOOCULOFACIAL SYNDROME	0.00075643	0.05060590406183513
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.00075643	0.05060590406183513
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00075643	0.05060590406183513
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.00075643	0.05060590406183513
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.00075643	0.05060590406183513
TYROSINEMIA TYPE 2	0.00075643	0.05060590406183513
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00075643	0.05060590406183513
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.00075643	0.05060590406183513
VELOCARDIOFACIAL SYNDROME	0.00075643	0.05060590406183513
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.00075643	0.05060590406183513
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.00075643	0.05060590406183513
JOHNSON NEUROECTODERMAL SYNDROME	0.00075643	0.05060590406183513
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00075643	0.05060590406183513
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.00075643	0.05060590406183513
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.00075643	0.05060590406183513
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00075643	0.05060590406183513
LARYNGEAL ABDUCTOR PARALYSIS	0.00075643	0.05060590406183513
JOHANSON-BLIZZARD SYNDROME	0.00075643	0.05060590406183513
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00075643	0.05060590406183513
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00075643	0.05060590406183513
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.00075643	0.05060590406183513
207790 ARACHNOID CYSTS, INTRACRANIAL	0.00075643	0.05060590406183513
JUBERG-HAYWARD SYNDROME	0.00075643	0.05060590406183513
JUNG SYNDROME	0.00075643	0.05060590406183513
KABUKI SYNDROME	0.00075643	0.05060590406183513
SANJAD-SAKATI SYNDROME	0.00075643	0.05060590406183513
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00075643	0.05060590406183513
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00075643	0.05060590406183513
BOWEN-CONRADI SYNDROME	0.00075643	0.05060590406183513
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.00075643	0.05060590406183513
BANGSTAD SYNDROME	0.00075643	0.05060590406183513
HYPO- AND HYPERMELANOTIC CUTANEOUS MACULES-RETARDED GROWTH-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.05060590406183513
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.00075643	0.05060590406183513
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.00075643	0.05060590406183513
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.00075643	0.05060590406183513
ACHALASIA-MICROCEPHALY SYNDROME	0.00075643	0.05060590406183513
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.00075643	0.05060590406183513
5Q35 MICRODUPLICATION SYNDROME	0.00075643	0.05060590406183513
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.00075643	0.05060590406183513
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00075643	0.05060590406183513
LARYNGEAL ABDUCTOR PARALYSIS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.05060590406183513
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.00075643	0.05060590406183513
MICROFORM HOLOPROSENCEPHALY	0.00075643	0.05060590406183513
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00075643	0.05060590406183513
MOYNAHAN SYNDROME	0.00075643	0.05060590406183513
GENITOPALATOCARDIAC SYNDROME	0.00075643	0.05060590406183513
SUPRABULBAR PARESIS, CONGENITAL	0.00075643	0.05060590406183513
RUVALCABA SYNDROME	0.00075643	0.05060590406183513
ISOLATED OSTEOPOIKILOSIS	0.00075643	0.05060590406183513
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.00075643	0.05060590406183513
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.00075643	0.05060590406183513
ANGELMAN SYNDROME (TYPE 1)	0.00075643	0.05060590406183513
CERNUNNOS-XLF DEFICIENCY	0.00075643	0.05060590406183513
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00075643	0.05060590406183513
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.00075643	0.05060590406183513
NON-DISTAL TRISOMY 10Q	0.00075643	0.05060590406183513
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00075643	0.05060590406183513
DISTAL TRISOMY 15Q	0.00075643	0.05060590406183513
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00075643	0.05060590406183513
PSEUDOPROGERIA SYNDROME	0.00075643	0.05060590406183513
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00075643	0.05060590406183513
GROWTH HORMONE INSENSITIVITY SYNDROME	0.00075643	0.05060590406183513
LEUKOCYTE ADHESION DEFICIENCY	0.00075643	0.05060590406183513
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00075643	0.05060590406183513
RENAL TUBULAR DYSGENESIS	0.00075643	0.05060590406183513
ENCEPHALOMALACIA, MULTILOCULAR	0.00075643	0.05060590406183513
DISTAL MONOSOMY 13Q	0.00075643	0.05060590406183513
FANCONI ANEMIA	0.00075643	0.05060590406183513
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.00075643	0.05060590406183513
CRI DU CHAT SYNDROME (5P DELETION)	0.00075643	0.05060590406183513
CRANIOFRONTONASAL DYSPLASIA	0.00075643	0.05060590406183513
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.00075643	0.05060590406183513
ANE SYNDROME	0.00075643	0.05060590406183513
DISTAL MONOSOMY 17Q	0.00075643	0.05060590406183513
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.00075643	0.05060590406183513
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00075643	0.05060590406183513
MILLER-DIEKER SYNDROME (MDS)	0.00075643	0.05060590406183513
COG5-CDG	0.00075643	0.05060590406183513
DISTAL MONOSOMY 7Q36	0.00075643	0.05060590406183513
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00075643	0.05060590406183513
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.00075643	0.05060590406183513
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.00075643	0.05060590406183513
NEU-LAXOVA SYNDROME	0.00075643	0.05060590406183513
ANGELMAN SYNDROME (TYPE 2)	0.00075643	0.05060590406183513
ATAXIA-PANCYTOPENIA SYNDROME	0.00075643	0.05060590406183513
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.00075643	0.05060590406183513
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00075643	0.05060590406183513
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.00075643	0.05060590406183513
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.00075643	0.05060590406183513
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00075643	0.05060590406183513
CONGENITAL RUBELLA SYNDROME	0.00075643	0.05060590406183513
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.00075643	0.05060590406183513
DIABETIC EMBRYOPATHY	0.00075643	0.05060590406183513
FETAL METHYLMERCURY SYNDROME	0.00075643	0.05060590406183513
1Q21.1 RECURRENT MICRODELETION (SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.00075643	0.05060590406183513
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.00075643	0.05060590406183513
FAMILIAL VISCERAL MYOPATHY	0.00075643	0.05060590406183513
SEVERE COMBINED IMMUNODEFICIENCY	0.00075643	0.05060590406183513
POLAND SYNDROME	0.00075643	0.05060590406183513
KERATOSIS FOLLICULARIS-DWARFISM-CEREBRAL ATROPHY SYNDROME	0.00075643	0.05060590406183513
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.00075643	0.05060590406183513
LOWRY-WOOD SYNDROME	0.00075643	0.05060590406183513
2P15-16.1 MICRODELETION SYNDROME	0.00075643	0.05060590406183513
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00075643	0.05060590406183513
OLIVER SYNDROME	0.00075643	0.05060590406183513
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.000545554	0.03649809418525231
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.000545554	0.03649809418525231
PHACE ASSOCIATION	0.000545554	0.03649809418525231
HURLER SYNDROME	0.000545554	0.03649809418525231
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.03649809418525231
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.000545554	0.03649809418525231
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.03649809418525231
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.03649809418525231
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000545554	0.03649809418525231
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000545554	0.03649809418525231
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000545554	0.03649809418525231
ALG6-CDG	0.000545554	0.03649809418525231
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.03649809418525231
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.000545554	0.03649809418525231
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.03649809418525231
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000545554	0.03649809418525231
NOONAN SYNDROME 2; NS2	0.000545554	0.03649809418525231
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.000545554	0.03649809418525231
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.000545554	0.03649809418525231
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.03649809418525231
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.03649809418525231
CHAR SYNDROME	0.000545554	0.03649809418525231
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.03649809418525231
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.03649809418525231
CURRY-JONES SYNDROME	0.000545554	0.03649809418525231
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000545554	0.03649809418525231
GRACILE BONE DYSPLASIA; GCLEB	0.000545554	0.03649809418525231
PELGER-HUET ANOMALY; PHA	0.000545554	0.03649809418525231
CDAGS SYNDROME	0.000545554	0.03649809418525231
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.03649809418525231
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.03649809418525231
PERMANENT NEONATAL DIABETES MELLITUS	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000545554	0.03649809418525231
JOUBERT SYNDROME 7	0.000545554	0.03649809418525231
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.03649809418525231
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.03649809418525231
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.03649809418525231
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.000545554	0.03649809418525231
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.03649809418525231
611961 STEVENSON-CAREY SYNDROME	0.000545554	0.03649809418525231
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.000545554	0.03649809418525231
8P23.1 DUPLICATION SYNDROME	0.000545554	0.03649809418525231
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000545554	0.03649809418525231
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.03649809418525231
JOUBERT SYNDROME 8	0.000545554	0.03649809418525231
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000545554	0.03649809418525231
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000545554	0.03649809418525231
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.03649809418525231
TRANSIENT NEONATAL DIABETES MELLITUS	0.000545554	0.03649809418525231
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.03649809418525231
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.03649809418525231
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.000545554	0.03649809418525231
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.000545554	0.03649809418525231
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000545554	0.03649809418525231
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000545554	0.03649809418525231
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000545554	0.03649809418525231
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.03649809418525231
GABA-TRANSAMINASE DEFICIENCY	0.000545554	0.03649809418525231
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.03649809418525231
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.000545554	0.03649809418525231
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000545554	0.03649809418525231
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.03649809418525231
HOLOPROSENCEPHALY 7	0.000545554	0.03649809418525231
NIEMANN-PICK DISEASE, TYPE C2	0.000545554	0.03649809418525231
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.000545554	0.03649809418525231
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.000545554	0.03649809418525231
JOUBERT SYNDROME 2	0.000545554	0.03649809418525231
KAGAMI-OGATA SYNDROME	0.000545554	0.03649809418525231
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.03649809418525231
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.03649809418525231
INFANTILE REFSUM DISEASE	0.000545554	0.03649809418525231
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.03649809418525231
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.03649809418525231
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000545554	0.03649809418525231
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.03649809418525231
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.03649809418525231
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.000545554	0.03649809418525231
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.03649809418525231
FRIAS SYNDROME	0.000545554	0.03649809418525231
PALLISTER-HALL SYNDROME	0.000545554	0.03649809418525231
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.03649809418525231
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.000545554	0.03649809418525231
WOLMAN DISEASE	0.000545554	0.03649809418525231
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.03649809418525231
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.000545554	0.03649809418525231
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000545554	0.03649809418525231
PRADER-WILLI SYNDROME; PWS	0.000545554	0.03649809418525231
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000545554	0.03649809418525231
JOUBERT SYNDROME 6	0.000545554	0.03649809418525231
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000545554	0.03649809418525231
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.000545554	0.03649809418525231
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.03649809418525231
CURRARINO SYNDROME	0.000545554	0.03649809418525231
HEREDITARY FOLATE MALABSORPTION	0.000545554	0.03649809418525231
ELEJALDE DISEASE	0.000545554	0.03649809418525231
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.03649809418525231
NIEMANN-PICK DISEASE, TYPE A	0.000545554	0.03649809418525231
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.03649809418525231
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000545554	0.03649809418525231
TEMTAMY SYNDROME; TEMTYS	0.000545554	0.03649809418525231
OROTIC ACIDURIA	0.000545554	0.03649809418525231
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.03649809418525231
DISTAL MONOSOMY 19P13.3	0.000545554	0.03649809418525231
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.03649809418525231
PELLAGRA-LIKE SYNDROME	0.000545554	0.03649809418525231
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.03649809418525231
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.03649809418525231
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.03649809418525231
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.000545554	0.03649809418525231
RITSCHER-SCHINZEL SYNDROME 1	0.000545554	0.03649809418525231
COACH SYNDROME	0.000545554	0.03649809418525231
RECOMBINANT 8 SYNDROME	0.000545554	0.03649809418525231
ARGININEMIA	0.000545554	0.03649809418525231
GRISCELLI SYNDROME, TYPE 1	0.000545554	0.03649809418525231
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.03649809418525231
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.03649809418525231
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000545554	0.03649809418525231
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.03649809418525231
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.03649809418525231
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.03649809418525231
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.03649809418525231
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.000545554	0.03649809418525231
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000545554	0.03649809418525231
SIALIDOSIS TYPE 2	0.000545554	0.03649809418525231
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.000545554	0.03649809418525231
THYROID HYPOPLASIA	0.000545554	0.03649809418525231
SULFOCYSTEINURIA	0.000545554	0.03649809418525231
HURLER SYNDROME	0.000545554	0.03649809418525231
SPINOCEREBELLAR ATAXIA TYPE 7	0.000545554	0.03649809418525231
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.03649809418525231
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.03649809418525231
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.000545554	0.03649809418525231
HARTNUP DISORDER	0.000545554	0.03649809418525231
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.000545554	0.03649809418525231
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.03649809418525231
PITUITARY STALK INTERRUPTION SYNDROME	0.000545554	0.03649809418525231
HYPERPROLINEMIA, TYPE I	0.000545554	0.03649809418525231
THYROID ECTOPIA	0.000545554	0.03649809418525231
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.000545554	0.03649809418525231
ATHYREOSIS	0.000545554	0.03649809418525231
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.000545554	0.03649809418525231
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.000545554	0.03649809418525231
ARIMA SYNDROME	0.000545554	0.03649809418525231
ABLEPHARON MACROSTOMIA SYNDROME	0.000545554	0.03649809418525231
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.03649809418525231
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.03649809418525231
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.03649809418525231
RICHARDS-RUNDLE SYNDROME; RRNS	0.000545554	0.03649809418525231
KETOADIPICACIDURIA	0.000545554	0.03649809418525231
FAMILIAL THYROID DYSHORMONOGENESIS	0.000545554	0.03649809418525231
LANDAU-KLEFFNER SYNDROME	0.000545554	0.03649809418525231
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.03649809418525231
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000545554	0.03649809418525231
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.000545554	0.03649809418525231
PFEIFFER SYNDROME TYPE 2	0.000545554	0.03649809418525231
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.03649809418525231
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.03649809418525231
THYROID HEMIAGENESIS	0.000545554	0.03649809418525231
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.03649809418525231
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000545554	0.03649809418525231
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.03649809418525231
WAISMAN SYNDROME; WSMN	0.000545554	0.03649809418525231
ALSTROM SYNDROME; ALMS	0.000545554	0.03649809418525231
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000545554	0.03649809418525231
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.03649809418525231
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.03649809418525231
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000545554	0.03649809418525231
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.000545554	0.03649809418525231
SHUKLA-VERNON SYNDROME; SHUVER	0.000545554	0.03649809418525231
GAUCHER DISEASE, TYPE II	0.000545554	0.03649809418525231
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.03649809418525231
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.03649809418525231
SYNDROMIC DIARRHEA	0.000545554	0.03649809418525231
CRANIOFRONTONASAL SYNDROME; CFNS	0.000545554	0.03649809418525231
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.03649809418525231
MENTAL RETARDATION, X-LINKED 9	0.000545554	0.03649809418525231
TARP SYNDROME; TARPS	0.000545554	0.03649809418525231
MENTAL RETARDATION, X-LINKED 104; MRX104	0.000545554	0.03649809418525231
SPINOCEREBELLAR ATAXIA TYPE 13	0.000545554	0.03649809418525231
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000545554	0.03649809418525231
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000545554	0.03649809418525231
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.03649809418525231
CODAS SYNDROME	0.000545554	0.03649809418525231
SEPTOOPTIC DYSPLASIA	0.000545554	0.03649809418525231
SCHIZENCEPHALY	0.000545554	0.03649809418525231
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.03649809418525231
CHROMOSOME 2Q37 DELETION SYNDROME	0.000545554	0.03649809418525231
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.03649809418525231
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.03649809418525231
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000545554	0.03649809418525231
TIMOTHY SYNDROME; TS	0.000545554	0.03649809418525231
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.03649809418525231
KEUTEL SYNDROME	0.000545554	0.03649809418525231
MENTAL RETARDATION, X-LINKED 103	0.000545554	0.03649809418525231
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.03649809418525231
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.03649809418525231
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.03649809418525231
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000545554	0.03649809418525231
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000545554	0.03649809418525231
AUSTRALIA ANTIGEN	0.000545554	0.03649809418525231
WAARDENBURG-SHAH SYNDROME	0.000545554	0.03649809418525231
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.03649809418525231
ZEBRA BODY MYOPATHY	0.000545554	0.03649809418525231
TREACHER-COLLINS SYNDROME	0.000545554	0.03649809418525231
RIGID SPINE SYNDROME	0.000545554	0.03649809418525231
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000545554	0.03649809418525231
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.03649809418525231
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.000545554	0.03649809418525231
RAYNAUD-CLAES SYNDROME; MRXSRC	0.000545554	0.03649809418525231
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.000545554	0.03649809418525231
MENTAL RETARDATION, X-LINKED 72	0.000545554	0.03649809418525231
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.03649809418525231
ARGININOSUCCINIC ACIDURIA	0.000545554	0.03649809418525231
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.000545554	0.03649809418525231
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.03649809418525231
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.000545554	0.03649809418525231
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.03649809418525231
MENTAL RETARDATION, X-LINKED 41	0.000545554	0.03649809418525231
MENTAL RETARDATION, X-LINKED 90	0.000545554	0.03649809418525231
MENTAL RETARDATION, X-LINKED 88	0.000545554	0.03649809418525231
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.03649809418525231
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000545554	0.03649809418525231
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.03649809418525231
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.03649809418525231
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000545554	0.03649809418525231
MEND SYNDROME; MEND	0.000545554	0.03649809418525231
ROIFMAN-CHITAYAT SYNDROME	0.000545554	0.03649809418525231
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.03649809418525231
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.03649809418525231
NOONAN SYNDROME 11; NS11	0.000545554	0.03649809418525231
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.000545554	0.03649809418525231
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.03649809418525231
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.03649809418525231
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000545554	0.03649809418525231
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.03649809418525231
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.000545554	0.03649809418525231
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000545554	0.03649809418525231
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.000545554	0.03649809418525231
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000545554	0.03649809418525231
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.000545554	0.03649809418525231
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.03649809418525231
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.000545554	0.03649809418525231
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.03649809418525231
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000545554	0.03649809418525231
POPOV-CHANG SYNDROME; POPCHAS	0.000545554	0.03649809418525231
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.000545554	0.03649809418525231
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.000545554	0.03649809418525231
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000545554	0.03649809418525231
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.03649809418525231
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000545554	0.03649809418525231
TRANSALDOLASE DEFICIENCY	0.000545554	0.03649809418525231
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.000545554	0.03649809418525231
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.03649809418525231
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.03649809418525231
FUCOSIDOSIS	0.000545554	0.03649809418525231
PROPIONIC ACIDEMIA	0.000545554	0.03649809418525231
ISOLATED PLAGIOCEPHALY	0.000545554	0.03649809418525231
DEXTROCARDIA	0.000545554	0.03649809418525231
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.000545554	0.03649809418525231
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.000545554	0.03649809418525231
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.000545554	0.03649809418525231
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.03649809418525231
MULTIPLE CARBOXYLASE DEFICIENCY	0.000545554	0.03649809418525231
CINCA SYNDROME	0.000545554	0.03649809418525231
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.03649809418525231
XQ21 MICRODELETION SYNDROME	0.000545554	0.03649809418525231
AURICULOCONDYLAR SYNDROME	0.000545554	0.03649809418525231
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.000545554	0.03649809418525231
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.000545554	0.03649809418525231
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.03649809418525231
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.000545554	0.03649809418525231
CONGENITAL DISORDER OF GLYCOSYLATION	0.000545554	0.03649809418525231
AYMÉ-GRIPP SYNDROME	0.000545554	0.03649809418525231
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.000545554	0.03649809418525231
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.000545554	0.03649809418525231
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.000545554	0.03649809418525231
COFFIN-SIRIS SYNDROME 7; CSS7	0.000545554	0.03649809418525231
HYPEREKPLEXIA 4; HKPX4	0.000545554	0.03649809418525231
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.000545554	0.03649809418525231
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.000545554	0.03649809418525231
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.000545554	0.03649809418525231
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.03649809418525231
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.000545554	0.03649809418525231
DYSTONIA-APHONIA SYNDROME	0.000545554	0.03649809418525231
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.000545554	0.03649809418525231
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.000545554	0.03649809418525231
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.000545554	0.03649809418525231
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.000545554	0.03649809418525231
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000545554	0.03649809418525231
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.000545554	0.03649809418525231
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.03649809418525231
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.03649809418525231
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.03649809418525231
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.000545554	0.03649809418525231
MEND SYNDROME	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.000545554	0.03649809418525231
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.000545554	0.03649809418525231
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000545554	0.03649809418525231
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.03649809418525231
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000545554	0.03649809418525231
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.03649809418525231
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.000545554	0.03649809418525231
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.000545554	0.03649809418525231
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.000545554	0.03649809418525231
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000545554	0.03649809418525231
PRADER-WILLI-LIKE SYNDROME	0.000545554	0.03649809418525231
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.000545554	0.03649809418525231
JOUBERT SYNDROME 35; JBTS35	0.000545554	0.03649809418525231
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.000545554	0.03649809418525231
SAUL-WILSON SYNDROME; SWILS	0.000545554	0.03649809418525231
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.03649809418525231
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.03649809418525231
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.03649809418525231
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.03649809418525231
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.03649809418525231
MOSAIC TRISOMY 14	0.000545554	0.03649809418525231
DISTAL TRISOMY 18Q	0.000545554	0.03649809418525231
TRISOMY 8Q	0.000545554	0.03649809418525231
OCULOFACIOCARDIODENTAL SYNDROME	0.000545554	0.03649809418525231
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.03649809418525231
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000545554	0.03649809418525231
OTOFACIOCERVICAL SYNDROME	0.000545554	0.03649809418525231
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.03649809418525231
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.03649809418525231
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.000545554	0.03649809418525231
OROFACIODIGITAL SYNDROME TYPE 2	0.000545554	0.03649809418525231
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.03649809418525231
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.000545554	0.03649809418525231
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.03649809418525231
WILSON-TURNER SYNDROME	0.000545554	0.03649809418525231
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.03649809418525231
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.03649809418525231
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.03649809418525231
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.03649809418525231
17Q12 MICRODELETION SYNDROME	0.000545554	0.03649809418525231
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.03649809418525231
DISTAL 16P11.2 MICRODELETION SYNDROME	0.000545554	0.03649809418525231
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.000545554	0.03649809418525231
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.03649809418525231
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.03649809418525231
W SYNDROME	0.000545554	0.03649809418525231
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.000545554	0.03649809418525231
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.03649809418525231
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.000545554	0.03649809418525231
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.000545554	0.03649809418525231
HEREDITARY OROTIC ACIDURIA	0.000545554	0.03649809418525231
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.000545554	0.03649809418525231
1P21.3 MICRODELETION SYNDROME	0.000545554	0.03649809418525231
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.03649809418525231
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.03649809418525231
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.03649809418525231
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.03649809418525231
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000545554	0.03649809418525231
TARP SYNDROME	0.000545554	0.03649809418525231
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.000545554	0.03649809418525231
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.000545554	0.03649809418525231
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.03649809418525231
SEVERE CANAVAN DISEASE	0.000545554	0.03649809418525231
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.03649809418525231
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.000545554	0.03649809418525231
SENIOR-LOKEN SYNDROME	0.000545554	0.03649809418525231
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.000545554	0.03649809418525231
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.03649809418525231
1Q21.1 MICRODUPLICATION SYNDROME	0.000545554	0.03649809418525231
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.000545554	0.03649809418525231
ARTERIAL TORTUOSITY SYNDROME	0.000545554	0.03649809418525231
DONNAI-BARROW SYNDROME	0.000545554	0.03649809418525231
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.000545554	0.03649809418525231
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.03649809418525231
HARTNUP DISEASE	0.000545554	0.03649809418525231
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.000545554	0.03649809418525231
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.000545554	0.03649809418525231
SPINOCEREBELLAR ATAXIA TYPE 29	0.000545554	0.03649809418525231
GERODERMA OSTEODYSPLASTICA	0.000545554	0.03649809418525231
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.03649809418525231
COLE-CARPENTER SYNDROME	0.000545554	0.03649809418525231
FLOATING-HARBOR SYNDROME	0.000545554	0.03649809418525231
COWDEN SYNDROME	0.000545554	0.03649809418525231
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.000545554	0.03649809418525231
ADULT-ONSET DYSTONIA-PARKINSONISM	0.000545554	0.03649809418525231
EAST SYNDROME	0.000545554	0.03649809418525231
WEAVER SYNDROME	0.000545554	0.03649809418525231
EARLY MYOCLONIC ENCEPHALOPATHY	0.000545554	0.03649809418525231
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.03649809418525231
ACROMELIC FRONTONASAL DYSPLASIA	0.000545554	0.03649809418525231
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.000545554	0.03649809418525231
ZECHI-CEIDE SYNDROME	0.000545554	0.03649809418525231
CITRULLINEMIA TYPE II	0.000545554	0.03649809418525231
FARBER DISEASE	0.000545554	0.03649809418525231
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.03649809418525231
CENTRAL BILATERAL MACROGYRIA	0.000545554	0.03649809418525231
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.000545554	0.03649809418525231
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.03649809418525231
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.03649809418525231
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.000545554	0.03649809418525231
USHER SYNDROME TYPE 1	0.000545554	0.03649809418525231
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.000545554	0.03649809418525231
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.000545554	0.03649809418525231
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.03649809418525231
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.000545554	0.03649809418525231
PERIPHERAL HYPOTHYROIDISM	0.000545554	0.03649809418525231
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.000545554	0.03649809418525231
PRIMARY CONGENITAL HYPOTHYROIDISM	0.000545554	0.03649809418525231
PERMANENT CONGENITAL HYPOTHYROIDISM	0.000545554	0.03649809418525231
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.03649809418525231
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.03649809418525231
NEPHROGENIC DIABETES INSIPIDUS	0.000545554	0.03649809418525231
17P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.03649809418525231
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.03649809418525231
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.03649809418525231
LEBER CONGENITAL AMAUROSIS	0.000545554	0.03649809418525231
SCHAAF-YANG SYNDROME; SHFYNG	0.000545554	0.03649809418525231
XIA-GIBBS SYNDROME	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.03649809418525231
IMMUNODEFICIENCY 23; IMD23	0.000545554	0.03649809418525231
MAPLE SYRUP URINE DISEASE	0.000545554	0.03649809418525231
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000545554	0.03649809418525231
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.03649809418525231
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000545554	0.03649809418525231
JOUBERT SYNDROME 21	0.000545554	0.03649809418525231
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000545554	0.03649809418525231
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.03649809418525231
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.03649809418525231
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.000545554	0.03649809418525231
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000545554	0.03649809418525231
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.03649809418525231
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.03649809418525231
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000545554	0.03649809418525231
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000545554	0.03649809418525231
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.03649809418525231
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.000545554	0.03649809418525231
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.000545554	0.03649809418525231
CULLER-JONES SYNDROME; CJS	0.000545554	0.03649809418525231
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000545554	0.03649809418525231
HELSMOORTEL-VAN DER AA SYNDROME	0.000545554	0.03649809418525231
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.03649809418525231
CATEL-MANZKE SYNDROME; CATMANS	0.000545554	0.03649809418525231
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000545554	0.03649809418525231
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.03649809418525231
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.03649809418525231
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000545554	0.03649809418525231
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000545554	0.03649809418525231
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.000545554	0.03649809418525231
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.03649809418525231
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.03649809418525231
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.03649809418525231
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.03649809418525231
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.03649809418525231
BARDET-BIEDL SYNDROME 2	0.000545554	0.03649809418525231
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000545554	0.03649809418525231
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.03649809418525231
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000545554	0.03649809418525231
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.03649809418525231
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.03649809418525231
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.000545554	0.03649809418525231
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000545554	0.03649809418525231
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.03649809418525231
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.03649809418525231
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000545554	0.03649809418525231
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.03649809418525231
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000545554	0.03649809418525231
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.03649809418525231
MEDULLOBLASTOMA	0.000545554	0.03649809418525231
NETHERTON SYNDROME	0.000545554	0.03649809418525231
STEEL SYNDROME; STLS	0.000545554	0.03649809418525231
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.03649809418525231
ALSTRÖM SYNDROME	0.000545554	0.03649809418525231
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000545554	0.03649809418525231
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.03649809418525231
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.03649809418525231
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.000545554	0.03649809418525231
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.03649809418525231
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.03649809418525231
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.03649809418525231
JOUBERT SYNDROME 15	0.000545554	0.03649809418525231
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.000545554	0.03649809418525231
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.000545554	0.03649809418525231
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.03649809418525231
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000545554	0.03649809418525231
WYBURN-MASON SYNDROME	0.000545554	0.03649809418525231
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.03649809418525231
CRANIOPHARYNGIOMA	0.000545554	0.03649809418525231
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.000545554	0.03649809418525231
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000545554	0.03649809418525231
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.03649809418525231
PEROXISOME BIOGENESIS DISORDER 6B	0.000545554	0.03649809418525231
PEROXISOME BIOGENESIS DISORDER 5B	0.000545554	0.03649809418525231
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000545554	0.03649809418525231
ATELOSTEOGENESIS TYPE III	0.000545554	0.03649809418525231
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000545554	0.03649809418525231
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.03649809418525231
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000545554	0.03649809418525231
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.000545554	0.03649809418525231
PONTINE TEGMENTAL CAP DYSPLASIA	0.000545554	0.03649809418525231
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.03649809418525231
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.000545554	0.03649809418525231
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.000545554	0.03649809418525231
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000545554	0.03649809418525231
HAREL-YOON SYNDROME; HAYOS	0.000545554	0.03649809418525231
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.03649809418525231
IMMUNODEFICIENCY 49; IMD49	0.000545554	0.03649809418525231
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.000545554	0.03649809418525231
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000545554	0.03649809418525231
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.000545554	0.03649809418525231
SHASHI-PENA SYNDROME; SHAPNS	0.000545554	0.03649809418525231
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.000545554	0.03649809418525231
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.03649809418525231
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.000545554	0.03649809418525231
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.03649809418525231
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000545554	0.03649809418525231
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.000545554	0.03649809418525231
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.03649809418525231
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000545554	0.03649809418525231
JOUBERT SYNDROME 28	0.000545554	0.03649809418525231
JOUBERT SYNDROME 27	0.000545554	0.03649809418525231
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000545554	0.03649809418525231
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.000545554	0.03649809418525231
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.03649809418525231
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.000545554	0.03649809418525231
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.03649809418525231
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.03649809418525231
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000545554	0.03649809418525231
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.000545554	0.03649809418525231
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.000545554	0.03649809418525231
JOUBERT SYNDROME 30; JBTS30	0.000545554	0.03649809418525231
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000545554	0.03649809418525231
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.03649809418525231
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000545554	0.03649809418525231
MECKEL SYNDROME 13; MKS13	0.000545554	0.03649809418525231
SOTOS SYNDROME	0.000545554	0.03649809418525231
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.03649809418525231
RAHMAN SYNDROME	0.000545554	0.03649809418525231
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000545554	0.03649809418525231
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.000545554	0.03649809418525231
20Q11.2 MICRODELETION SYNDROME	0.000545554	0.03649809418525231
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.000545554	0.03649809418525231
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000545554	0.03649809418525231
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000545554	0.03649809418525231
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.000545554	0.03649809418525231
MIRAGE SYNDROME; MIRAGE	0.000545554	0.03649809418525231
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.000545554	0.03649809418525231
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.000545554	0.03649809418525231
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.000545554	0.03649809418525231
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.03649809418525231
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000545554	0.03649809418525231
SENIOR-LOKEN SYNDROME 9	0.000545554	0.03649809418525231
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.03649809418525231
AU-KLINE SYNDROME; AUKS	0.000545554	0.03649809418525231
NOONAN SYNDROME 9; NS9	0.000545554	0.03649809418525231
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.000545554	0.03649809418525231
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.03649809418525231
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.03649809418525231
TRANSKETOLASE DEFICIENCY	0.000545554	0.03649809418525231
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.03649809418525231
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.000545554	0.03649809418525231
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000545554	0.03649809418525231
CHOPS SYNDROME; CHOPS	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.000545554	0.03649809418525231
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.03649809418525231
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.03649809418525231
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.03649809418525231
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.000545554	0.03649809418525231
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.000545554	0.03649809418525231
CHAR SYNDROME	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000545554	0.03649809418525231
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000545554	0.03649809418525231
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000545554	0.03649809418525231
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000545554	0.03649809418525231
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000545554	0.03649809418525231
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.03649809418525231
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.03649809418525231
CHROMOSOME 16P13.2 DELETION SYNDROME	0.000545554	0.03649809418525231
LUSCAN-LUMISH SYNDROME; LLS	0.000545554	0.03649809418525231
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.03649809418525231
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000545554	0.03649809418525231
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.03649809418525231
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.000545554	0.03649809418525231
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.000545554	0.03649809418525231
JOUBERT SYNDROME 26	0.000545554	0.03649809418525231
JOUBERT SYNDROME 25	0.000545554	0.03649809418525231
GABRIELE-DE VRIES SYNDROME; GADEVS	0.000545554	0.03649809418525231
